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CHAPTER 1 
INTRODUCTION 
Myocardial ischaemia results from a supply-demand imbalance between 
coronary blood flow and myocardial metabolic requirements leading to 
a cascade of events that alters all functions of the myocardium. 1 The 
sequence of events during myocardial ischaemia begins with 
mal distribution of the coronary blood flow between territories supplied 
by the stenotic and non stenotic coronary arteries. This is followed by 
left ventricular (LV) diastolic dysfunction and regional wall motion 
abnormalities.2-4 The latest events are ischaemic electrocardiographic 
(ECG) changes and angina.2,3 Several studies2.5 suggested that the 
impairment of LV diastolic function precedes the development of 
systolic dysfunction and that changes in diastolic parameters may be 
considered the earliest indicators of myocardial ischaemia. Because of 
these observations there is a clinical interest in investigating regional as 
well as global LV performance and to consider both systolic and 
diastolic function. 
Advanced degrees of coronary arterial obstruction may exist without 
signs of myocardial ischaemia or underperfusion at rest.6 Manifestations 
of myocardial ischaemia can be provoked by a variety of stimuli. 
Provocative stress tests can be divided into two groups according to their 
influence on the pathophysiological mechanism of ischaemia: (a) stress 
modalities that induce or enhance maldistribution of myocardial blood 
flow and therefore diminish the coronary flow to an area supplied by a 
stenotic coronary artery "coronary steal". These include pharmacologic 
coronary vasodilators such as dipyridamole 7 and adenosine8 or 
vasopressors such as ergonovine; and (b) stress modalities that primarily 
increase myocardial oxygen demand by increasing heart rate and 
contractility. These include physical exercise;·l1 rapid atrial pacing,'2 
mental stress,13 cold pressor test,14 and inotropic agents. These include 
isoproterenol,15 dopamine,'6 dobutamine17 and more recently 
arbutarnine.'8 Among several non-exercise stress modalities dobutantine 
and dipyridamole are the most commonly used pharmacologic stress 
agents in conjunction with myocardial perfusion scintigraphy, 
echocardiography and Doppler in the diagnosis and prognosis of patients 
with coronary artery disease (CAD)Y·19,20 There is evidence from 
experimental2I and clinical22 studies that dobutamine is more effective 
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in precipitating myocardial dysfunction than dipyridamole and is well 
suited for imaging modalities that rely on functional assessment of CAD. 
The presence of CAD is identifiable on the basis of anatomic 
narrowing of coronary arteries, and the noninvasive detection of stress-
induced markers of myocardial ischaemia. The later include ECG 
changes compatible with ischaemia, scintigraphic perfusion defects, 
regional wall motion abnormalities or global systolic and diastolic 
abnormalities. Coronary angiography accurately identifies the presence 
of anatomic narrowing of coronary arteries, but may fail to predict the 
functional consequences.23,24 Exercise ECG has a well established value 
for the diagnosis and prognosis of patients with CAD. However, the 
limited sensitivity and specificity and the inability of the exercise ECG 
to provide accurate assessment of the localization, extent and severity of 
the jeopardized myocardium have led to its combination with cardiac 
imaging techniques.25 Myocardial perfusion scintigraphy and radionuclide 
ventriculography are well established techniques for the identification of 
perfusion defects, wall motion abnormalities and changes in global LV 
systolic and diastolic function during different forms of stress.26.27 The 
use of radionuclide techniques requires the use of a radioisotope and the 
availability of a gamma camera and is relatively expensive for routine 
use. When factors such as biological hazards, ease of use, applicability 
during or immediately after stress and costs of installation and 
maintenance are taken into account, echo-Doppler may be the most 
cost-effective technique.28 Echocardiographic techniques used with 
exercise and non-exercise stress protocols have been shown to provide 
information regarding the presence, severity and distribution of CAD 
with a comparable sensitivity and specificity to radionuclide 
techniques.29-31 Doppler techniques offer alternative and complementary 
indicators of ischaemic impairment of both systolic and diastolic global 
LV function and has been validated against other invasive and non-
invasive techniques.l2-34 Abnormalities of Doppler-derived parameters of 
either systolic or diastolic LV performance in response to physiologic 
and pharmacologic interventions have been described in few studies. 
These studies suggested that Doppler examination might be an useful 
adjunct to stress testing for the identification of patients with 
CAD .19.20.35.36 
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Studies presented in this thesis: 
In Chapter 1 an introduction of the thesis is presented. 
In chapter 2 the general methodology used in this research is 
described. The pharmacological effects of dobutarnine and the rationale 
of its use as a stress agent; methods of assessment of LV wall motion by 
echocardiography; and methods of Doppler assessment of LV systolic 
and diastolic function and the physiologic and pathologic factors that 
influence Doppler parameters are presented in Chapter 2. 
In chapter 3 the advantages of adding atropine to dobutarnine to 
perform stress echocardiography will be discussed. Beta blockers 
partially antagonize the chronotropic and inotropic effects of 
dobutamine. Withdrawal of beta blockers may be impractical in patients 
with CAD. To retain the inotropic effect of dobutamine, but to 
overcome the lack of chronotropic effect, we combined atropine with 
dobutarnine and assessed the safety and diagnostic accuracy of this 
combined pharmacologic stress test for detecting CAD. 
In chapter 4 the initial experience in the use of dobutarnine-atropine 
stress echocardiography for assessment of patients before and early after 
angioplasty is discussed. The effect of successful angioplasty has 
previously been assessed by exercise echocardiography:7 dipyridamole 
echocardiography,39 and perfusion scintigraphy.38 We used dobutamine 
stress echocardiography to assess the functional effect of the change in 
myocardial perfusion early after angioplasty. 
In chapters 5 and 6 Doppler-derived parameters of global LV systolic 
and diastolic function and their response to high dose dobutarnine is 
presented. Doppler parameters of LV ejection and filling have been 
used to detect ischaemia induced by dipyridamole, exercise or pacing 
stress tests.20,3S,36 Doppler reports on improvements in resting LV 
diastolic function early after angioplasty are conflicting.40•41 Studies on 
LV filling during exercise are impractical with echo-Doppler and have 
been limited to radionuclide angiography.42 We investigated Doppler 
parameters of LV ejection and filling dynamics in healthy subjects, 
patients with single vessel coronary disease and in patients with CAD 
before and after angioplasty; to assess the changes in Doppler-derived 
parameters of LV systolic and diastolic function induced by high dose 
dobutarnine-stress and their utility in detection of CAD. 
In chapter 7. Reproducibility is a major feature of a stress test that 
needs to be defined when using the test for assessing efficacy of 
therapeutic interventions. Inter- intra-observer and intertest variability 
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of dobutamine-atropine echocardiography testing with regard to time of 
onset of symptoms, hemodynamic parameters, LV wall motion 
abnormalities and ECG changes are presented in Chapter 7. 
In chapter 8. The use of the Doppler technique with dobutamine 
stress, as well as other interventions, is limited by the uncertainty as to 
whether a change induced by dobutamine is indeed significant or caused 
by measurement variability. We assessed the reproducibility of Doppler 
measurements of let ventricular filling during dobutamine stress in 
normal subjects and patients with CAD and estimated threshold values 
which can be used as a reference to detect significant changes in 
Doppler measurements from baseline to peak dobutamine in an 
individual patient. The results are presented in Chapter 8. 
In chapter 9 the general discussion, summary and conclusions of the 
studies are presented. The applications of dobu tamine stress 
echocardiography and Doppler in the diagnosis of CAD and assessment 
of coronary angioplasty; the limitations of the techniques; a review of the 
literature on the use of stress-Doppler in the evaluation of patients with 
CAD; and directions for future research are discussed. 
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CHAPTER 2 
METIIODOLOGY 
Dobutamine as a Pharmacologic Stress Agent 
Dobutamine is a synthetic catecholamine which originally developed as 
a selective inotropic drug,l However, when dobutamine is used in a high 
dose in patients with coronary artery disease (CAD), myocardial 
ischaemia may develop,2 
Mechanism of action: The effects of dobutamine are mediated by 
strong BI adrenergic receptor stimulation and mild stimulation of B2 and 
"I receptors,3 The relative inotropic selectiviry of dobutamine is 
mediated by both BI and "I with BI stimulation alone is responsible for 
its chronotropic effect,' The B2 mediated vasodilatation and "I mediated 
vasoconstriction effects in the peripheral vasculature are relatively 
balanced resulting in little net effect on systemic vasculature,2 
Haemodynamic responses: The haemodynamic effects of dobutamine 
correlate linearly with plasma concentration and dose,s,6 Intravenous 
infusion of dobutamine causes an increase in cardiac output mainly 
through an augmentation of ventricular contractility and a decrease in 
systemic vascular resistance largely due to reflex withdrawal of 
sympathetic tone secondary to the increase in cardiac output. I 
Tachycardia and mild increase of systolic pressure usually result when 
dobutamine is used in a high dose,6,7 
The haemodynamic alterations during dobutamine-induced ischaemia 
involve a decrease in stroke volume with no change in pulmonary wedge 
pressure,6 Dobutamine, as well as other BI adrenoceptor agonists, 
enhances left ventricular (LV) early diastolic distensibility by 
accelerating relaxation. This is mainly due to the BI mediated increase 
in intracellular cyclic adenosine 3',5'-monophosphate, which accelerates 
the rate of calcium re-uptake by the sarcoplasmic reticulum and thus 
stimulating the myocardial deactivation process,8,9 
Rationale for the use as a pharmacologic stress agent: The use of 
dobutamine as an "exercise simulator" for detection of functionally 
significant coronary stenosis is based on the concept that myocardial 
ischaemia results from increased myocardial oxygen demand,lO 
Dobutamine increases myocardial oxygen demand mainly by increasing 
heart rate (HR) rather than augmenting contractiIity,u Dobutamine-
8 
induced ischaemia may also results from maldistribution of coronary 
flow between endocardium and epicardium due to coronary 
vasodilatation.7 
Dobutamine stress protocol: Specific protocols vary with respect to 
precise dosage range and the timing of interval stages. Table I shows 
some of the commonly followed protocols for dobutamine stress testing. 
Table I Commonly used protocols for dobutamine stress testing 
Starting dose Maximum dose Interval stages 
(~g/kg/min) (~g/kg/min) (min) 
Mannering!2 (1988) 5 20 6·8 
Mazeika!3 (1992) 5 20 8 
Segar!4 (1992) 5 30 3 
SawadalS (1991) 25 30 3 
Pierard6 (1989) 5 40 5 
McNeill16 (1992) 10 40" 3 , 
--
At the Thoraxcentre we modified the dobutamine stress protocol by 
the addition of atropine.!6 This modification is based on the assumption 
that addition of atropine to dobutamine causes a significant increase in 
HR to overcome the poor chronotropic response observed in patients on 
B blocker therapyP 
The procedure of dobutamine stress testing presented in this thesis is as 
follows: 
Baseline recording of 12-lead electrocardiogram (ECG), cuff blood 
pressure and standard echo views; including parasternal long and short 
axes and apical four and two chamber views. 
- Baseline recordings of Doppler aortic and mitral flow. 
- Dobutamine was then administered intravenously using an infusion 
pump and a graded stress regimen of 10, 20, 30 and 40 /Lg/kg/minute 
at 3 minutes stages with the last stage for 6 minutes. Atropine (0.25 -
1 mg) was added, while continuing dobutamine, in patients without 
signs of ischemia (wall motion abnormalities [WMA], ST-changes or 
angina) who had not achieved 85% predicted maximum exercise HR 
during dobutamine alone. During the test the ECG and 
echocardiogram were continuously monitored. ECG was recorded each 
minute and cuff blood pressure every 3 minutes. Echo images were 
recorded on VHS video-tape during the last minute of stages 1 to 3, 
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and continuously for the last 4 minutes of stage 4 and 10 minutes after 
discontinuation of infusion. In the Doppler studies, aortic and mitral 
blood flow were recorded at peak dobutamine infusion. 
- Criteria to stop the test were, ST segment depression <: 2 mm 80 rns 
after the J point or ST elevation, severe angina, severe new WMA, 
significant arrhythmias, achievement of <: 85% predicted maximum 
HR, or any complication regarded as being due to dobutamine. 
Side effects: Major side effects during dobutamine stress testing include 
significant cardiac arrhythmias, hypotension, bradycardia, severe angina 
pectoris, and less commonly hypertensionY·,6.,8.,9 Other minor and less 
frequent side effects include chills, headache, and anxiety. Recently, we 
reported the side effects of dobutamine-atropine stress test in 652 
examinations.l8 Hypotension, defined as a decrease in systolic blood 
pressure of > 20 mmHg from baseline values, was the most frequent side 
effect (n = 34 examinations). Significant arrhythmias occurred in 24 
examinations; one patient had ventricular fibrillation (successfully 
resuscitated); 3 patients had sustained and 12 non-sustained ventricular 
tachycardia; and 8 patients had atrial fibrillation or atrial flutter. 
Echocardiographic techniques for the evaluation of CAD 
Echocardiographic techniques, at rest and during stress, have proven 
useful for the diagnosis and management of CAD.20 When regional and 
global as well as systolic and diastolic aspects of LV function are 
considered, several indicators can be obtained for detection of 
abnormalities induced by myocardial ischaemia?' 
Stress echocardiography for assessment of regional myocardial function 
The primary purpose of stress echocardiography is to detect transient 
LV WMA as a result of induced ischaemia. Such abnormalities can vary 
in degree from hypokinesia, through akinesia, up to dyskinesia.22 
Assessment of regional myocardial function can be achieved by 
recording and comparing LV wall motion at baseline, during, at peak, 
and after stress.23 In this situation, the standard parasternal long and 
short axis views and the apical four and two chamber views are recorded 
on videotape or captured digitally in a continuous loop format.24 Cine 
loop images allow side-by-side display of rest and stress images and 
images of slightly higher quality.23 This is particularly useful for exercise 
echocardiography, where respiratory artifacts interfere with image quality 
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and minimal acqUIsition time is mandatory to obtain adequate 
information. However, digital techniques may be less helpful during 
pharmacologic stress echocardiography, where image quality is less 
affected by hyperventilation. In our experience cine loop analysis of 
dobutamine echocardiography had no advantages for the interpretation 
of the images over the analysis from video tape.2S Therefore, we did not 
routinely use a continuous loop format for assessment of dobutarnine 
stress echocardiography. 
Regional wall motion can be analyzed using a qualitative, semi-
quantitative, or quantitative approach.26. A semi-quantitative analysis can 
be used by estimating a wall motion score and currently preferable to 
the existing wall motion quantitation algorithms.z6 In our studies, we 
used a 16-segment LV mode1.27 Using this approach, each myocardial 
segment is given a numerical score according to its wall motion as 
follows27: 1 = normal or hyperkinetic; 2 = hypokinetic; 3 = akinetic; 
and 4 = dyskinetic. A wall motion score index can then be calculated as 
the sum of score assigned to each segment divided by the number of 
segments.28 A score index of 1 implies normal motion in all segments, 
while higher score imply abnormality. 
Interpretation of wall motion analysis: Analysis of regional wall motion 
can identify the followini9-31: (1) the normal wall motion at rest which 
becomes hyperkinetic with increased systolic thickening and essentially 
normal diastolic dimensions in response to stress; (2) evidence of prior 
infarction with nonviable myocardium, defined as WMA that exist at rest 
and do not change in response to stress; (3) evidence of viable but 
dysfunctional myocardium (hibernating or stunned myocardium), defined 
as WMA that exist at rest but improve in response to a provocative 
manoeuvre (low-dose dobutamine); and (4) evidence of myocardial 
ischaemia, defined as the development of new WMA in an area which 
was normal at rest or worsening of WMA during or at peak stress in a 
segment which was abnormal at rest. 
Doppler assessment of LV systolic function 
Pulsed or continuous wave Doppler recordings of the ascending aortic 
flow may be obtained from the apex, a high right parasternal position, 
or from the suprasternal notch. The suprasternal approach usually gives 
the highest velocity in normal subjects and in many patients with a high 
success rate.32 
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For the assessment of LV ejection dynamics using Doppler ultrasound, 
the ejection phase has been divided into 2 phases:33,34 
- Early active phase: This phase starts when the aortic valve opens and 
lasts until the velocity of blood flow in the aorta reaches its peak. During 
this time, pressure in the LV exceeds pressure in the aorta and blood in 
the aorta gains momentum.33 The rate of increase in blood velocity 
during early systolic ejection is normally constant.34 Events during this 
phase are influenced mainly by the state of myocardial contractility. This 
is because the greatest rate of rise in blood velocity (peak acceleration) 
occurs during the initial 30 to 50 ms of ejection, when the main 
opposition to LV ejection is inertial, so that the resistive and capacitative 
properties of the arterial bed have a limited effects.3S Doppler 
measurements of this phase include (Figure 1):36-38 (a) acceleration time 
(AT), defined as the time interval form the onset of ejection to the point 
of peak aortic velocity; (b) peak aortic velocity, which is determined as 
the midpoint of the Doppler flow spectrum at the time of maximum flow 
velocity; and (c) average aortic acceleration; which is calculated by 
dividing the peak flow velocity by the acceleration time. 
i 
~ 
f 
(lUeetIoD TIme) 
Figure 1: Schematic representation of Doppler aortic velocity 
profile, showing measurements which can be obtained. AT = 
acceleration time, DT = deceleration time, PEP = pre-
ejection period, TV! = systolic time velocity integral. 
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- Latter, more passive, LV ejection: This phase starts at a point when 
blood velocity reaches its peak and lasts until the momentum of the 
blood falls to zero?3 During this phase LV volume decreases and the 
long axis of the LV shortens. In fact, the LV is supporting the aortic 
pressure at this time, maintaining, rather than actively generating a 
force. The blood has enough momentum from the active phase to 
complete the normal ejection. Unlike the early active phase, the 
duration of the second phase varies with the state of the arterial bed.33.34 
Doppler measurements of this phase include (Figure 1):36,37 
(a) deceleration time (DT), defined as the time interval from the point 
of peak aortic velocity to the end of systolic ejection; (b) average aortic 
deceleration, which is calculated by dividing the peak aortic velocity by 
the deceleration time. 
The systolic time velocity integral (TV!) represents the Doppler index 
of stroke volume. It is measured as the area under the aortic velocity 
signal and represents the forward distance travelled by the blood during 
the ejection phase (Figure 1).36 
Factors influencing Doppler ejection variables 
(1) Effect oj the inotropic state: Peak aortic velocity and peak or average 
aortic acceleration are reliable measures of LV contractility.3& Initial 
studies suggested that peak velocity and in particular the maximal 
acceleration of blood flow in the ascending aorta are sensitive indicators 
of the inotropic state and relatively insensitive to the loading conditions 
of the heart.39.40 This is confirmed by subsequent studies, using 
electromagnetic velocity catheters:! and more recently using Doppler-
echocardiography.13,36,42,43. 
(2) Effect oj myocardial ischaemia: Data from animal studies 
demonstrated that in the presence of critical coronary stenosis Doppler 
indices of LV function, specifically peak acceleration, fail to increase 
during conditions which increase myocardial oxygen requirements 
(isoprotrenol) to levels reached in the absence of such stenosis.44 In 
addition, the percent reduction of peak acceleration has been shown to 
correlate best with the percent ischaemic mass at risk, followed by 
ejection fraction, TV! and peak velocity.'s The results of these animal 
studies and other clinical studies,37,46 'encouraged combining Doppler 
examination of global LV systolic function, with cardiac stress testing for 
the detection of significant CAD. 
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(3) Effect of abrupt coronary occlusion: Balloon inflation during coronaI)' 
angioplasty, in patients without collaterals, has been shown to 
significantly reduce ejection indices derived by continuous wave 
Doppler.47 Whereas, in patients with collaterals coronaxy flow, ejection 
indices may remain unchanged during coronaI)' occlusion. 47 
(4) Effect of myocardial infarction: Doppler measurement of velocity 
based indices of LV systolic function during acute myocardial infarction 
demonstrated: (a) a significantly lower peak velocity, maximal 
acceleration and TVI in patients with acute infarction than their age-
matched healthy subjects;37 (b) a marked improvement in LV function, 
based on serial measurements of peak aortic acceleration, in patients 
with a first myocardial infarction not complicated by heart failure and 
no significant recovery in patients with a previous infarction or those 
with a first infarction complicated by heart failure.48 
(5) Effects of B-blockade and B-stimulation: Adminstration of a B-
adrenergic blocking agent causes a smaller rise in peak ejection velocity 
and mean aq:eleration with exercise in normal subjects compared to a 
drug free state.49 B-stimulation using dobutamine 5 I'g/kg/min in normal 
subjects results in significant increase in maximal aortic acceleration with 
minimal increase in stroke volume.so 
(6) Effects of preload, afterload, HR and body posItion: Increased 
afterioad, by controlled infusion of methoxamine, while maintaining 
constant HR, by means of transoesophageal pacing, in normal subjects, 
significantly reduces peak aortic velocity and acceleration with no change 
in TVI.S1 On the other hand, reduced afterioad, by adminstration of 
nitroprusside, while maintaining preload, by infusion of saline, in CAD 
patients, results in a significant increase in Doppler ejection indices, 
while adminstration of saline alone results in no significant increase in 
the three parameters.52 
Alterations in HR, results in a consistent inverse linear relation 
between HR and Doppler-derived average aortic acceleration, peak 
velocity and TVI in normal subjects.53 Finally, it has been noted that 
changing the subject position from the supine to the upright position 
results in a decline in Doppler variables of aortic flowP,54 
(7) Effects of age, gender and body surface area: Doppler-derived aortic 
ejection parameters have been shown to decrease progressively with age 
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either at rest or during exercise in normal subjects.55,56 No significant 
relationship has been found between body surface area and normal 
resting Doppler aortic flow measurements.55 The impact of gender on 
Doppler ejection indices is rather controversial. Lazarus et alS6 
demonstrated that gender did not affect Doppler aortic indices, either 
at rest or during exercise, in normal subjects. In contrast, Mowat et al57 
reported that aortic peak velocity and acceleration are significantly 
higher in males than in females. 
Doppler Assessment of LV diastolic function 
The transmitral flow velocity pattern reflects the changing diastolic 
pressure differences between the LV and the left atrium.58 The use of 
Doppler techniques for the detection of LV filling abnormalities is based 
on: (1) defining normal Doppler velocities and patterns, and 
understanding how these velocities relate to filling characteristics of the 
LV;58,59-63 (2) understanding the determinants of LV diastolic filling 
patterns;58,60,64,6S (3) understanding the influence of factors such as HR, 
loading condition, age and drugs on LV filling patterns;9,68,69 and (4) 
understanding the natural history of LV filling abnormalities in cardiac 
disease states and how the Doppler velocity patterns relate to patient 
symptoms, and haemodynamics;60,66,67 
Normal transmitral flow pattern 
For the assessment of diastolic function, the diastolic period has been 
divided into four phases be~inning with aortic valve closure and ending 
with mitral valve closure.60, 7 
- Isovolumic relaxation: No filling occurs during this phase, however, 
processes that determine the rate of fall of isovolumic pressure may 
influence ventricular filling following mitral valve opening.70 It is 
usually assessed by measuring the isovolumic relaxation period (IRP) 
as the time from aortic valve closure detected by phonocardiography 
or Doppler to mitral valve opening (Figure 2). Events during this 
phase are attributed primarily to myocardial relaxation.60 
- Rapid LV filling: This phase exteads from the onset of mitral flow to 
the point where LV filling plateaus. The onset of flow begins when 
the LV pressure drops below the left atrial pressure. At this point the 
blood within the mitral apparatus is subjected to a growing force 
generated by the atrioventricular pressure gradient, which causes the 
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blood to accelerate.62 The acceleration time (AT) for early filling is the 
time interval from mitral valve opening to peak early filling velocity 
(Figure 2). During this period, the LV pressure decreases more rapidly 
than the left atrial pressure due to progressive active myocardial 
relaxation and diastolic suction of the LV creating a pressure gradient 
between the left atrium and the LV.7J This gradient produces a high 
initial peak velocity (E) due to rapid forward filling60 (Figure 2). When 
LV relaxation nears completion, the transmitral velocity decelerates.72 
The rate of decline in the mitral velocity can be measured by the 
deceleration time (DT), which is the time interval from peak E to an 
extrapolation of the deceleration slope to the baseline (Figure 2).60 
! 
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Figure 2: Schematic representation of transmitral velocity profile, 
demonstrating Doppler measurements of LV filling. A = peak atrial 
filling; A2 = aortic component of second heart sound; AT = 
acceleration time, DT = deceleration time; E = peak early filling 
velocity; IRP = isovolumic relaxation period; TV! = diastolic time 
velocity integral. 
- Slow filling phase "diastasis": During this phase the left atrial and LV 
pressures are nearly equilibrated and only the blood returning from 
the lungs flows through the left atrium into the LV.72 This results in 
continued low velocity forward flow. This phase is felt to be related 
to LV compliance.62 
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- Atrial contraction: During this phase the atrial pressure increases 
producing a left atrial-to-LV pressure gradient that propels blood into 
the LV with the resultant second peak (A) velocity66 (Figure 2). In 
addition to atrial contractile force, this phase is felt to be the portion 
of diastole that may be most modified by LV stiffness and pericardial 
restraint. 67 
Factors determining diastolic filling of the LV 
In general, factors that determine LV filling will influence the 
Doppler transmitral velocity profile.63 Despite the fact that a multitude 
of factors affect LV filling, it appears that they all act through their 
influence on the transmitral pressure gradient. 66 These factors 
include:63•64•73 
Myocardial relaxation and elastic properties 
- Regional myocardial relaxation 
- Nonuniformity of regional myocardial relaxation in time and space 
- Diastolic suction: elastic recoil or inertial properties 
Chamber stiffness or compliance 
Passive properties 
- Ventricular geometry: size, shape and wall thickness 
- Composition of ventricular wall: muscle, connective tissue (amount, 
type, and configuration), amyloid, haemosiderin, oedema. 
Dynamic properties: 
- Viscoelastic myocardial properties 
- External forces: pericardial constraints, right ventricular loading, 
lung pressure, and tumours 
Left atrial pressure 
Other factors 
- HR and rhythm 
- Age, gender and body surface area 
- Loading conditions 
- Technical factors: sample volume position and respiration 
(1) Myocardial relaxation: Myocardial relaxation is an active energy-
requiring process, in which calcium is sequestered by the sarcoplasmic 
reticulum with the consequent dissociation of actin-myosin crossbridges.70 
It starts before aortic valve closure, lasts throughout and influences early 
filling and usually ends by the middle of diastole and thus does not 
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normally affect diastasis or atrial filling.61 The rate of LV relaxation is 
inversely related to the peak rate of LV filling.60·6S Thus, fasterrelaxation 
increases early filling with consequent increase in mitral E wave velocity, 
while slower relaxation results in a decrease in atrioventricular pressure 
gradient and lower E wave velocity.58.60,6S,74 
Factors that accelerate myocardial relaxation includes increased HR 
and catecholanlines.9,75 Whereas factors that slow myocardial relaxation 
include advanced age, myocardial ischaemia, LV hypertrophy, dilated 
cardiomyopathy, hypothyroidism and intracellular calcium overload.60,61 
Nonuniformity of relaxation may influence any of the parameters of 
LV filling. Normally, the rate of relaxation of the different LV segments 
is variable. This variability may be exaggerated under different disease 
states and may affect the mitral velocity profile.60 
Experimental studies,75,76 supported the concept of diastolic suction 
of blood from the atria to fill the ventricles as an action caused by 
elastic recoil or by inertial properties of the myocardium. 
(2) LV chamber stiffness or compliance: Chamber stiffness is a function 
of both myocardial stiffness and the thickness and geometry of the 
ventricle.59 LV chamber stiffness is variable during the rapid filling of 
e"Ily diastole, low during diastasis and increasing steadily as LV filling 
becomes complete during late diastole.64 LV chamber stiffness is 
proportional to LV diastolic pressure. Increased chamber stiffness results 
in an increase in left atrial pressure and a high mitral opening pressure 
causing increased early filling velocity and shortened IRP.67 The 
nondistensible LV also produces a rapid equilibration of left atrial and 
LV pressures and reduced atrial transport. This will result in a short DT 
and a decreased A velocity, respectively.62,67 
Increased LV stiffness has been demonstrated in conditions associated 
with marked ventricular hypertrophy;64.7S and in patients with altered 
composition of LV wall such as those with myocardial scar after 
myocardial infarction, 79 chronic CAD and scattered myocardial fibrosis;80 
or restrictive cardiomyopathies.64 
Viscosity of elements within ventricular wall regresents a resistance 
to filling that is proportional to the rate of filling. 1 The viscous effects 
will be enhanced, if a given diastolic volume is rapidly entered into the 
ventricle, resulting in greater wall force and chamber pressure rise,64 
The pericardium, right ventricle and lungs are structures that 
surround the heart and constitute the external constraints of the LV.61 
The distending pressure of the LV is the difference between the internal 
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and external pressure.81 An elevated pericardial pressure or right 
ventricular volume will result in restriction of LV filling.82 
(3) Left atrial pressure: Left atrial pressure is a major determinant of 
transmitral pressure gradient,58 It is determined by the interaction of 
several factors including, left atrial contractility and its timing, left atrial 
compliance, left atrial volume and LV chamber stiffness.63 Reduction in 
left atrial pressure will result in a decrease in transmitral pressure 
gradient and consequently a reduced early filling velocities.6O While an 
increase in left atrial pressure will result in a higher driving pressure 
across the mitral valve with subsequent increase in early filling 
velocities.66 In presence of increased HR or prolongation of the PR 
interval, atrial systole may occur during the deceleration slope of early 
filling resulting in its reduction and increase in atrial filling velocity.63 
(4) Interaction of myocardial relaxation, chamber stiffness, and left atrial 
pressure: Coexistence of reduced relaxation and increased left atrial 
pressure, due either to increased chamber .stiffness or abnormalities in 
loading conditions, results in contrasting effects on LV diastolic filling.66 
Thus, the presence of equally significant impaired relaxation and 
increased stiffness may maintain the balance between early and late 
diastolic filling, causing the mitral velocity profile to undergo 
"pseudonormalization".63,66 
(5) Heart rate and rhythm: Experimental and clinical studies= 
demonstrated that, increasing HR significantly increases atrial 
contribution to filling with no significant change in early filling. The 
presence of arrhythmias such as atrial fibrillation or multiple ventricular 
ectopic beats complicates the interpretation of LV filling pattern. 
Abnormal electrical activation of the LV (such as bundle branch block) 
slows LV relaxation.56 In patients with atrioventricular dissociation, the 
mitral velocity will vary according to the timing of atrial contraction. 60 
(6) Age, gender and body surface area: With increasing age, LV early 
filling gradually decreases with gradual increase in filling during atrial 
contraction.66 Progressive slowing of relaxation has been suggested as the 
primary underlying· mechanism. Advancing age may also increase 
myocardial stiffness due to increase LV mass.87 This would increase the 
Ej A ratio and not reduce it as is commonly observed in aging. Recently, 
Davidson88 suggested that increased viscoelastisity of the ventricle with 
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aging could be an alternative hypothesis. Doppler findings may show 
lengtbening of the IRP and DT, a reduction in peak: E velocity, an 
increase in peak: A velocity and a decrease in the E/ A velocity ratio to 
approximately one.69,89.90 Several studies69•89 showed no significant 
relation between Doppler parameters of LV filling and either body 
surface area or gender. 
(7) Loading conditions: Changes in preload influence the LV filling 
pattern through their effect on left atrial pressure.62.66 With increased 
preload, there will be a higher left atrial pressure relative to LV 
pressure in early diastole.7S This results in a transmitral velocity profile 
similar to that of restricted LV filling.58 Conversely, a decrease in 
preload results in a lower initial pressure gradient and consequently the 
Doppler pattern may simulate that of impaired LV relaxation.6O 
Acute elevations of blood pressure in healthy subjects had no 
independent effect on the Doppler indices of LV filling.68,91 However, 
chronic volume overload, e.g., severe aortic regurgitation, increases LV 
early diastolic pressure resulting in rapid equa1ization of left atrial and 
LV pressures and the DT will be shortened.92 Severe mitral regurgitation 
causes a high initial pressure gradient across the mitral valve and results 
in a high E wave velocity.92 However, the presence of trivial mitral 
regurgitation probably does not affect the transmitral velocity profile.6O 
(8) Respiration: During inspiration there is a decrease in LV filling 
velocities.93 The effects of respiration can be minimized by acquiring 
Doppler data during periods of apnoea or by averaging multiple 
consecutive beats. 
(9) Sample volume position: When obtaining mitral flow velocity 
recordings, the position of the sample volume should be standardized. 
Placing the sample volume at the level of the mitral valve annulus has 
the advantage of less change in cross-sectional area,6O but yields a lower 
early filling velocity and shorter deceleration time than sampling at the 
tips of the mitralleaflets.94•95 Conversely, the mitral leaflet tip site yields 
the highest velocity change and most discrete signals, although the cross-
sectional area varies throughout diastole.58 Since flow velocities are 
closely related to the left atrial-LV pressure gradient and pressure 
gradient is the major determinant of transvalvular flow, the velocities 
recorded at the leaflet tips are generally accepted as the best indirect 
measure of the driving force across the mitral valve.6O,66 
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Abstract 
Patients undergoing dobutamine stress echocardiography are often using 
beta antagonists which limit heart rate response and sensitivity of the test 
for detection of coronary artery disease. The aim of this study was to assess 
the effect of addition of atropine to dobutamine on clinical, 
electrocardiographic and echocardiographic outcomes. 
Dobutamine echocardiography was performed starting at and increasing 
every 3 minutes by 10 ltg/kg/min to a maximum of 40 ltg/kg/min (stage 
4) which was continued for 6 minutes. In patients not achieving 85% 
predicted maximal exercise heart rate and in whom the test was not judged 
to positive on echocardiographic or ECG criteria, atropine was added 
starting at a dose of 0.25 mg intravenously and repeated if necessary to 
achieve an adequate heart rate or until the test was stopped because of 
chest pain or BCG changes. 
Of 80 consecutive patients undergoing dobutamine echocardiography 
within 2 weeks of coronary angiography, 49 required atropine (group A) 
and 31 required only dobutamine (group B). After dobutamine alone, 
lAm J CardioI1992;70:41·46 
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mean ± SD heart rate was higher in group B than in group A: 129 ± 20.1 
compared with 90 ± 18.4, P < 0.0001, but after addition of atropine, heart 
rate in group A increased to 120 ± 19.6. Overall sensitivity for the 
detection of coronary disease was 70%; after addition of atropine, 
sensitivity for group A was 65% and in group B, sensitivity was 81%. 
Overall specificity for detection of coronary disease was 88%; specificity 
was 89% after atropine in group A and 87% in group B. There were no 
severe complications and no difference between groups in the frequency 
of complications or the requirement of beta blocker for relief of symp-
toms. 
The addition of atropine to DSE in patients in whom the test is negative 
and who do not achieve 85% predicted maximal heart rate during 
dobutamine alone, increases the sensitivity of the test for detection of 
coronary artery disease without loss of specificity and without severe side 
effects. 
Introduction 
Stress echocardiography with exercise has a high sensitivity, specificity 
and reproducibility,,2 for non-invasive detection of coronary artery disease 
but requires adequate cooperation and motivation; this may be impossible 
in patients with orthopaedic or neurological conditions that preclude 
exercise. An alternative is to combine echocardiography with 
pharmacological stress with dobutamine3, dipyridamole', or adenosines. 
Dobutamine is a sympathomimetic agent with both positive 
chronotropic and inotropic effects6, which in high dose increases 
myocardial oxygen demands inducing myocardial ischaemia in the 
presence of significant coronary stenoses, Comparison of dobutarnine 
stress echocardiography and exercise electrocardiography in patients 
taking B antagonists shows lower mean peak heart rate and systolic blood 
pressure during dobutamine than during exercise.3 We postulated that this 
relatively low peak heart rate during dobutamine stress may adversely 
affect the sensitivity of dobutamine stress echocardiography, Accordingly, 
we altered the protocol for dobutamine stress echocardiography to 
incorporate the addition of atropine at the end of the usual dobutamine 
infusion in patients not achieving 85% predicted maximal exercise heart 
rate, and in whom the stress test was not regarded as positive during 
dobutamine alone, The aim of the study was to assess the effect of the 
addition of atropine to dobutamine on clinical, electrocardiographic and 
echocardiographic outcomes of the stress test, and to assess the sensitivity 
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and specificity of this combined pharmacologic stress test for detecting 
coronary artery disease. 
Methods 
Patient selection: Patients who received atropine in this study formed a 
subgroup of consecutive patients undergoing dobutamine stress 
echocardiographywho (1) also underwent coronary angiography within 2 
weeks of stress testing; (2) had negative results after dobutamine stress 
echocardiography with administration of dobutamine alone; and (3) did 
not achieve 85% predicted maximal exercise-induced heart rate for age 
and sex during dobutamine alone. 
Stress echocardiography (Figure 1): After informed verbal consent, 2-
dimensional precordial echocardiography was performed at rest using 
Hewlett-Packard Sonos 1000 echo apparatus with 2.5 and 3.5MHz 
transducers. Standard apical and parasternal views were recorded on video 
tape. The optimal transducer positions were marked on the chest and 
baseline 12-lead electrocardiogram performed. When the standard 
position of a chest electrode coincided with the marked transducer 
position the electrode was moved one space higher or lower. 
After baseline 12-lead electrocardiogram, dobutamine infusion was 
administered intravenously using an infusion pump, starting at a dose of 
10 mcg/kg/minute for 3 minutes, and increasing by 10 mcg/kg/min every 
3 minutes to a maximum of 40 mcg/kg/minute (stage 4); this was 
continued for 6 minutes. In patients not achieving 85% predicted maximal 
exercise heart rate, atropine (0.25 mg) was given intravenously at the end 
of stage 4, and repeated to a maximum of 1 mg if necessary with the 
continuation of dobutamine for up to a further 5 minutes if necessary to 
achieve 85% predicted maximum exercise heart rate. 
Throughout dobutamine infusion the electrocardiogram was 
continuously monitored, 12-lead electrocardiogram recorded each minute 
and cuff blood pressure taken every 3 minutes. Two-dimensional 
echocardiography was continuously monitored; standard parasternal and 
apical images were acquired by one of the authors and were recorded on 
videotape for the last minute of each of stages 1 to 3, the last 4 minutes of 
stage 4 and continuously for up to 5 minutes after atropine administration. 
The infusion was stopped if the patient developed obvious new wall 
motion abnormality, ST depression of > 2 mm 80 rns after the J point, ST 
elevation, significant chest pain, ventricular tachycardia, a decrease in 
blood pressure > 20 mm Hg from resting value or any complication 
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considered to be due to dobutamine. Metoprolol was available and used 
to reverse the effects of dobutamine or atropine if these did not revert 
spontaneously and quickly. 
Time (minutes) 
I I I I 
~1 0 3 6 9 12 IS 18 21 
Atropine (0.25 mg) 
30 40 -J. -J.-J.-J. 
~ Dobutamine (ug/ks/min) 
Echocardiogram (4 views) 
II II II II1II II II1II II1II II 
12·1ead Eectrocardiogram 
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Blood Pressure 
Figure 1. Schematic representation of the study protocol. 
Echocardiographic assessment: In addition to assessment of echo images 
during acquisition, additional assessment was also performed by 2 
experienced investigators following acquisition. Both on· and off·line 
assessments were done without knowledge of the patients' coronary 
anatomy but with knowledge of the doses of dobutamine and atropine 
used. When there was disagreement between the 2 off·line assessors, a 
third investigator viewed the images without knowledge of the previous 
assessments and a majority decision was achieved. For this 
semiquantitative assessment the left ventricular wall was divided into 16 
segments 7 and scored using a 4 point scale: 1 = normal, 2 = hypokinetic, 
3 = akinetic, and 4 = dyskinetic. An increase in score between rest and 
stress in 1 or more segments, i.e, a new or worsened wall motion 
abnormality, constituted a positive test. Using this system an index of 
global left ventricular wall motion (wall motion score index) was 
calculated as sum of the scores in the visualized segments/number of 
segments visualized; indexes were derived for images acquired at baseline, 
peak dobutamine and after atropine. In our laboratory inter· and intra· 
observer agreement for stress echocardiographic assessment is 91%;8 
recent data indicate that assessment of 100 stress echocardiograms is 
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adequate training for diagnostic accuracy in this technique9 and all 
investigators in our center have such experience. We do not routinely use 
a continuous loop format for assessment of pharmacological stress 
echocardiography because we previously tested if cine loop analysis of 
dobutamine echocardiography had advantages over analysis of images 
from video tape and found the same results by the 2 techniques3• 
Coronary angiography: Coronary angiography was performed by the 
Judkins' technique within 2 weeks of stress echocardiography. A lesion of 
> 50% diameter stenosis is taken as representing significant coronary 
artery disease. The decision to perform coronary angiography was never 
based on the results of stress echocardiography. 
Statistical analysis: Results are expressed as mean ± SD and 95% 
confidence intervals (CI) are given where appropriate. Discrete variables 
were compared using the chi-square test or Fisher's exact test; continuous 
variables were compared using paired and unpaired Student's t tests or 1 
way analysis of variance as appropriate. 
Results 
Study population: Eighty consecutive patients undergoing dobutamine 
stress echocardiography and coronary angiography were included in the 
study. Clinical details are summarised in Table I. Forty-nine patients 
received atropine in addition to dobutamine (group A) and 31 achieved 
a test end point with dobutamine alone (group B). There was no 
difference between these 2 groups with regard to the overall incidence of 
significant coronary artery disease, but there was a trend toward more 1-
vessel disease in group A: 24 of 31 (77%) patients with coronary disease 
in group A had I-vessel disease compared with 8 of 16 (50%) in group B, 
p = 0.11. The distribution of diseased vessels was different between the 2 
groups, with a greater proportion of patients from group A having left 
anterior descending and circumflex lesions and more patients in group B 
having right coronary lesions. Mean age was lower and B antagonist use 
was more frequent in group A. There was no difference between groups 
in the frequency of previous infarction, angioplasty or coronary artery 
bypass grafting. 
Reasons for termination of the test: The primary reasons for termination 
of the stress test in the 2 groups are listed in Table II. In some cases a 
patient had an additional reason for stopping, e.g, chest pain 
accompanying ST elevation. There was no difference between groups in 
the reasons for termination of the test; in > 60% of patients from both 
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groups, the test was discontinued primarily because an adequate heart rate 
was achieved. In only 1 patient was the test stopped because of new wall 
motion abnormality. 
Table I. Clinical characteristics of patients receiving atropine (group A) 
and no atropine (group B). 
Group A GroupB p Value 
No. of patients 49 31 
Men:women 40:9 19:12 0.08 
Mean age ± SD 57 ± 12 62 ± 10 0.05 
Coronary artery disease 31 (63%) 16 (52%) NS 
l-vessel:multivessel 24:7 8:8 0.11 
LAD:LC:right 21:12:7 8:5:11 0.05 
Previous MI 19 (39%) 9 (29%) NS 
Previous PTCA 24(49%) 15 (48%) NS 
Previous CABG 2(4%) 2(7%) NS 
.8 antagonists 46 (94%) 18 (58%) 0.0003 
Calcium antagonist 29 (59%) 15 (48%) NS 
Nitrates 20 41% 13 42% NS 
CABG = coronary artery bypass grafting, LAD = left anterior descending, LC = left 
circumflex, M1 = myocardial infarction, NS = not statistically significant, PTCA = 
percutaneous transiuminaJ coronary angioplasty. 
Table II. Frequency of primary reasons for stopping stress test. 
No. of patients 
Adequate heart rate 
Chest Pain 
ST elevation 
ST depression 
New wall motion abnormality 
Chills 
Group A 
49 
30 (61%) 
12(25%) 
2(4%) 
3(6%) 
o 
2(4%) 
Group B 
31 
19 (61%) 
7 (23%) 
4 (13%) 
o 
1(3%) 
o 
Hemodynamic changes: Changes in heart rate and systolic blood 
pressure with dobutamine and atropine are shown in Tables ill and IV. In 
group A, both heart rate and systolic blood pressure increased significantly 
after dobutamine alone and increased further after addition of atropine. 
Within group A there was no difference between patients with and without 
coronary artery disease for either mean heart rate or systolic blood 
pressure at baseline, after dobutamine or after addition of atropine. In 
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group B, mean heart rate and systolic blood pressure increased 
significantly from baseline to peak dobutamine, and there was no 
difference between those with and without coronary artery disease for 
values at base and peak stress. 
Comparison of heart rate data between groups A and B showed a 
higher baseline value in group B: 76±13.6 beats/min compared with 
64±9.6 beats/min, p < 0.0001. At peak dobutamine, heart rate in group A 
was 90±18.4 beats/min compared with 129±20.1 beats/min in group B, 
P < 0.0001. There was a small difference between peak stress (peak 
atropine in group A, peak dobutamine in group B) heart rates in the 2 
groups: 120±19.6 beats/min for group A and 129±20.1 beats/min for 
group B, p=O.04. 
Table TIL Changes in heart rate after dobutamine and atropine. 
Peak Peak 
Base Dobutamine Atropine p Value 
Group A (all) 64 ± 9.6 90 ± 18.4 120 ± 19.6 <0.0001 
(+CAD) 63 ± 9.8 88 ± 18.7 118 ± 19.0 <0.0001 
(·CAD) 66 ± 9.7 92 ± 18.3 l22 ± 20.0 <0.0001 
Group B (all) 76 ± 13.6 129 ± 20.1 <0.0001 
(+CAD) 74 ± 14.6 128 ± 21.4 <0.0001 
(-CAD) 77 ± 12.8 130 ± 19.3 <0.0001 
Analysis in group A was performed by l·way analysis of variance and in group B by 
paired t tests. 
+ CAD = patients with significant coronary artery disease, -CAD = patients VlithoUl 
significant coronary artery disease. 
Table IV. Changes in systolic blood pressure after dobutamine and 
atropine. 
Peak Peak 
Base Dobutamine Atropine p Value 
Group A (all) 129 ± 17 139 ± 19 147 ± 24 <0.0001 
(+CAD) 127 ± 16 140 ± 19 149 ± 25 <0.0003 
(-CAD) 131 ± 19 139 ± 18 142 ± 23 0.25 
Group B (all) 136 ± 22 148 ± 30 0.001 
(+CAD) 142 ± 25 154 ± 33 0.03 
(-CAD) 130 ± 17 141 ± 25 0.01 
Explanation and abbreviations as Table ill. 
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Base and peak dobutamine systolic blood pressures tended to be higher 
in group B although the differences did not reach statistical significance: 
129±17 = Hg compared with 136±22 = Hg, P = 0.09 for baseline 
values, and 139±19 = Hg compared with 148±30 = Hg, P = 0.13 for 
peak dobutamine. There was no difference between groups A and B for 
peak stress systolic blood pressure: 147±24 = Hg and 148±30 = Hg, 
P = 0.86. 
Sensitivity and specificity of stress echocardiography: Of the 47 patients 
with significant coronary artery disease, 33 developed a new or worsened 
wall motion abnormality in the area of myocardium judged to be 
subtended by the stenotic coronary artery after either dobutamine or 
atropine (an overall sensitivity of 70%, 95%CI 55 to 83%).In group A, off-
line review revealed new wall motion abnormalities which had been 
unrecognised during on-line assessment in 2 of 31 (7%, 95%CI 1 to 21%) 
patients with coronary artery disease before addition of atropine, and 20 
of 31 had new wall motion abnormalities after addition of atropine 
(sensitivity for group A of 65%, 95%CI 45 to 81%). In group B, new or 
worsened wall motion abnormalities occurred in 13 of 16 patients with 
coronary artery disease (sensitivity of 81%, 95%CI 54 to 96%) (Figure 2). 
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Figure 2. Sensitivity of echocardiography (Echo), chest pain and ST 
segment changes for detection of coronary artery disease. Group A 
atropine = sensitivities after addition of atropine; Group A dobutamine 
= sensitivities in group A before addition of atropine. 
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The overall specificity of stress echocardiography for detection of 
coronary artery disease was 88%, 95%CI 72 to 97% (4 of 33 patients 
without significant coronary disease developed a new or worsened wall 
motion abnormality after either dobutamine or atropine). In group A, 
none of the 18 patients without coronary disease had a positive echo with 
dobutamine alone, but in 2 patients the echo became positive after 
addition of atropine (specificity of 89%, 95%CI 65 to 99%). In group B, 
2 of the 15 patients without coronary disease had a positive echocardiogra-
phic results after dobutamine (specificity of 87%, 95%CI 60 to 98%) 
(Figure 3). 
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Figure 3. Specificity of echocardiography (Echo), chest pain and ST 
depression for detection of coronary artery disease. Group A atropine = 
specificities after addition of atropine; Group A dobutamine = 
specificities in group A before addition of atropine. 
Sensitivity and specificity of ST changes and chest pain: Sensitivities of ST 
changes and chest pain induced by dobutamine or atropine as indicators 
of coronary artery disease are also shown in Figure 1. In group A, 2 of 31 
patients (7%, 95%CI 1 to 21 %) with coronary disease had ST depression 
of 1 mm 80 IDS after the J point during dobutamine alone, while 6 (19%, 
95%CI 8 to 38%) had ST changes (4 depression, 2 elevation) after 
addition of atropine. In group B, 7 of 16 patients (44%, 95%CI 20 to 70%) 
with coronary disease had ST changes (4 elevation) during administration 
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of dobutamine. In the 6 studies that resulted in ST elevation, this quickly 
resolved on termination of the stress test and administration of 
intravenous metoproloL Three of these patients had previous infarction 
and 1 had a totally blocked right coronary artery despite no history of 
infarction; 3 had multivessel and 3 single vessel disease. 
Of 31 patients with coronary artery disease in group A, chest pain 
occurred in 3 (10%, 95%CI 2 to 26%) during dobutamine alone, and in 14 
(45%, 95%CI 27 to 64%) after addition of atropine. In group B, 8 of 16 
patients (50%, 95%CI 25 to 75%) with coronary artery disease had chest 
pain during dobutamine therapy. 
Specificities of dobutamine- and atropine-induced ST segment changes 
and chest pain for detection of coronary artery disease are shown in Figure 
3. There was no ST depression or chest pain in the 18 patients without 
coronary disease in group A during dobutamine therapy alone, but ST 
depression occurred in 5 patients (specificity 72%, 95%CI 47 to 90%) and 
chest pain in 4 (specificity 78%, 95%CI 52 to 94%) after addition of 
atropine. In group B, 4 of the 15 patients without coronary disease 
developed ST depression during dobutamine therapy, (specificity 73%, 
95%CI 45 to 92%), and 5 experienced chest pain (specificity 67%, 95o/oCI 
38 to 88%). 
Table V. Side effects at peak stress during dobutamine or atropine. 
I liroupA GroupB 
Continuing chest pain 10 11 
Ventricu1ar tachycardia (3 beats) 2 1 
Atrial ectopics 1 0 
Nodal rhythm 1 0 
Chills 2 1 
Headache 1 0 
Dyspnea 0 1 
Wall motion score indexes: There was no change in mean wall motion 
score index between rest and peak dobutamine (1.04±0.13 compared with 
1.06±0.14, p = 0.21) in patients with coronary artery disease in group A, 
but there was a significant increase in mean wall motion score index 
between peak dobutamine and peak atropine (1.06±0.14 to 1.17±0.15), 
p < 0.0001. Mean wall motion score index for patients with coronary artery 
disease in group B increased from 129±0.42 at baseline to 152±0.43 after 
dobutamine, p < 0.0001. There was no change in wall motion score index 
for patients without coronary disease in either group A or group B. 
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Complications: There were no serious complications related to either 
dobutamine or atropine. One or more minor side effects occurred at peak 
stress in 15 patients from group A (31%) and 13 patients (42%) from 
group B (Table V); 11 patients (23%) from group A and 12 (39%) from 
group B required intravenous metoprolol after peak stress, usually for 
relief of chest pain which did not settle quickly and spontaneously. There 
was no significant difference between groups in the incidence of side 
effects or requirement for metoprolol (Table V). 
Discussion 
Study Rationale: Patients undergoing non-invasive cardiac 
investigations at our institution are often receiving beta antagonists3,. for 
suspected angina, after infarction or for hypertension, and withdrawal of 
medication may be impractical of even potentially hazardous. Dobutamine 
has beta stimulant properties7 that result mainly in increased inotropic 
and, to a lesser extent, increased chronotropic effects that are reduced in 
patients using B blockers. We postnlated that this may limit the sensitivity 
of dobutamine stress testing for detection of coronary artery disease in 
these patients. Our suspicions were supported by data from other canters 
that showed a high incidence of electrocardiographic changes'O,ll during 
dobutamine infusion in patients with coronary disease who are not taking 
B antagonists, and by recent data that indicate that antianginal therapy 
including B blockade limits the sensitivity of dipyridamole 
echocardiography12, 
The negative chronotropic effect of B antagonists can be overcome by 
atrial pacing, which is an alternative nonexercise stress; however, even by 
the oesophageal route13 this requires adequate patient cooperation and 
suitable pacing electrodes and has no effect on inotropic action. 
Therefore, to retain the inotropic effect of dobutantine, but to overcome 
the lack of chronotropic effect seen especially in patients receiving B 
antagonists, we combined dobutamine stress echocardiography with the 
addition of atropine to increase heart rate14 in patients with negative stress 
echocardiography who did not achieve 85% predicted maximal exercise-
induced heart rate with dobutamine alone. We compared the results of 
this combined stress test with those seen in the same patients after 
dobutamine alone, and with the outcome of stress echocardiography in 
consecutive patients undergoing dobutantine stress testing without the 
requirement for atropine, during the same time period as those who 
received atropine. 
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Stress echocardiography: sensitivity, specificity, and wall motion score 
index: In accordance with the protocol, no patient with a positive 
echocardiogram during dobutamine therapy alone should have received 
atropine. However off-line review revealed minor new wall motion 
abnormalities which had not been detected on-line before addition of 
atropine to 2 patients from group A The sensitivity for detection of 
coronary lesions with >50% diameter stenosis was 65% for patients in 
group A, and 81 % for group B, resulting in an overall sensitivity of 70%, 
with very similar CIs for groups A and B; this similar sensitivity was 
achieved despite a tendency towards more multivessel disease in group B, 
a factor which we have previously shown to increase positivity of 
dobutamine stress echocardiographyS. Had these patients been studied 
using our former protocol, stopping after 15 minutes dobutamine infusion 
regardless of heart rate, 15 of the 47 patients with coronary disease would 
have had a positive echocardiogram, resulting in a significantly lower 
sensitivity of 32%, 95%CI 19 to 47%. 
The overall sensitivity for detection of coronary disease of 70% with a 
95% CI of 55 to 83% is slightly lower but comparable to that reported for 
tomographic thallium scintigraphy after exerciseS or pharmacologic stress 
with adenosines or dipyridamole!S; however, our study of patients with 
predominantly I-vessel disease cannot be directly compared with other 
studies in which a greater proportion of patients had multivessel disease. 
In addition, stress echocardiography has the advantage of requiring only 
readily available equipment compared with that required for perfusion 
scintigraphy, and avoids the exposure to a radioisotope. 
In this study we did not use the side-by-side analysis of rest- and stress-
digitized image. However, it is unlikely that this could explain the 
relatively low sensitivity of the test, as we have recently reported3• 
The increased sensitivity as a result of adding atropine was associated 
with only a small reduction in specificity; after dobutamine alone 31 of the 
33 patients without coronary disease had a negative echocardiogram 
(specificity of 94%,950/£180 to 99%) compared with 29 of 33 (specificity 
of 88%, 95%CI 72 to 97%) after the addition of atropine. 
The effect of atropine in increasing diagnostic yield is also reflected by 
the changes in wall motion score index seen in group A For patients with 
coronary artery disease in group A there was no significant increase in wall 
motion score index after dobutamine alone, but a significant increase after 
the addition of atropine. However in accordance with the lack of effect of 
atropine on specificity, wall motion score index did not increase after 
atropine in patients without coronary disease. Similarly in group B there 
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was an increase in wall motion score index at peak stress in patients with 
coronary disease, but no increase in those without coronary disease. 
Safety of the combined stress test: There were no severe side effects at 
peak dobutamine or atropine and no difference between the incidence of 
side effects between groups A and B. In particular the requirement for 
metoprolol was the same between the 2 groups. This was usually given for 
chest pain that did not resolve within 5 minutes of stopping dobutamine. 
In those patients who developed ST elevation, metoprolol was 
immediately given and resulted in rapid resolution of ST elevation and 
chest pain in all cases. Although there were no severe arrhythmias (2 
patients had 3 beats of ventricular tachycardia at peak stress, and 1 patient 
developed nodal rhythm with maintenance of normal blood pressure), the 
test should only be performed with attention to electrocardiographic 
monitoring, 12 lead ST-segment assessment and blood pressure recording, 
and with resuscitation facilities available. 
Relationship to other studies: Recent studies of dobutamine 
echocardiography have reported sensitivities of 86 to 89% for detection of 
coronary disease'6,17. These sensitivities are outside the 95% confidence 
limits for sensitivity in our study but there are several important 
differences between these studies and ours. Cohen et al'6 reported an 
overall sensitivity of 86% but their patients were studied without B 
blockade and 16 of 51 patients with significant coronary disease had 1-
vessel disease, for whom the sensitivity was 69%, whereas sensitivity for 
patients with multivessel disease was 94% (33 of 35 patients). Sawada et 
al'7 reported a sensitivity of 89%, but only a small amount of patients were 
taking B blockers and only patients with normal resting echocardiograrns 
were considered in this analysis. Our overall sensitivity of 70% and the 
sensitivity of 93% for multivessel disease is comparable with the sensitivity 
of other imaging techniques including tomographic thallium imaging after 
exerciseS•IS or pharmacological stress with adenosines or dipyridamole'9• 
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CHAPTER 4 
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Abstract 
Myocardial function was assessed by stress echocardiography in 28 
patients before and after successful elective coronary angioplasty. 
Dobutamine stress echocardiography was performed using up to 40 
ILg/kg/minute, followed by addition of atropine in 20 patients to achieve 
85 % of the predicted maximal exercise heart rate. The initial studies were 
performed 1 day before and second ones within 3 days (mean 13) after 
angioplasty. The frequency of dobutarnine-induced new wall motion 
abnormalities decreased from 20 (71%) before to 4 (14%) after 
angioplasty (p<0.0001). Before angioplasty wall motion score index (an 
indicator of left ventricular wall motion, an increase in which index 
indicates impaired wall motion due to myocardial ischaemia) increased 
from 1.06 at rest to 1.23 at peak stress (p < 10-6) but there was no 
significant increase in this index in the study after angioplasty. Before 
angioplasty, 14 (50%) patients developed chest pain during the stress test 
compared with 6 (21%) after angioplasty (p = 0.05), and before 
angioplasty the stress test was stopped before target heart rate was 
achieved, because of symptoms, ST-segment change or severe new wall 
lAm J CardioI1992;69:740-745 
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motion abnormality in 14 patients compared with 7 after angioplasty (p = 
0.09). Thus early after angioplasty there is a reduction in myocardial 
ischaemia as assessed by dobutarnine stress echocardiography. 
Introduction 
Non-invasive assessment of patients with suspected coronary artery 
disease is most often performed by exercise electrocardiography. However 
the limited sensitivity and specificity of this technique' have led to its 
combination with either radionuclide scintigraphy with planar2 or 
tomographic imagint to identify stress induced perfusion defects, orwith 
2-dimensional echocardiography to identify abnormalities of left 
ventricular wall motion which develop with the onset of ischaemia
"
'. 
An alternative is to combine echocardiography with non-exercise stress 
using atrial pacini or pharmacological stress using dobutamine6, 
dipyridamole or adenosine8• There is evidence from animal experiments 
that dobutarnine, a sympathomimetic agent with both positive chronotro-
pic and inotropic effects9, is the pharmacological stress agent of choice for 
combination with imaging techniques that assess left ventricular systolic 
function, including echocardiographylo. 
The stepwise incremental protocol in which the dose of dobutarnine is 
increased and the increase in heart rate and blood pressure associated 
with dobutarnine, make the test analagous to exercise stress testing6• 
The effect of successful angioplasty has previously been assessed by 
exercise stress echocardiographyll or perfusion scintigraphyl2 and by 
dipyridamole echocardiography13. However, we are not aware of data on 
the use of dobutarnine stress echocardiography in this clinical setting. 
Accordingly, in this study we investigated if dobutarnine stress 
echocardiography could assess the functional effect of the change in 
myocardial perfusion early after angioplasty. 
Methods 
Patient selection: Consecutive patients with stable angina pectoris in 
whom elective coronary angioplasty was planned were prospectively 
enrolled in the study. Previous infarction, angioplasty or coronary artery 
grafting were not contraindications. All patients gave informed verbal 
consent to undergo dobutarnine stress echocardiography. It was 
consideredMwnethical and potentially dangerous to withdraw antianginal 
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therapy including B-blockers, especially owing to the risk of rebound 
instability occurring at the time of angioplasty. 
Dobutamine stress echocardiography: Patients underwent dobutamine 
stress echocardiography one day before, and within 3 days after elective 
angioplasty, unless there was some contraindication to repeating the study. 
Two-dimensional echocardiographywas performed at rest using Hewlett-
Packard Sonos 1000 echo apparatus with 25 and 35 Mhz transducers. 
Standard apical and parasternal views were recorded on video tape. The 
optimal transducer positions were marked on the chest and baseline 12-
lead electrocardiograph recorded. When the standard position of a chest 
electrode coincided with the marked transducer position, the electrode 
was moved one space higher or lower. 
Dobutamine was administered intravenously using an infusion pump, 
starting at a dose of 10 /Lg/kg/minute for 3 minutes and increasing by 10 
/Lg/kg/minute every 3 minutes to a maximum of 40 /Lg/kg/min (stage 4), 
which was continued for 6 minutes. Because antianginal therapy, including 
B blockers, was continued during the test, patients infrequently developed 
tachycardia despite exposure to high levels of dobutamine. Accordingly as 
was previously suggested!4, 025 mg of atropine was given intravenously at 
the end of stage 4, and repeated up to a maximum of 1 mg with 
continuation of dobutamine to achieve 85% of the predicted maximum 
exercise heart rate in those patients who did not achieve this target heart 
rate and in whom the test was negative with dobutamine alone. In this way 
it was attempted to achieve the same peak heart rate in both stress tests 
before and after angioplasty. 
Throughout the stress test, 2-dimensional echocardiogram was 
monitored; images were acquired by one of the authors and recorded on 
video tape for the last minute of each of stages 1 to 3, the last 4 minutes 
of stage 4 and continuously for up to 10 minutes after dobutamine was 
discontinued or after administration of atropine. Infusion was stopped if 
the patient developed an obvious new wall motion abnormality, ST 
depression> 2 rom 80 IDS after the J point, ST elevation, significant chest 
pain, reduction in systolic blood pressure > 20 rom Hg from that at rest, or 
any side effect regarded as being due to dobutamine. Metoprolol was 
available and used to reverse the effects of dobutamine, if they did not 
revert spontaneously and quickly. 
Angioplasty: was performed by the femoral route using standard 
equipment and techniques within 1 day of the initial stress 
echocardiography. Severity of the stenosis before and after the procedure 
was assessed by either visual or quantitative analysis15 without knowledge 
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of the results of the stress echocardiographic tests. Angioplasty was 
indicated in cases of persistent anginal symptoms despite medication, and 
of coronary disease with a diameter stenosis ::::50%. The result of 
angioplasty was considered positive if the diameter stenosis was reduced 
to <50%. 
Echocardiographic assessment: In addition to assessment of 
echocardiographic images during acquisition, assessment was performed 
by 2 experienced investigators after acquisition. Both on-line and off-line 
assessments were performed without knowledge of the site of angioplasty 
or of patient's coronary anatomy before or after angioplasty. When there 
was disagreement between the 2 off-line assessors, a third investigator 
viewed the images without knowledge of the previous assessments and a 
majority decision was achieved. For this semiquantitative assessment, the 
left ventricular wall was divided into 16 segments16, and each segment was 
scored using a 4 point scale: 1 = normal, 2 = hypokinetic, 3 = akinetic 
and 4 = dyskinetic (Figure 1). The 16 segments were combined into 5 
myocardial areas: anterior, septal, lateral, inferior and apical. The 
anterior, septal and lateral areas and septal, anterior and lateral segments 
of the apex were regarded as being in the territory of the left anterior 
descending coronary artery, whereas the inferior and lateral areas and 
apical inferior segment were in the territory of the circumflex or right 
coronary artery. An increase in score in :::: 1 segment from rest to stress 
constituted a positive test. Using this scoring system, an index of global left 
ventricular wall motion (wall motion score index) was calculated as: the 
sum of scores in visualised segments/number of segments visualised, at 
baseline and peak stress for both studiesbefore and after angioplasty. 
Statistical analysis. Results are expressed as mean ± standard deviation, 
and 95% confidence intervals are given where appropriate. Discrete 
variables were compared using the chi-square test and continuous 
variables using paired t tests. 
Results 
Study patients: Dobutamine stress echocardiography was performed in 
48 consecutive patients in whom elective angioplasty was planned. 
Angioplasty was performed in 33 patients; the procedure was not 
performed in the remaining 15 because of <50% diameter stenosis of the 
target vessel in 7 (stress echocardiogram negative in 6), multivessel disease 
not suitable for angioplasty in 4 (stress echocardiogram positive in 3), total 
occlusion of the target vessel in 3 (stress echocardiogram positive in 1) and 
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left main stem lesion in 1 (stress echocardiogram positive). Five patients 
undergoing angioplasty did not have stress echocardiography performed 
after angioplasty; 2 refused repeat study, 1 had acute infarction after 
angioplasty, 1 had tamponade at angioplasty and 1 had dissection and 
proceeded to bypass grafting. The data presented relate to the 28 patients 
who had dobutamine stress echocardiography before and after successful 
angioplasty. 
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Figure 1. Representation of 16-segment regional wall motion analysis, 
derived from Bourdillon et al'6• ANT = anterior; INF = inferior; LAT = 
lateral; LAX = parasternal long-axis view; POST = posterior; SAX PM 
= short axis at papillary muscle level; SEPT = septal; 2C = 2-chamber 
apical view; 4C = 4-chamber apical view. 
Nineteen patients were men (mean age was 60 ± 11.6 years). Eleven 
patients had previous myocardial infarction, 4 had previous angioplasty 
and 2 had previous bypass grafting. Twenty-three patients were receiving 
B blockers, 14 oral nitrate preparations and 16 calcium antagonists. 
Twenty-four patients had I-vessel coronary disease. The target vessel 
was the left anterior descending in 11 cases, the right coronary artery in 11 
and the circumflex in 7; 1 patient had lesions in 2 arteries dilated. For all 
29 lesions the residual lesion after angioplasty was < 50% diameter 
stenosis. 
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Stress echocardiography studies: All 28 patients underwent dobutamine 
stress echocardiography 1 day before and within 3 days after angioplasty. 
Mean time of the second study was 13 ± 0.6 days after angioplasty; in 22 
patients, the study was repeated within 1 day after angioplasty. 
Table 1. Haemodynamic changes during stress testing before and after 
angioplasty. 
Base Peak P Value 
Heart rate(beats/min) Before PTCA 67 ± 12 121 ± 22 <10" 
After PTCA 73 ± 13 124 ± 24 <10-6 
p value 0.03 059 
SP(mmHg) Before PTCA 133 ± 17 146 ± 22 0.002 
AfterPTCA 127 ± 17 138 ± 21 0.003 
value 0.1 0.1 
Results expressed as mean ± $0. 
PTCA = percutaneous transluminal coronary angioplasty, SP = systolic blood 
pressure. 
Table I shows the haemodynamic changes during the 2 studies. Atropine 
(up to 1 mg intravenously) was administered at the end of stage 4 to 20 
patients, 15 in both studies before and after angioplasty, and 5 in one or 
the other stud only. Twenty-three patients were receiving B blockers at the 
time of the study; 19 of the 20 who needed atropine were receiving B 
blockers. In both studies before and after angioplasty there was a 
significant increase in both heart rate and systolic blood pressure from 
base to peak stress. Although baseline heart rate was higher in the study 
after angioplasty, peak heart rate was the same in both studies. There was 
no significant difference between systolic blood pressure before and after 
angioplasty, at either baseline or peak stress. 
Wall motion abnormalities at rest were seen in 5 patients on 
echocardiograms before and after angioplasty. Figure 2 shows the 
percentage of patients with stress induced new wall motion abnormalities, 
chest pain and ST segment changes before and after angioplasty. Before 
angioplasty,20 (71%, 95% confidence interval 51 to 87%) developed new 
wall motion abnorma1ities compared with 4 (14%, 95% confidence 
interval 4 to 33%) after angioplasty (p<O.OOOl). The frequency of positive 
stress echocardiography for each of the dilated coronary arteries is shown 
in table II. 
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Figure 2. Percentage of patients with positive echo, chest pain and ST 
changes before and after angioplasty. 
Table II Frequency of positive stress echocardiogram for each of the 
dilated coronary arteries. 
Vessel Dilated No. of Positive Echocardiograms (%) 
BeforePTCA AfterPTCA 
Left anterior descending 67 ± 12 121 ± 22 
Left circumflex 73 ± 13 124 ± 24 
Ri t coron arte 0.Q3 0.59 
PTCA = percutaneous transluminaI coronary angioplasty. 
Of the 20 patients with a positive test before angioplasty, the site of new 
wall motion abnormality was consistent with the diseased coronary artery 
in 17. In the remaining 3 patients, 1 with circumflex disease had new wall 
motion abnormality in the anterior and septal areas, 1 with right coronary 
disease had resting inferior abnormalities that extended to the posterior 
septum at stress, and the 1 who had lesions dilated in both left anterior 
descending and circumflex arteries developed changes in both inferior and 
lateral areas. The site of new wall motion abnormality was consistent with 
the site of the dilated vessel in 3 of the 4 patients with positive stress 
echocardiography after angioplasty; in the fourth (who had the 2-vessel 
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dilatation), the new wall motion abnormalities again developed in the 
inferior and lateral areas. 
The frequency of chest pain also decreased; before angioplasty, 14 
patients (50%, 95% confidence interval 31 to 69%) developed chest pain 
compared with 6 (21%, 95% confidence interval 8 to 41%) after 
angioplasty (p = 0.05). Before angioplasty, 10 patients (36%, 95% 
confidence interval 19 to 56%) developed ST changes (6 depression, 4 
elevation), and 8 (29%, 95% confidence interval 13 to 49%) had ST 
changes after angioplasty (7 depression, 1 elevation). 
The 85% of predicted maximal exercise heart rate for sex and age was 
achieved in 14 patients before angioplasty (1 for new wall motion 
abnormality, 5 for ST changes and 8 for chest pain) compared with 7 after 
angioplasty (1 for ST changes, 5 for chest pain and 1 for chills), p = 0.09. 
Of the 4 patients with multivessel disease, the test after angioplasty was 
positive in 2, including the 1 who had 2 lesions dilated. Of the 2 patients 
with multivessel disease and a negative stress test after angioplasty, 1 had 
total occlusion of the right coronary artery, and 1 had previous coronary 
grafting with patent grafts. When patients with a previous myocardial 
infarct were separately analyzed, 10 of 11 had positive echocardiography 
before angioplasty compared with 2 after angioplasty. Furthermore, of 5 
patients in this group, 4 had positive echocardiography before angioplasty, 
which was reduced to 2 after angioplasty. 
To further assess the change in dobutamine-induced ischaemia before 
and after angioplasty, new wall motion abnormalities, chest pain and ST 
depression were regarded as markers of ischaemia, and the number of 
patients with 0, 1, 2 and 3 markers before and after angioplasty are shown 
in figure 3. The distribution of frequency of markers of ischaemia was 
different before and after angioplasty, with more patients having 2 or 3 
markers before angioplasty, and more having no markers after angioplasty 
(chi-square 15.4, degrees of freedom 3, p = 0.002). 
Wall motion score indexes: Regional wall motion analysis was performed 
in 95% of the ventricular segments, and a wall motion score was derived 
both before and after angioplasty. Before angioplasty, mean wall motion 
score index (figure 4) increased from 1.06 ± 0.15 at baseline to 1.23 ± 0.22 
at peak stress (p < 10-6). After angioplasty there was a small but 
insignificant increase in wall motion score index from 1.08 ± 0.20 to 1.10 
±0.22. There was no significant difference between baseline wall motion 
score indexes before and after angioplasty, but the index at peak stress was 
significantly higher in the study before angioplasty (1.23 ± 0.22 vs 1.10 ± 
0.22, p = 0.00002). 
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Figure 3. Number of patients with 3, 2, 1 and 0 markers of ischaemia 
during stress tests before and after angioplasty. 
Complications: There were no serious complications related to either 
dobutamine or atropine. Before angioplasty, 2 patients had frequent 
ventricular ectopics including couplets, 1 had frequent atrial ectopics, 1 
nodal rhythm and 1 chills. After angioplasty i patient had ventricular 
ectopics, 1 nodal rhythm and 1 chills. Metoprolol was needed by 10 
patients before angioplasty either for relief of chest pain that did not 
resolve spontaneously within 5 minutes of stopping the stress test, or for 
ST elevation; after angioplasty, metoprolol was administered to 5 patients 
for the same reasons. 
Discussion 
This is the first study that uses dobutamine stress echocardiography for 
assessment of patients before and early after angioplasty. The reduction 
in frequency of development of new wall motion abnormalities, and 
difference in change in wall motion score index after angioplasty indicate 
the reduction in dobutamine-induced myocardial ischaemia after 
angioplasty. Similar changes were seen in the incidence of chest pain 
before and after angioplasty, although the use of such a subjective end 
point may be misleading, because patients may confuse discomfort 
associated with tachycardia with ischaemic heart pain, despite careful 
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questioning. The total incidence of ST segment changes (both elevation 
and depression) did not change after angioplasty; before angioplasty, 10 
patients had ST changes, 4 of whom had elevation (2 with previous Q-
wave infarction), and after angioplasty, 8 had ST changes, 1 of whom had 
ST elevation (no previous infarction). Of the latter 8 patients, the test after 
angioplasty was stopped for ST elevation in 1, chest pain in 2, and because 
an adequate heart rate was achieved in 5. Inspection of the data before 
angioplasty of these patients showed that the test was stopped for ST 
elevation in 2, pain in 5, and in only 1 did the test proceed to achievement 
of target heart rate. Therefore, although preliminary inspection of the data 
on ST segment changes suggests no reduction in ischaemia as assessed by 
ST changes, such inspection without consideration of other indicators of 
ischaemia may be misleading, because those patients with ST changes 
after angioplasty often stopped the stress test before angioplasty because 
of other evidence of ischaemia that may have occurred before ST changes. 
Accordingly, in an attempt to overcome such confounding influences of 
the various indicators of ischaemia, we used the number of patients 
completing the stress test (i.e, achieving 85% of the predicted maximal 
exercise heart rate, without significant chest pain or ST changes 
necessitating termination of the test).Although these results did not reach 
the conventional level of statistical significance, the trend was towards 
more patients completing the test after angioplasty (75% vs 50%; p=O.09). 
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Figure 4. Mean wall motion score indices (WMSI) before and after 
angioplasty. ns = nonsignificant. 
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Similarly, a combination of ischaemic events during the test showed that 
more patients had no markers of ischaemia after angioplasty, and more 
had 2 or 3 markers of ischaemia before. 
Twenty patients developed new wall motion abnormalities during the 
stress test before angioplasty, indicating a sensitivity of 71% for the 
detection of coronary artery disease. Recent datal7 show that sensitivity of 
stress echocardiography for detection of coronary disease using 
dipyridamole is reduced in patients on antianginal therapy. Continuation 
of a blockers (as in 23 of these patients) antagonizes the a-adrenergic 
effect of dobutamine9, and this lintited the sensitivity of dobutamine stress 
echocardiography in our laboratory6. Accordingly, the protocol for 
dobutamine stress echocardiography has been changed with the addition 
of atropine at the end of 15 minutes of dobutamine infusion (maximum 
dose 40 )Lg/kg/minute) in those patients who have not achieved 85% of 
the predicted maximal exercise heart rate and not developed obvious new 
wall motion abnormalities, ST changes, chest pain or side effects regarded 
as being due to dobutamine and needing termination of the test. 
Accordingly, 20 of these patients received atropine, 15 in both studies and 
5 in either the study before or after angioplasty. Of 19 patients who 
received atropine in the study before angioplasty, off-line analysis showed 
a new wall motion abnormality that had been unrecognised during on-line 
assessment in 1 during dobutamine alone and in 11 after atropine. Using 
our previous protocol without the addition of atropine, dobutamine stress 
echocardiography would have been positive in 10 of 28 patients, resulting 
in a sensitivity of 36%. 
The mean time to the stress test after angioplasty was 13 days; in 22 
patients; the test was repeated within 1 day of angioplasty, and at this stage 
there was already a reduction in dobutamine-induced new wall motion 
abnormalities. The time of the study after angioplasty, and the frequency 
of patients with persisting positive studies are similar to those reported by 
Picano et all3 using dipyridamole as the stress agent. This is in contrast to 
a previous study reported by Manyari et allS using exercise thallium scin-
tigraphy to assess myocardial perfusion after angioplasty, which showed a 
delay in intprovement in myocardial perfusion in 12 of 43 patients studied 
Later repeat stress echocardiography may have detected a further 
intprovement in myocardial function in our patients; however, our study 
is not directly comparable to that of Manyari, because thallium uptake is 
an indicator of perfusion and metabolic integrityl9, whereas stress 
echocardiography, being dependent on the development of systolic 
dysfunction, is an indicator of true myocardial ischaemia. 
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In su=ary, this study shows that before angioplasty, stress 
echocardiography using dobutamine with the addition of atropine, if 
necessary, to achieve target heart rate has a sensitivity of 71% for 
detection of coronary artery disease in patients, with mainly 1-vessel 
disease on medication. The relief of a coronary stenosis reverses 
dobutarnine stress-induced ischaemia early after angioplasty, and more 
patients proceed to complete the stress testing protocol without stopping 
because of chest pain, ST changes or obvious new wall motion 
abnormalities. 
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CHAPTERS 
DOBUTAMINE STRESS-DOPPLER ECHOCARDIOGRAPHY 
BEFORE AND AFTER CORONARY ANGIOPLASTY1 
El-Said MEl-Said MB Bch MS, Paolo M Fioretti MD, Jos RTC 
Roelandt MD, Albert J McNeill MD, Hans Rijsterborgh PhD, 
Tamas Forster MD, C DiMario, and David T Linker MD. 
Thoraxcenter, University Hospital Rotterdam-Dijkzigt and Erasmus 
University, Rotterdam, The Netherlands. 
Abstract 
To determine if dobutamine-induced myocardial ischaemia causes 
abnormalities in Doppler parameters of left ventricular ejection and 
filling and to assess early effects of successful coronary angioplasty 
(PTCA) on these parameters, dobutamine stress echocardiography and 
Doppler studies were performed once in 11 normal volunteers and twice 
in 17 patients (within 1 day pre- and post-PTCA). Dobutamine induced 
wall motion abnorma1ities, ST changes and angina in 11, five and five 
patients, respectively, before and three, two and one patients, 
respectively, after PTCA Doppler indices of both systolic and diastolic 
function were comparable at rest, before and after PTCA Dobutamine 
induced similar increases in peak aortic velocity and average 
acceleration in healthy individuals (39% and 53%) and in patients with 
one-vessel disease both before (38% and 39%) and after PTCA (39% 
and 40%). In the three patients with multivessel disease peak aortic 
velocity showed a blunted response (-03%) before PTCA but increased 
by 17% after PTCA, while acceleration decreased both before (12%) 
and after PTCA (14%). There were significant differences (p<0.0001) 
lEuropean Heart Journal 1993;14:1011-1021 
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between healthy individuals and pre-PTCA patients in the effect of 
dobutamine on peak early (E) filling velocity (+ 34% vs -19%), E-
acceleration (+35% vs -26%), peak early to atrial filling velocity ratio 
(EfA) (-0.7%vs -37%) and diastolic time velocity integral (1VI) (+34% 
vs -22%). After PTCA, the response of Doppler diastolic indices 
improved during dobutamine, as shown by the increase in E and E-
acceleration (+ 8%, + 24%, respectively) and by the decline in the 
reduction of EfA and TV! (-17% and -10%, respectively). Thus, the 
response of Doppler diastolic parameters to dobutamine stress is a 
sensitive indicator of significant coronary disease and is superior to 
changes in ejection indices. Successful PTCA resulted in improvement 
in diastolic filling response to dobutamine stress. 
Introduction 
Myocardial ischaemia causes changes in left ventricular systolic and 
diastolic function1,2. Percutaneous transluminal coronary angioplasty 
(PTCA) is an effective therapeutic modality of revascularization for 
patients with significant coronary artery disease3• Intprovements in left 
ventricular systolic and diastolic function either at rest or during stress 
have been reported after PTCA 4,5, but data concerning early 
improvements in resting left ventricular diastolic properties are 
conflictini,6. However, studies of left ventricular filling during exercise 
after PTCA have been limited to radionuclide angiography'. Doppler 
parameters of left ventricular ejection and filling have now been well 
validated7•9 and have been used to detect stress-induced myocardial 
ischaemialO.13.14. 
The use of pharmacological stress echocardiography with dobutamine 
for evaluating the functional significance of coronary disease is 
increasing15•16. We have previously shown that dobutamine stress 
echocardiography is useful in detection of myocardial ischaemia and its 
reduction after PTCA16.17• However no information is available 
concerning the effect of high dose dobutamine stress test on Doppler 
indices of left ventricular ejection and filling dynamics in patients 
undergoing PTCA 
The aims of this study were to determine whether dobutamine-
induced myocardial ischaemia in patients undergoing PTCA causes 
abnormalities in Doppler-derived parameters of left ventricular systolic 
and diastolic function and to assess the early effect of successful PTCA 
on these parameters. 
55 
Subjects and Methods 
Study population: This study included two groups. Group I consisted 
of clinically healthy volunteers (11 men, ranging in age from 25 to 67 
years; mean 41) in whom the following criteria were satisfied:(l) no 
history of acute or chronic cardiac or any other disease, (2) normal 
physical examination, resting 12-lead electrocardiogram and two-
dimensional echocardiogram with colour flow mapping and Doppler, (3) 
no use of any medication. Group II consisted of 20 consecutive patients 
with stable angina pectoris and > 50% reduction in the luminal diameter 
of at least one major coronary artery referred for elective PTCA 
Dobutamine stress test was not repeated after PTCA in three patients, 
one patient refused, and two patients had an PTCA-related 
complications. Group II, therefore, consisted of 17 patients (13 men and 
four women, ranging in age from 38 to 80 years; mean 60). No patient 
had left ventricular hypertrophy, frequent ectopy, valvular or congenital 
heart disease, significant valvular regurgitation (grade two or more) or 
impairment of the global left ventricular systolic function. Eight patients 
had prior myocardial infarction and two had previous PTCA For ethical 
considerations and to avoid confounding effects of medications, the 
medical therapy was kept unchanged and at the same dosages both 
before and after PTCA Twelve patients were treated with f3 blockers, 
eight with oral nitrates and seven with calcium antagonists. Fourteen 
patients had single-vessel disease and three had multivessel disease. 
Dobutamine-stress test: All subjects gave informed verbal consent to 
undergo dobutamine stress test after full explanation of the procedure. 
Dobutamine stress test was performed once in the healthy individuals 
and twice in the patients (within 1 day pre- and post-PTeA). Following 
baseline 12-lead electrocardiography, blood pressure and two-
dimensional echocardiography and Doppler, a graded dobutamine stress 
regimen of 10, 20, 30 and 40 I'g/kg/min in 3 min stages with the last 
stage (stage 4) lasting for 6 min, was started. Atropine (0.25 - 1 mg) was 
then added, while continuing dobutamine, if there were no signs of 
ischaemia including new wall motion abnormalities (WMA), ST changes 
or angina and 85% predicted maximum exercise heart rate was not 
achieved during dobutamine alone'8. Twelve patients received atropine 
pre-PTCA and nine post-PTCA Throughout the test, two-dimensional 
echocardiography and electrocardiography were continuously monitored, 
12-lead electrocardiogram was recorded each minute and cuff blood 
pressure every 3 min. Criteria for discontinuation of the test were, ST 
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depression ~ 2 mm 80 rns after the J point, ST elevation, significant 
angina or any complication regarded as being due to dobutamine. 
Echocardiographic technique and analysis: Using a Hewlett-Packard 
Sonos 1000 echo apparatus, standard parasternal and apical views were 
acquired with 2.5 MHz transducer and recorded on VHS video-tape 
during the last minute of each of stages 1 to 3 and continuously for the 
last 4 min of stage 4 and during atropine. All echocardiograrns were 
assessed on-line by the cardiologist and off-line by 2 experienced 
investigators without knowledge of the patient's clinical or angiographic 
data. Wall motion of the baseline and peak recordings were 
semiquantitatively assessed and scored using a 16-segment left 
ventricular model'9 and a 4 point score: 1 = normal, 2=hypokinetic, 
3 = akinetic, 4 = dyskinetic. An ischaemic response was defined as the 
development of new WMA associated with abnormal myocardial 
thickening in an area which was normal at rest or worsening of WMA 
at peak stress in a segment which was abnormal at rest. A wall motion 
score index was calculated as the sum of scores assigned to each segment 
divided by the number of segments and used as an index of global left 
ventricular wall motion. 
Doppler technique and analysis: Doppler signals of ascending aortic 
blood flow and transmitral flow were recorded at baseline and peak 
dobutamine (stage 4) before addition of atropine. Aortic flow signals 
were obtained with the subject in the supine position by a 2.5 MHz 
nonimaging continuous wave Doppler transducer placed at the 
suprasternal notch. Using a 2.5 MHz pulsed Doppler transducer, the 
transmitral flow velocity profile was recorded from the apical four-
chamber view while the patient was in the left lateral recumbent 
position, with the sample volume located at the mitral leaflet tips. 
Special care was taken to maintain the depth of the sample volume 
throughout each study both before and after PTCA Doppler signals with 
simultaneous electrocardiogram and phonocardiogram were recorded on 
paper at a speed of 50-100 mm/s. 
All Doppler measurements were performed by an experienced 
cardiologist by tracing the outermost portion of the velocity envelope 
utilizing an off-line computer, a digitizing tablet and a dedicated 
software program20. Aortic peak velocity was measured and average 
acceleration was determined by dividing peak velocity by the time from 
onset of the flow to peak velocity. Parameters of left ventricular filling 
including peak velocities of both early (E) and atrial (A) diastolic filling 
and their ratio (E/ A), peak E-wave acceleration and deceleration rates, 
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diastolic time velocity integral (TV!) and isovolumic relaxation period 
(time from aortic valve closure to the onset of mitral flow) with the 
corresponding heart rate were measured from simultaneous Doppler 
signals of mitral flow, phonocardiogram and electrocardiogram 
recordings. For each of the Doppler measurements eight consecutive 
cardiac cycles were analyzed and the results averaged. 
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Figure 1 Individual, mean and standard deviation values of the minimal 
luminal diameter and percent diameter stenosis of the dilated coronary 
segment obtained by quantitative analysis before and after PTCA 
Coronary angiopZasty: Using standard equipment and techniques21 
angioplasty was performed within 1 day of the initial stress test. 
Quantitative analysis of the stenotic coronary segments pre- and post-
PTCA was performed with the computer assisted Cardiovascular 
Angiography Analysis System (CAAS), which has been described and 
validated earlie~.23. Standardization of acquisition and analysis of 
cineangiograrns was done as previously described24• The vessel dilated 
was the circumflex in nine, the left anterior descending in seven and the 
right coronary in two, including dilatation of two vessels in the only 
patient with two-vessel disease. PTCA was considered successful in all 
patients, defined as a < 50% residual stenosis by visual inspection which 
has been confirmed quantitatively. The minimal luminal diameter of the 
dilated segment increased significantly from 1.01 ± 0.33 mm before to 
1.82 ± 0.33 mm after PTCA (Figure 1). Also, there was a significant 
reduction in the % diameter stenosis from 62% before to 31 % after 
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PTCA (Figure 1), which gives a mean difference in the stenosis diameter 
between pre- and post-PTCA of 31%. 
Variability of measurements: Overall random variation (beat-to-beat 
variation plus intra-observer error) was estimated by applying a one-way 
analysis of variance to data from 14 randomly selected subjects, and 
expressed as standard deviation and percentage deviation (Table 1). 
Based on these results, the minimum significant difference needed to 
decide whether a change induced by dobutamine is indeed significant for 
an individual patient was defined as a percent change in Doppler 
parameter from baseline to peak dobutamine that exceeds the limits of 
the measurement variability. 
Table 1. Measurement variability in Doppler trans mitral flow 
parameters. 
Mean±SD Random measurement variability 
(SD) (SD%) 
E (em/s) 66±19 3.6 ±5% 
A (ern/s) 64±17 4.4 ±7% 
E/A 1.2±0.5 0.116 ±10% 
E-ACC (m/s2) 9.4±2.9 1.12 ±12% 
E-DEC (m/s2) 3.8±1.1 0334 ±9% 
TV! (em) 15.8±4 0.% ±6% 
IRP (ms) 78±14 3.059 ±4% 
A = peak atrial filling velocity; E = peak early filling velocity, E/ A = peak early to 
atrial fllling velocity ratio; E-ACC = E-wave acceleration; E-DEC = E-wave 
deceleration; IRP = isovolumic relaxation period; SD = standard deviation; TVI = 
diastolic time velocity integral. 
Statistical analysis: Results are expressed as mean ± standard 
deviation. Continuous variables, before and after dobutamine and before 
and after PTCA, were compared using paired t-test. The significance of 
the differences among the groups was assessed by an unpaired t-test. A 
level of p < 0.05 was considered to be statistically significant. 
Results 
Dobutamine-stress test: All patients had technically adequate 
echocardiograms and Doppler recordings. There were technical 
difficulties with the phonocardiogram in two patients and Doppler 
recordings of aortic flow in one patient. 
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Angina, ST changes and wall motion analysis: All subjects were in sinus 
rhythm. None of the healthy volunteers had dobutamine-induced 
markers of ischaemia. In all subjects hyperkinetic wall motion with 
enhanced systolic thickening were seen in the normal segments during 
dobutamine infusion. No serious complications occurred during the test. 
Three patients with multivessel disease and prior myocardial infarction 
showed baseline WMA both before and after PTCA These consisted of 
hypokinesia of the inferior wall in two patients and of the inferolateral 
wall in one patient. Wall motion score index was comparable before and 
after PTCA (1.05 ± 0.13 vs 1.07 ± 0.18, p=NS). 
Table 2. Markers of ischaemia during dobutarnine stress test before and 
after PTCA 
Markers of ischaemia pre-PTCA post-PTCA 
n = 17 n = 17 
Wall motion abnormalities 11 3 
ST changes 5 2 
Angina 5 1 
None 2 12 
Table 3. Angiographic and echocardiographic findings in patients with 
post-PTCA dobutarnine-induced WMA 
Cor.angio/DS% WMA/SI 
Base Peak 
1 Pre CX/57% 
RC-LAD" 
1/1.25 1/15 
Post CX/37% 
RC-LAD" 
1/1.25 1/15 
2 Pre LAD/65% S/121 
Post LAD/2S% S/121 
3 Pre CX/58% I,L/15 I,L/2 
LAD/54% 
Post CX/37% 1,L/1.75 I,L/1.88 
LAD/29% 
oil _ total occlusion; Cor.angiojDS% - coronary angiography/percent diameter 
stenosis; ex = circumflex coronary artery; I = inferior; L = lateral; LAD = left 
anterior descending; pre and post = before and after PTCA; RC = right coronary 
artery; WMA/SI = wall motion abnormalities/score index. 
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The frequency of dobutamine-induced markers of ischaemia before 
and after PTCA are shown in Table 2. Wall motion analysis before 
PTCA showed abnormalities that had been unrecognized during 
dobutamine alone in four patients after atropine, while after PTCA 
abnormalities occurred in one patient after atropine. Three patients had 
post-PTCA dobutamine-induced WMA which were the same as those 
pre-PTCA (Table 3). Wall motion score index increased significantly 
from 1.05 ± 0.13 to 1.24 ± 0.3 (p = 0.003) pre-PTCA, compared to 
insignificant increase from 1.07 ± 0.18 to 1.1 ± 0.22 (p = 0.4) post-
PTCA Both before and after PTCA the minimal luminal diameter and 
the % diameter stenosis did not differ between patients with and without 
dobutamine-induced WMA 
Table 4. Haemodynamic variables and Doppler parameters of left 
ventricular ejection and filling at baseline and peak dobutamine in 
healthy individuals and patients before and after PTCA 
Healthy individuals pre-PTCA post-PTCA 
Base Peak Base Peak Base Peak 
Haemodynamics 
· 114±19: I HR (beats/min) 71±S 100±13 63±9 lOS±lS· 68±15 
SBP (mm Hg) 122±8 160±11· 131±14# 144±22· 121.11+ 135.18 
Aortic indices 
PV (em/s) 122±22 170.33· 117±31 155.49· 12l±33 163.46· 
A-ACC (m/s2) 19.2 28.9±6 16.1.4# 21±5.6·# 17.1.6 22±6· 
Mitral indices 
E (em/s) 67±10 90±13 · 62.13 50±13·# 65±12 70±14·+ 
A (em/s) 50±10 61.12 · 67±13# 85±13·# 66±14 86±13 
E/A 1.4±0.4 1.4±0.4 0.9±03# 0.6±0.2·# 1.1±03 0.8±0.2·+ 
E-ACC (m/':') 10±15 13±2· 9.1.2 1.2.(# 11±3 13±2"+ 
E-OEC (m/s2) 43±0.8 5.1±1 · 2.9±0.9# 3±0.~ 3.2±0.8 3.8±0.8· + 
TV! (em) 13.2 17.1.7 . 17±3# 13.2±2.7·# 16.7±4 15±4+ 
IRP (ms) 78±4 55±6 · 93.11 67.15· 92±12 65±9· 
. 
p < 0.01 baseline vs dobutamine, #p < 0.01 Healthy individuals vs pre-PTCA, + p 
< 0.01 pre- vs post-PTCA. A = peak atrial fuling velocity; A-ACC = average aortic 
acceleration; E = peak early fllling velocity; E/ A = peak early to atrial filling 
velocity ratio; E~Acc = E~wave acceleration; E-Dec = E-wave deceleration; HR = 
heart rate, IRP = isovolumic relaxation period; PV = peak aortic velocity; SBP = 
systolic blood pressure; TV! = diastolic time velocity integral. 
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Haemodynamic variables (Table 4): Heart rate and systolic blood 
pressure at peak dobutamine were not significantly different between the 
study groups. Addition of atropine at the end of stage 4, resulted in a 
significant increase in heart rate from 108 ± 18 to 128 ± 15 beats/min 
(p <0.001) pre-PTCA and from 114 ± 19 to 130 ± 17 beats/min (p 
<0.001) post-PTCA In order to prevent a possible effect of a different 
heart rate on the Doppler response between the study groups, peak 
dobutamine in healthy volunteers was compared to peak dobutamine in 
patients before addition of atropine. 
Doppler analysis: Because of the considerable overlap in the absolute 
Doppler values either at baseline or peak dobutamine between the study 
groups (Table 4, Figure 2 [ a-cD, the % change from baseline to peak 
dobutamine was, in our hands, more reliable as an indicator of the 
Doppler response than the absolute values (Figure 3 [a-c]). 
Doppler indices of left ventricular ejection (Table 4): As a group patients 
with coronary disease showed a significant increase in peak aortic 
velocity in response to dobutamine, which was comparable to the 
response in healthy volunteers. The increase in acceleration, however, 
was less in patients than in healthy individuals. There were no significant 
differences between pre- and post-PTCA values of both indices either at 
baseline or at peak dobutamine. 
Subgroup analysis showed that the response of peak velocity and 
average acceleration was the same in healthy individuals (39% and 53%) 
and patients with single-vessel disease both before (38% and 39%) and 
after PTCA (39% and 40%). Patients with multivessel disease (the same 
patients with resting WMA) showed no significant differences in baseline 
values of both indices either before or after PTCA However, these 
patients had a reduced acceleration both before (-12%) and after 
PTCA( -14%). Aortic velocity showed greater variability in response. 
Before PTCA, aortic velocity was reduced in two patients (one with total 
occlusion of two major coronaries in addition to the dilated artery and 
the other with <50% stenosis of two major arteries in addition to the 
target artery), but increased in the only patient with> 50% stenosis of 
two vessels. After PTCA the aortic velocity response was modified to an 
increase of 17% compared to the blunted response (- 0.3%) before 
PTCA 
No significant differences existed in the response of both indices 
between patients with and without dobutamine-induced WMA before 
PTCA However, after PTCA patients with dobutamine-induced WMA 
showed reduction in acceleration (-18%) which did not differ from 
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before PTCA (-8%). Similarly the aortic velocity response in these 
patients remained blunted (8%) after PTCA compared to before PTCA 
(6%). 
No significant differences existed in either baseline or the % change 
of both indices between patients with and without myocardial infarction 
before or after PTCA 
Doppler indices of left ventricular filling: At baseline, patients had a 
higher A, but a lower Ej A ratio and E-wave deceleration, longer 
isovolumic relaxation period and larger TVI compared to healthy 
individuals (Table 4). Baseline values of filling indices did not differ 
before and after PTCA (Table 4), or among patients with and without 
myocardial infarction or in those with and without resting or 
dobutamine-induced WMA either before or after PTCA 
Three patterns of response of Doppler indices of left ventricular filling 
to dobutamine were defined, based on random measurement variability. 
The first response was a significant increase from baseline to peak 
dobutamine. The second was a blunted or insignificant change. The third 
was a significant decrease from baseline to peak dobutamine. 
Changes in A, E-deceleration and isovolumic relaxation period with 
dobutamine did not differ among all groups (Table 4). The mean % 
change of Ej A showed a flattened response in healthy individuals, a 
significant fall in patients before PTCA and a significant reduction in fall 
post-PTCA compared to pre-PTCA (Table 4). However there was 
overlap in the % change of this parameter between the three groups 
(range of -21% to 20% in normals, -16% to -56% pre-PTCA, and -36% 
to 7% post-PTCA). 
The Doppler indices that showed pronounced difference in their 
response to dobutamine between the study groups were E, E-
acceleration and TVI. There was no overlap in the % change of these 
indices between healthy volunteers and pre-PTCA patients (Figure 3 [a-
c]). All healthy individuals had a significant increase in the three indices 
except one subject had a blunted response of E-acceleration (Table 5). 
Both before and after PTCA the patients had two types of response of 
these indices to dobutamine. Prior to PTCA the response was a 
significant decrease (majority) or blunted response (minority). Post-
PTCA the response of E and E-acceleration changed to a significant 
increase in 13 patients and a blunted response in four, while the 
response of TVI was heterogenous, as shown in Table 5. 
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Figure 2 Individual, mean and standard deviation values obtained at 
baseline and peak dobutamine from healthy individuals and patients 
before and after PTCA (a) peak early (E) filling velocity; (b) E-wave 
acceleration (E-ACC); (c) diastolic time velocity integral (TVI). 
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Figure 3 Individual, mean and standard deviation values of the % 
change from baseline and peak dobutarnine, in healthy individuals and 
patients before and after PTCA The levels that distinguished between 
the three groups are (a) peak early (E) filling velocity; (b) E-wave 
acceleration (E-ACC); (c) diastolic time velocity integral (TV!). 
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Before PTCA, there was a greater reduction in E among patients with, 
compared to those without, dobutamine-induced WMA, including 
patients with previous myocardial infarction and those with multivessel 
disease or baseline WMA, (-23% vs -13%, p <0.01). However, no 
significant difference existed in the response of filling indices between 
these subgroups after PTCA 
Table 5. Classification of dobutamine-induced responses in Doppler 
indices of flow in relation to clinical status 
Healthy individuals (n=11) pre·PTCA (n=l7) post-PTCA (n=l7) 
n Mean %, range n Mean%, range n Mean%, range 
E 34% ·19% 8% 
1 11 18 to 65 13 5 to 17 
--
1 -05 14 ·2 to 2 
I 16 -7 to-36 
E-ACC 35% ·26% 24% 
1 10 14 to 72 13 15 to 59 
--
1 ·6 4 ·7 to-11 4 ·11 to 10 
I 13 ·12 to ·36 
TV! 34% -22% -10% 
1 11 11 to 59 4 7 to 15 
--
1 2 2 0.1 to -4 
I 16 -7 to -39 11 ·8 to -44 
(1) = significant increase, (--) = blunted response,(l) = significant decrease; E = 
peak early filling velocity; E-Acc = E-wave acceleration rate; Mean % and range = 
mean and range of the percent change from base to peak dobutamine, n = number 
of subjects; TV! = diastolic time velocity integral. 
Discussion 
This study addresses the response of Doppler derived parameters of 
left ventricular systolic and diastolic performance to high dose 
dobutarnine stress testing in the evaluation of patients with significant 
coronary disease before and after PTCA 
Dobutamine stress test: We confirm the recently reported usefulness of 
dobutamine stress echocardiography in the diagnosis of coronary artery 
disease (CAD)16 as well as its value in the detection of reduction in 
stress-induced myocardial ischaemia early after PTCAI7• The sensitivity 
of stress echocardiography for detection of CAD in our patients (mainly 
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single-vessel disease and on medication) is 65% which is higher than that 
of chest pain (29%) or ST changes (29%). The relatively low sensitivity 
of dobutamine-echocardiography for diagnosis of coronary disease in this 
study could be related to the small number of patients with multivessel 
disease (3/17), which increases the number of positive tests16 and to the 
possible effect of medications. 
Improvements in stress-induced ischaemia occurred after PTCA, as 
evident by the increased frequency of patients lacking markers of 
ischaemia (12 patients after PTCA vs two before PTCA). The tinle of 
the post-PTCA study and the frequency of patients with persistent stress-
induced WMA are similar to those reported by Picano et al2S using 
dipyridamole as the stress agent. Although the finding of persistent 
WMA after PTCA can be explained by incomplete revascu1arization, as 
was present in one patient, other mechanisms such as PTCA-induced 
local trauma and distal vasoconstriction or embolization, are possible26. 
Doppler indices of left ventricular ejection: Peak aortic velocity and 
aortic acceleration have been shown to be altered by the presence of 
significant coronary disease in response to exercise or dipyridamole 
stress27.28. In this study the absolute baseline and peak dobutamine 
values of peak velocity did not differ among all groups, while those of 
average acceleration were lower in patients than in healthy individuals. 
However, both indices were comparable before and after PTCA The 
differences in the absolute values of acceleration can be attributed to the 
effect of agint<>, medication31 and the possible technical problems in 
conditions such as horizontal hearts or atherosclerotic aorta. 
The insignificant difference in the response of both peak velocity and 
acceleration seen before and after PTCA and between patients with 
single-vessel disease and healthy individuals or those with and without 
dobutamine-induced WMA suggest that the extent of dobutamine-
induced ischaemic myocardium was not large. Compensatory-enhanced 
contractility in normal segments may have masked the presence of 
regional dysfunction. In contrast, the blunted response of peak velocity 
and the reduction in acceleration in patients with multivessel disease 
suggest that the extent of stress-induced ischaemic myocardium may have 
been larger, with the normal segments unable to compensate in order to 
enhance the global left ventricular performance in the presence of 
advanced coronary disease. Despite differences in methodolo~ this 
finding is supported by those of Bryg et al27 and Labovitz et al who 
showed that the response of aortic peak velocity and acceleration to 
exercise and dipyridamole stress were particularly sensitive in the 
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detection of multivessel disease. Our findings are in agreement with 
those of Mazeika et al29 who studied the effect of dobutamine (up to 20 
JLg/kg/min) on pulsed-Doppler left ventricular ejection indices and 
observed similar response in healthy individuals and coronary patients 
and a blunted response in six patients with WMA in ;8 segments all of 
whom had multivessel disease. 
Doppler indices of left ventricular filling: The Doppler pattern of left 
ventricular filling obtained in our patients at baseline demonstrated 
greater contribution of atrial filling, slower deceleration rate of early 
filling and a longer isovolumic relaxation period as compared to healthy 
individuals. This pattern is consistent with previous Doppler reports6,32 
of diastolic filling abnormalities in patients with coronary artery disease. 
However, the interpretation of this pattern as an indicator of coronary 
artery disease may be difficult due to the possible effect of anti-anginal 
medications, the overlap of the individual values between groups (Figure 
2 [a-cD and finally the nonspecificity of this pattern for coronary 
disease33• On the other hand, changes in baseline values of Doppler 
indices after PTCA were insignificant. This finding is consistent with 
previous Doppler and radionuclide reports of unchanged resting diastolic 
parameters early after PTCA4,6. In contrast, there is disagreement 
between our findings and those of Castello et als who showed 
modification in left ventricular filling pattern in 31 patients (16 with 
unstable angina) 24 hours after PTCA, and those of Masuyama et al34 
who demonstrated gradual improvement in diastolic filling in 50 patients 
(25 with multivessel disease) 2 and 9 days after PTCA. Differences in 
patient populations and methodology may explain these findings. 
Changes in E, E-acceleration, E/A and TV! induced by dobutamine 
were the most useful for distinguishing healthy subjects from pre-PTCA 
patients and for identifying the beneficial effects of PTCA (Figure 3 [a-
c]). In healthy subjects E, E-Acc and TV! increased significantly while 
E/ A remained unchanged. In contrast, the response of these parameters 
in pre-PTCA patients was different and significantly decreased. After 
PTCA, improvements in the response of these indices occurred during 
dobutamine, as evidenced by changing the direction of the response for 
E and E-acceleration from decreasing pre-PTCA to increasing post-
PTCA and by the significant decline in the reduction of E/ A and TV! 
post-PTCA compared to pre-PTCA. If one consider that a significant 
increase (above the limits of measurement variability) is the normal 
response of Doppler filling indices to dobutamine, and a significant 
decrease (below the limits of measurement variability) and/or a blunted 
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response (within the limits of measurement variability) is the abnormal 
responses (Table 5), the response of E to dobutamine: (1) correctly 
identified 11 of 11 healthy individuals, (2) predicted the presence of 
significant coronary disease in 17 of 17 patients, and (3) identified 
improvements after PTCA in 13 of 17 patients (Table 5). Although E 
failed to increase in four patients after PTCA, there was a significant 
modification among those four in whom the response changed from a 
significant decrease of -21% pre-PTCA to a blunted response of -0.8% 
post-PTCA (Figure 2 raJ). 
The pattern of augmented diastolic filling seen in healthy subjects is 
in agreement with previous clinical3S,36 reports, which demonstrated that 
inotropic stimulation utilizing dobutamine increases early filling rate with 
augmented filling velocities. The response of Doppler indices of diastolic 
filling to dobutamine in our patients was similar to that previously 
reported in patients during ischaemia induced by coronary occlusion 
during PTCA2, pacing!3 or dipyridamole stress!4. Despite the absence of 
simultaneous intracardiac pressure and quantitative left ventricular 
volume measurements, these abnormalities in the response of mitral 
velocity pattern to high dose dobutamine suggest that dobutamine 
induced myocardial ischaemia was a possible mechanism for these 
alterations. This is further supported by the observed greater reduction 
in E in patients with, as compared to patients without, new WMA at 
peak dobutamine. 
Our observation of improved Doppler response of diastolic function 
during dobutamine after PTCA is in agreement with that of Lewis et al4, 
who demonstrated improvement in exercise diastolic function after 
PTCA as assessed by radionuclide angiography. The inability of Doppler 
filling indices to respond to dobutamine after PTCA to the same extent 
as in healthy individuals may be explained by the differences in age 
between the two groups or by the concept of stunned myocardium32. 
Repeated later, the test could have shown further normalization of the 
Doppler response. 
Limitations oj the study: Doppler patterns of left ventricular ejection 
and filling are influenced by a number of well known factors25,27.28. Some 
of these are particularly relevant to this study. A number of our patients 
had received anti-anginal medications, including ,B-blockers, which may 
have attenuated the effect of dobutamine to induce myocardial 
ischaemia !6,26. However, since medications were not changed during 
studies, we believe that this should not affect our results. A second 
problem is the age differences between healthy individuals and coronary 
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patients which, may explain some of the observed abnormalities in the 
response of Doppler diastolic indices before PTCA. However, the fact 
that the Doppler response of filling indices changed towards the normal 
after PTCA suggests that the abnormalities seen before PTCA were the 
results of coronary disease rather than aging alone. Finally, other factors 
which may confound analysis of Doppler profile, such as significant 
arrhythmias and fusion of E and A waves at high heart rates were not 
a problem in our population. 
Conclusions. The response of Doppler parameters of left ventricular 
filling during dobutamine stress testing is a more sensitive indicator of 
significant coronary disease than that of ejection parameters. 
Dobutamine-induced changes in Doppler indices of left ventricular 
ejection were the same before and after PTCA. The evaluation of the 
response of left ventricular filling to dobutamine stress before and early 
after successful PTCA in the same patient was useful in identifying 
improvements in diastolic response that were not evident at rest. These 
initial results suggest that Doppler examination of mitral flow could be 
usefully added to wall motion analysis during dobutamine stress test. 
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CHAPTER 6 
ABNORMAL LEFT VENTRICULAR EARLY DIASTOLIC 
FILLING DURING DOBUTAMINE STRESS DOPPLER 
ECHOCARDIOGRAPHY IS A SENSITIVE INDICATOR OF 
SIGNIFICANT CORONARY ARTERY DISEASE1 
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Paolo M Fioretti MD, Albert J McNeill MD, 
T Forster, David T Linker MD FACe. 
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University, Rotterdam, The Netherlands. 
Abstract 
Objective. This study was designed to assess changes in Doppler 
parameters of left ventricular ejection and filling in response to high 
dose (40 I-'gjkgjmin) dobutamine stress and their utility in detection of 
coronary artery disease compared to new wall motion abnormalities. 
Methods. Ten patients with low likelihood of coronary artery disease, 
served as a control group, and 23 patients with documented single vessel 
coronary artery disease underwent baseline and peak dobutamine -
echocardiography and Doppler studies. 
Results. In both groups dobutamine induced similar increases in heart 
rate and systolic blood pressure. During the test 14 patients had new 
wall motion abnormalities, 13 angina, and 7 ST changes. No markers of 
ischemia occurred in the control subjects. Dobutamine induced 
1 J Am Coll Cardiol 1994; in press 
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qualitatively similar changes from baseline to peak in controls and 
patients in peak aortic velocity (46% vs 42%, p = NS), average aortic 
acceleration (61% vs 43%, p=O.04), and systolic time velocity integral 
(7% vs 2%, p=NS). Dobutamine caused marked increases in controls 
and decreases in patients in peak early filling velocity (E) (33% vs -22%, 
p<O.0001), and average E-acceleration (76% vs -28%, p<O.OOOl). The 
response of Doppler early filling indices to dobutamine stress was 
abnormal in all patients. There was no overlap in the percent change 
from baseline to peak dobutarnine, between controls and patients for E 
and E-acceleration. 
Conclusions. During dobutamine-stress test, an abnormal response of 
Doppler parameters of left ventricular early filling is a more sensitive 
marker of significant single vessel coronary disease than new wall motion 
abnormalities and is far superior as a predictor of coronary artery 
disease than the response of Doppler ejection parameters. 
Introduction 
Myocardial ischemia is well known to alter both systolic and diastolic 
properties of the left ventricle1•2• Both peak velocity and acceleration of 
blood out of the left ventricle are closely correlated with global left 
ventricular performance3 •• , and have been used to detect stress induced 
ischemia in man (5.6). It has been proposed that left ventricular diastolic 
function can be more susceptible to ischemic disturbance than systolic 
function, in addition, changes in diastolic parameters often precede 
systolic changes and therefore may be more sensitive indicators of 
myocardial ischemia:!.7.8. Doppler echocardiography is a noninvasive 
technique that is capable of providing beat to beat information about 
left ventricular ejection 3.4 and filling dynamics9 either at rest or during 
stress. 
We have previously shown that dobutamine stress echocardiography 
is useful in detection of myocardial ischemialO•l1 • However, no 
information is available regarding the changes in Doppler parameters of 
either left ventricular ejection or filling in response to high dose 
dobutamine in subjects with and without coronary artery disease (CAD). 
This study was undertaken to assess the changes in Doppler-derived 
parameters of left ventricular systolic and' diastolic function induced by 
high dose dobutamine-stress and their utility in detection of CAD 
compared to wall motion analysis. 
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Methods 
Study population: This study comprised two groups. Group I consisted 
of 10 patients (6 men and 4 women with a mean age of 51 ± 9 years) 
referred for stress perfusion scintigraphy for assessment of atypical chest 
pain and low likelihood of CAD. They fulfilled the following criteria: (1) 
no history of cardiovascular disease, (2) normal physical examination, 
resting 12-lead electrocardiogram (ECG) and two-dimensional 
echocardiogram with colour flow mapping and Doppler, (3) normal 
symptom limited exercise ECG and perfusion technetium-99m MIBI 
single photon emission computed tomography. This population served as 
a control group. 
Group II consisted of 23 patients (19 men and 4 women, with a mean 
age of 56 ± 11 years) with stable angina pectoris and 2:50% diameter 
stenosis in a single major coronary artery and in whom elective 
angioplasty was planned. Patients with left ventricular hypertrophy, 
frequent ectopy, valvular or congenital heart disease, significant valvular 
regurgitation (grade two or more) or impairment of global left 
ventricular systolic function (ejection fraction < 0.50) were excluded. 
Ten patients had history of old myocardial infarction. Antianginal 
medication could not be discontinued in our patients. Fifteen patients 
were treated with beta blockers, 13 with nitrates and 10 with calcium 
antagonists. 
Study protocol: All subjects gave informed verbal consent to undergo 
dobutamine stress test after full explanation of the procedure. Following 
recordings of baseline ECG, blood pressure and two-dimensional 
echocardiography including Doppler, a graded dobutamine infusion was 
started at and increased by 10 Ilgjkgjminute at 3 minutes stages to a 
maximum of 40 Ilgjkgjmin with the last stage for 6 minutes. Atropine 
(0.25 -1 mg) was added while continuing dobutamine in patients without 
signs of ischemia (wall motion abnormalities, ST-changes, angina) who 
had not achieved 85% predicted maximum exercise heart rate during 
dobutamine alone12• Two-dimensional echocardiography and ECG were 
continuously monitored. ECG was recorded each minute and cuff blood 
pressure every 3 minutes. Criteria to stop th~ test were, ST depression 
2: 2 mm 80 rns after the J point, ST elevation, significant angina, 
significant arrhythmia or any complication regarded as being due to 
dobutarnine. 
Echocardiographic technique and analysis: Standard parasternal and 
apical views were acquired using a Hewlett-Packard Sonos 1000 echo 
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apparatus with 2.5 MHz transducer. The optimal transducer positions 
were marked on the chest. Echocardiograms were recorded on VHS 
video-tape during the last minute of each of stages 1 to 3, and 
continuously for the last 4 minutes of stage 4 and continuously for up to 
10 minutes after discontinuation of infusion. 
Wall motion analysis: Without knowledge of the patient's clinical or 
angiographic data, all echocardiograms were assessed on-line by the 
cardiologist and off-line by 2 experienced investigators. Wall motion and 
thickening of the baseline and peak recordings were semi quantitatively 
assessed and scored using a 16-segment left ventricular model'3 and a 4 
point score: 1 = normal, 2 = hypokinetic, 3 = akinetic, 4 = dyskinetic. The 
development of new wall motion abnormalities associated with 
worsening of wall thickening constituted a positive test. We did not use 
a continuous loop format because we have previously tested whether 
cine loop analysis of dobutamine echocardiography had advantages for 
the interpretation of the images over the analysis from video tape and 
found the same results by the two techniques12• 
Doppler technique: Doppler signals of the ascending aortic blood flow 
and the transmitral flow were obtained at baseline and peak 
dobutamine. With the subject in supine position, the ascending aortic 
blood flow velocity was obtained with 2.5 MHz non-imaging continuous 
wave Doppler transducer placed at the suprasternal notch. The 
transducer was positioned to gain optimal signals as judged by a 
combination of acoustic and visual feedback. Using the apical4-chamber 
view in the left lateral recumbent position, the transmitral blood flow 
velocity profile was recorded using a 2.5 MHz pulsed Doppler imaging 
transducer, with the sample volume located at the mitral leaflet tips. To 
maintain the sample volume location at the mitral leaflet tips the depth 
of the interrogation was recorded at baseline and reproduced at peak 
dobutamine. Doppler signals with simultaneous EeG and phonocardio-
gram were recorded on paper at a speed of 50-100 rom/so 
Analysis of Doppler data: All Doppler studies were analyzed by an 
experienced cardiologist by tracing the maximum velocity envelope. All 
measurements were performed utilizing an off-line computer, a digitizing 
tablet and a dedicated software. The following Doppler-derived 
parameters of left ventricular filling were measured: peak early filling 
velocity (E), peak atrial filling velocity (A), peak early to atrial velocity 
ratio (E/ A), average E-wave acceleration rate (determined by dividing 
peak E by the time from onset of the flow to peak E), average E-wave 
deceleration rate (determined by dividing peak E by the time from onset 
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of the flow to an extrapolation of the deceleration slope to the baseline), 
total diastolic time-velocity integral (TVID)' corresponding heart rate and 
isovolumic relaxation period (time from aortic valve closure on the 
phonocardiogram to the onset of mitral flow). Similarly, peak aortic 
velocity and total systolic time-velocity integral (TVIs) were measured 
from the Doppler signals of aortic flow and average acceleration was 
determined by dividing peak velocity by the time from onset of the flow 
to peak velocity. For each of the Doppler measurements eight 
consecutive cardiac cycles were analyzed and the results averaged. 
Coronary angiography: Angiography was performed within one day 
from dobutamine stress test with the use of standard techniques, with 
visualization of the coronary arteries in multiple projections. 
Quantitative analysis of the stenotic coronary segments was performed 
with the computer assisted Cardiovascular Angiography Analysis System 
(CAAS), which has been described and validated earlier!4. Standardiz-
ation of acquisition and analysis of cineangiograrns was done as 
previously described!5. The stenosed vessel was the left anterior 
descending in 11 patients, the circumflex in 8 and the right coronary in 
4. Quantitative analysis was not performed in 2 patients because of total 
occlusion ofthe left anterior descending in one patient and the right 
coronary in another. The median % diameter stenosis was 62% (range 
50% - 100%). 
Statistical analysis: Data are expressed as mean ± standard deviation. 
We used an unpaired t-test to compare between control subjects and 
patients and the paired t-test to compare between baseline and peak 
dobutamine. A level of p < 0.05 was considered to be statistically 
significant. 
Results 
Dobutamine-stress test: All patients had technically adequate 
echocardiograms and Doppler recordings of the mitral flow. There were 
technical difficulties in the phonocardiographic detection of the aortic 
component of the second heart sound in two patients. There were 
difficulties in the recordings of the aortic flow in 6 patients, therefore, 
data from Doppler aortic flow relate to 17 patients. 
Angina, ST changes and wall motion analysis: All subjects were in sinus 
rhythm. None of the patients in group I developed angina, ST changes 
or wall motion abnormalities. In this group dobutamine infusion induced 
hyperkinetic wall motion with enhanced systolic thickening. 
78 
Resting wall motion abnormalities were detected in 3 patients. In the 
group of patients with CAD during peak stress, including addition of 
atropine, new wall motion abnormalities occurred in 14 patients, angina 
in 13 and ST changes in 7 (6 depression> 1 mm and 1 elevation). Of the 
18 patients who received atropine, wall motion analysis showed new wall 
motion abnormalities that had been unrecognized during dobutamine 
alone in 7 patients after atropine. New wall motion abnormalities 
occurred in 8/11 patients with left anterior descending disease and in 
6/12 \vith left circumflex or right coronary artery disease. No serious 
complications occurred during the test. 
Hemodynamic variables (Table 1): At baseline heart rate was 
significantly lower in patients compared to controls, however, there were 
no differences in the hemodynamic variables between the two groups at 
peak dobutamine. In order to prevent a significant effect of heart rate 
on the Doppler response between the study groups and to avoid 
problems such as fusion of E and A waves at high heart rate, peak 
dobutamine in the control subjects was compared to peak dobutamine 
in patients with CAD before addition of atropine. 
Doppler aortic flow variables : Table 1 shows the mean ± standard 
deviation values, at baseline and peak dobutamine, of aortic flow indices 
in control subjects and CAD patients. There were no significant 
difference in baseline values of aortic flow indices between control 
subjects and patients. Dobutamine resulted in a significant increase in 
peak aortic velocity in control subjects and patients (46% vs 42%, 
respectively, p = 0.6). Average aortic acceleration increased significantly 
with dobutamine in both groups, however, the increase in the control 
subjects was significantly higher than in patients (61 % vs 43%, respe-
ctively, p = 0.04). The systolic time velocity integral increased slightly in 
the control subjects and patients (7% vs 2%, p = 0.4). Comparison 
between patients with and without new wall motion abnormalities at 
peak stress showed no significant difference in any of the aortic flow 
indices between the two subgroups. 
Doppler transmitral flow variables: The mean ± standard deviation 
values of Doppler transmitral variables at baseline and peak dobutamine 
in the study groups are also presented in Table 1. 
At baseline, patients had lower E-deceleration, longer isovolumic 
relaxation period and larger TVIo as compared to controls (Table 1). 
There were pronounced differences, between control subjects and CAD 
patients, in the effect of dobutamine on Doppler indices of left 
ventricular filling. In control subjects dobutamine induced marked and 
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significant increases in E, A, E-acceleration and TVID (Figures 1 and 2), 
marked shortening in isovolumic relaxation period and no change in 
Ej A ratio or E-deceleration (Table 1). In patients, changes in response 
to dobutamine showed significant reduction in E, E-acceleration, TVID 
(Figures 1 and 2), Ej A ratio and isovolumic relaxation period, with a 
significant increase in A (Figure 1). 
Table 1: Hemodynamic variables and Doppler parameters of left 
ventricular systolic and diastolic function at baseline and peak 
dobutamine in control subjects and patients with CAD. 
Control subjects Patients with CAD 
Base Peak Base Peak 
Hemodynamic variables 
HR (bpm) 74 ± 8 112 ± 14' 62 ± 8'" 109 ± 16' 
SBP (mm Hg) 131±7 160 ± 14 , 133 ± 14 153 ± 24" 
DBP (mm Hg) 78 ± 6 81 ± 8 78 ± 7 85 ± 8 
Aortic flow indices 
PV (em/s) 105 ± 16 154 ± 30' 120 ± 29 168 ± 41" 
A-Ace (m/t?-) 17.1 ± 15 27.4 ± 4.6' 16 ± 1.6 22.4 ± 4.9 '''' 
TVIs (em) 20 ± 4.3 215 ± 52' 25.3 ± 7.7 25.7 ± 8.3 
Mitral flow indices 
E (em/s) 65 ± 9 85 ± 13' 69 ± 13 54 ± 9'''' 
A (em/s) 57 ± 11 79 ± 19' 66±13 86 ± 13' 
E/A 1.2 ± 02 1.1 ± 0.3 1.1 ± 0.3 0.6 ± 0.1 '''' 
E-Ace (m/s2) 9.8 ± 1.3 17.3 ± 3.4' 10.8 ± 2.4 7.7 ± 2.1'''' 
E-Dec (m/t?-) 42 ± 0.9 4.6 ± 1 3.3 ± 0.9'" 32 ± 0.6'" 
TVID (em) 13 ± 2 15.4 ± 1.4' 18.3 ± 2.8'" 13.6 ± 2.5'''' 
IRP (ms) 81 ± 6 58 ± 7' 92 ± 10" 68 ± 14, 
" P < 0.Q1 baseline vs dobutamine, # p < 0.05 control subjects vs patients with 
CAD. A = peak atrial filling velocity, A-Acc = average aortic acceleration, DBP = 
diastolic blood pressure, E = peak early filling velocity, E/A = peak early to atrial 
filling velocity ratio, E~Acc = E-wave acceleration, E-Dec = E-wave deceleration, 
HR = heart rate, IRP = isovolumic relaxation period, PV = peak aortic velocity, 
SBP = systolic blood pressure, TVID and TVIs = diastolic and systolic time velocity 
integral, ,respectively. 
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Figure 1: Individual, mean and standard deviation values of peak early 
(E) and atrial (A) filling velocities obtained at baseline and peak 
dobutamine from control subjects and patients with CAD. 
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Figure 2: Individual, mean and standard deviation values of average E-
wave acceleration rate (E-Acc) and diastolic time velocity integral 
(TVID) obtained at baseline and peak dobutamine from control subjects 
and patients with CAD. 
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Figure 3: Individual, mean and standard deviation values of the percent 
change from baseline to peak dobutamine in peak early (E) filling 
velocity, average E-wave acceleration rate (E-Acc), and early to atrial 
filling velocity ratio (E/ A). Note the levels that distinguished patients 
with CAD from control subjects. 
Although the trends in the response of mitral Doppler indices to 
dobutamine were different between the 2 groups, there was a 
considerable overlap in the absolute baseline and peak dobutamine 
values (Figure 1 and 2). On the other hand there was no overlap in the 
range of percent change, from baseline to peak dobutamine, between 
controls and patients for peak E (mean 33%, range 5% to 67% in 
controls vs -22%, rang -11% to -38% in patients; p < 0.0001), and E-
acceleration (mean 76%, range 22% to 117% in controls vs -40%, rang-
6% to -55% in patients; p < 0.0001) as shown in Figure 3. Overlap in 
the percent change of TVID (mean 21 %, range -8% to 73% in controls 
vs -25%, rang 2% to -49% in patients; p < 0.0001), occurred in 4 control 
subjects who had reduction in TVID and 2 patients. 
Discussion 
Several studies described changes of Doppler-derived parameters of 
either systolid'·6 or diastolic16.17 left ventricular performance in response 
to various physiologic and pharmacologic interventions and suggested 
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that Doppler examination might be an useful adjunct to stress testing. 
This study describes the effects of high dose dobutamine (40 I'g/kg/min) 
on Doppler parameters of left ventricular systolic and diastolic function 
in a control group of patients with chest pain but low likelihood of CAD 
and patients with significant single vessel CAD and to assess the utility 
of this approach in detection of CAD compared to wall motion analysis. 
Dobutamine stress test: Hyperkinetic wall motion with increased 
systolic thickening of normal segments was observed in both groups. 
Dobutamine-induced new wall motion abnormalities were detected in 7 
patients only after addition of atropine. This may be due to continuation 
of antianginal medication in these patients'S• In the current study the 
sensitivity of dobutamine-atropine echocardiography for detection of 
single vessel CAD (61%) is com~arable with those reported by Cohen 
et al'9 (69%) and Mazeika et al2 (50%). The sensitivity was higher for 
left anterior descending disease. This is in agreement with previous 
reports of our grouV'. 
Doppler aortic flow indices: In this study changes in aortic flow indices 
with dobutamine showed qualitatively similar responses both in the 
control subjects and patients with CAD. Dobutamine-induced 
augmentation of ventricular contractility and reduction in peripheral 
vascular resistance may explain the increase in aortic velocity and 
acceleration observed in this studr. The statistically significant lower 
rise in aortic acceleration in patients compared to control subjects may 
suggest the proposed high sensitivity of this index in detecting subtle left 
ventricular dysfunction3.-. Against this concept is the insignificant 
difference in changes in aortic indices between patients with and without 
dobutarnine-induced wall motion abnormalities. Medications and in 
particular f3 blockers may have attenuated the rise in aortic acceleration 
in CAD patients23• These findings suggest that regional dysfunction was 
not severe enough to alter the global function, probably due to a 
compensatory hyperkinesia in the normal segments. Our findings are in 
agreement with those of Mazeika et al24 who studied the effect of 
dobutamine (up to 20 I'g/kg/min) on pulsed-Doppler left ventricular 
ejection indices and observed similar responses of aortic flow indices to 
dobutamine in normal subjects and patients with single vessel CAD. 
Doppler transmitral flow indices: In control subjects, dobutamine 
resulted in a uniform and a marked increase in E, A, TVID, E-
acceleration with no change in E/ A ratio or E-deceleration. The 
mechanism of this augmented diastolic filling may involve: (1) improved 
myocardial relaxation secondary to a 13, mediated increase in 
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intracellular cyclic adenosine 3',5' -monophosphate, which accelerates the 
rate of calcium reuptake by the sarcoplasmic reticulum and thus 
stimulates myocardial deactivation process25, (2) enhanced systolic 
performance augmenting filling by mechanical suction26, (3) increased 
heart rate which may accelerate myocardial relaxation27_ 
Abnormalities in Doppler indices of left ventricular filling, such as, 
reduced E with augmented A and low E/ A ratio, have been reported in 
patients with myocardial ischemia at rest9• In the current study the mitral 
velocity pattern obtained in patients at baseline demonstrated lower E-
deceleration and longer isovolumic relaxation period when compared to 
controls. This pattern, even in the absence of reduced E or E/ A, 
suggests altered relaxation9• However, the interpretation of these data 
may be difficult due to several factors: (1) slower heart rate in patients 
at baseline, (2) effect of antianginal medications, (3) the overlap of 
values between the two groups, (4) and finally the nonspecificity of this 
pattern for CAD28. 
In patients with CAD, and in response to dobutamine left ventricular 
filling was found to be significantly altered in all patients as evidenced 
by the marked decrease in E, E-acceleration, E/ A ratio and TVID and 
increase in A These findings coupled with similar previously reported 
alterations in left ventricular filling during acute ischemia induced by 
different modalities2,16,17, suggest that myocardial ischemia is a possible 
mechanism influencing diastolic filling pattern in response to high dose 
dobutamine. 
Left ventricular diastolic filling is predominantly mediated by a 
complex interaction of myocardial relaxation, passive filling properties, 
and left atrial pressure28. This complicate the interpretation of the 
alterations in mitral velocity pattern, specially in the absence of 
sinlultaneous intracardiac pressure and quantitative left ventricular 
volume measurements. However, some mechanisms can be proposed to 
explain such alterations. The reduction in parameters of early flliing 
(peak E and E-acceleration) observed in our patients may be attributed 
to impaired myocardial relaxation secondary to myocardial ischemia28. 
This is particularly true in the absence of significant increase in left 
atrial pressure, due either to increased chamber stiffness or 
abnormalities in loading conditions29. It is not expected that left atrial 
pressure will rise during dobutamine as has been previously 
demonstrated that dobutamine-induced ischemia results in a decrease in 
stroke volume with no change in pulmonary wedge pressure30• 
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Increased atrial contribution to filling may have resulted as a 
compensatory mechanism to reduced early filling or secondary to 
increased heart rate28.29. In presence of increased heart rate atrial systole 
may occur during the deceleration sl'?Pe of early filling resulting in 
increase in atrial contribution to filling"'. 
Changes in TVIo during dobutamine-induced ischemia may reflect a 
true reduction in stroke volume30 or may be due to shortening of the 
diastolic filling period secondary to increase heart rate. Against the first 
assumption is the insignificant change in TVIs> which theoretically should 
parallel changes in TVIo. In agreement with the second assumption is 
the fact that rapid heart rate considerably shorten diastolic filling time 
more than the duration of contraction. In our patients, the reduction in 
diastolic filling time from baseline to peak dobutamine (45%) was 
significantly higher than the reduction in ejection time (22%). 
Limiiations of the study: Doppler patterns of left ventricular ejection 
and filling are influenced by a number of well known factors23,28,31.33. 
Some of these are particularly relevant to this study. Previous studies 
have demonstrated that aortic flow indices and early filling indices 
obtained by Doppler decrease progressively with age31,33. A factor which 
may have contributed in part to some of the observed abnormalities in 
Doppler response in our patients. We believe that the abnormalities 
observed in early filling indices in response to dobutamine reflect true 
ischemia, and not merely due to the influence of age or medications. We 
have performed dobutamine stress Doppler echocardiography on 
patients before and after coronary angioplasty, and found that the 
Doppler response of filling indices changed towards the normal response 
after angioplasry3". Changes in heart rate have been shown to 
significantly alter the Doppler transmitral profile predominantly by 
increasing atrial contribution to fi!lin~. However, our conclusions were 
not based on changes of peak A or Ej A ratio. In spite of the limitations 
in Doppler methodology, our results sufficiently dramatic to encourage 
further investigations in larger population. 
Conclusions: Our findings demonstrate that: (1) in patients with low 
likelihood of CAD high dose dobutamine-stress enhances left ventricular 
systolic and diastolic performance, as evidenced by the marked increase 
in Doppler measurements of both ejection and filling dynamics and the 
hyperkinetic wall motion; (2) changes in Doppler parameters of systolic 
function with dobutamine stress can not be reliably used to identify 
individual patients with single vessel CAD; (3) during dobutamine stress 
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test all patients had an abnormal response of Doppler parameters of 
early filling. 
Thus, it appears that during dobutarnine-stress test, an abnormal 
response of Doppler parameters of left ventricular early filling is a more 
sensitive marker of significant single vessel CAD than new wall motion 
abnormalities. 
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Abstract 
To assess the reproducibility of dobutamine-atropine echocardiography 
testing, two studies (1 to 20 days apart [mean 3.3 days])were performed 
in 23 patients with stable effort angina pectoris or chest pain. During the 
study, 20 (87%) patients were receiving beta blockers alone or combined 
with nitrates or calcium antagonists. Dobutamine was infused at doses 
of 10 J.Lg/kg/minute every 3 minutes up to a maximum of 40 J.Lg/kg/min 
and this maximal dose was continued for 6 minutes. In patients not 
achieving 85% predicted maximal heart rate or myocardial ischemia, 
atropine (0.25 - 1 mg) was added and dobutamine continued for another 
3 minutes, until either an adequate heart rate was achieved or the test 
was considered positive. During dobutamine infusion 
electrocardiographic, echocardiographic, and blood pressure monitoring 
were obtained in each patient. Side effects including tremor, nausea, 
palpitation, dizziness, headache, and nonsustained ventricular tachycardia 
occurred in three patients. The same symptoms, but no ventricular 
tachycardia, developed during the same stage of the second test. Angina 
pectoris (eight patients), electrocardiographic changes (six patients), and 
'Echocardiography 1993;10:93-97. 
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ischemic wall-motion abnormalities (six patients), were observed at the 
same stage of the two tests. The mean values of heart rate, blood 
pressure and rate-pressure product were comparable for each stage in 
duplicate tests. Our data show that pharmacological stress 
echocardiography using dobutarnine-atropine has good reproducibility 
and provides a useful tool for assessing disease progression and the 
effects of therapeutic interventions in patients with coronary artery 
disease. 
Introduction 
Pharmacological echocardiography stress testing with adenosine, 
dipyridamole and dobutamine, is increasingly used for identifying 
patients with coronary artery diseasel •lO• In contrast to conventional 
exercise stress testing"·12, only a few studies exist regarding the 
reproducibility of sequential pharmacological stress echo!3, which is 
relevant when these tests are used to evaluate the efficacy of therapeutic 
interventions in patients with coronary heart disease. Accordingly, the 
present study was undertaken to assess the short-term reproducibility of 
dobutamine-atropine echocardiography testing with regard to time of 
onset of symptoms, hemodynamic parameters, left ventricular wall-
motion abnormalities, and electrocardiographic changes in patients with 
stable angina pectoris or a high probability of coronary disease. 
Methods 
Patients: Twenty-three consecutive patients (13 men and 10 women, 
mean age 62 ± 10 years) with stable effort angina pectoris or chest pain, 
referred to our laboratory for echocardiography stress testing were 
enroled after informed consent was obtained. The presence of coronary 
heart disease was documented in 21 (91%) of 23 patients by history of 
a previous myocardial infarction, coronary angiography, or exercise 
single-photon emission computed tomography perfusion. During the 
study, 20 (87%) patients were receiving therapy with beta blockers alone 
or combined with nitrates or calcium antagonists. 
Study protocol: In each patient, two dobutamine echocardiography 
tests were performed at an interval of 1 to 20 days (mean 3.3 days). 
Clinical condition and therapy remained stable between the two studies. 
Dobutamine-Atropine Test: Dobutamine was infused intravenously by 
an infusion pump with continuous electrocardiographic and 
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two-dimensional echocardiographic monitoring, using a protocol that 
included six operative stages organized as follows: 10 ILg/kg/minute over 
3 minutes (stage 1); 20 ILg/kg/minute over 3 minutes (stage 2); 30 
ILg/kg/minute over 3 minutes (stage 3); 40 ILg/kg/minute over 3 minutes 
(stage 4); 40 ILg/kg/minute over 3 minutes (stage 5); and atropine 0.25 
- 1 mg (stage 6) that was added on top of dobutamine when the target 
heart rate or an ischemic end point was not reached'. Dobutamine 
infusion was stopped when the heart rate reached 85% of the age 
predicted maximal heart rate, or at the onset of new significant 
electrocardiographic ST depression or elevation, clear echocardiographic 
wall-motion abnormalities, angina, or major side effects. If the test was 
strongly positive, in case of side effects or if the heart rate remained 
increased for longer than 5 minutes after the end of the infusion, an 
intravenous beta blocker was administered (metoprolol 1 to 5 mg). 
Blood pressure was measured by cuff sphygmomanometer at the end of 
each stage of the protocol, and 12-lead ECG was recorded every minute. 
Rate-pressure product, the time from the beginning of dobutarnine 
infusion to onset of symptoms, wall-motion abnormalities, and ECG 
changes were evaluated. 
Echocardiography: Two-dimensional echocardiographic images were 
obtained with a commercially available imaging system (Hewlett-
Packard SONOS 1000 [Hewlett- Packard, Andover, MA, USA]), and 
recorded on a connected videotape (Panasonic 6200 VHS) for later 
playback and analysis. In the baseline studies as well as during each 
stage, multiple sections, including parasternal long and short axes, apical 
two- and four-chambers views were obtained when possible. The 
echocardiograms were independently analyzed off line by two 
experienced observers unaware of the clinical findings and the study 
sequence. The judgment of a third observer was obtained in doubtful 
cases. A test was considered positive if a transient wall-motion 
abnormality or an extension of a previously asynergic area developed 
following administration of dobutamine-atropine. Left ventricular wall 
motion was visually evaluated by two observers, stage by stage, and 
scored as 1 (normal or hyperkinetic), 2 (hypokinetic), 3 (akinetic), and 
4 (dyskinetic) in a 14-segments left ventricular model. A wall-motion 
score index was calculated by adding the numeric value assigned to each 
segment and dividing by the number of segments visualized. 
Statistical Analysis: Heart rate, blood pressure, rate-pressure product 
and wall-motion scores were reported as mean values ± standard 
deviation. Differences for each stage and between the two tests were 
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compared using the paired Student's t-test. Categorical variables were 
evaluated with Chi-square test. For statistical significance a value of p 
< 0.05 was required. 
Results 
Clinical and hemodynamic results: Two sequential 
dobutamine-atropine tests were performed in all 23 patients. Minor side 
effects including palpitations, an episode of nonsustained ventricular 
tachycardia (9 beats), tremor, dizziness or headache were observed in 3 
(13%) patients during the first test. In each of these cases, the same side 
effects, with the exception of ventricular tachycardia, developed at the 
same stage of the second test. In addition to dobutamine, atropine was 
given intravenously in 10 (43%) patients at the first test, and in 12 
(52%) patients during the second. Beta blocker was administered in 12 
(52%) and in 13 (56%) patients at the end of the first and the second 
tests, respectively (Table I). Heart rate, systolic blood pressure, 
rate-pressure product at rest and during the other stages did not 
significantly differ between the two tests (Fig. 1). These parameters 
progressively and significantly increased during dobutamine-atropine 
infusion at a similar extent during the two tests. Angina pectoris 
occurred in 8 (35%) patients at the same stage in the first and the 
second test, while heart rate, blood pressure, and the double product 
were comparable in 7 of these patients (Table I). 
Electrocardiographic changes: Ischemic ST depression (1 mm or more) 
and one case of ST elevation were detected in six (26%) patients at the 
same stage of both tests; these induced ischemic changes were of similar 
extent and in the same territory for the two tests. 
Eclzocardiographic results: Resting echocardiographic wall-motion 
abnormalities were identified in ten (43%) patients, all with a history of 
a previous myocardial infarction. During dobutamine-atropine testing, 
new and transient dyssynergy occurred, with similar extent and 
localization, at the same stage of both tests in six (26%) patients, all 
with documented coronary disease. 
In the present study there was disagreement between the two 
observers for reading the stress echocardiography in 3 (6.5%) of 46 tests. 
These data are consistent with inter- and intraobserver variability of 
91 % and 92 %, respectively, as previously tested in our laboratory7. 
92 
Table 1 Clinical, electrocardiographic, and echocardiogarphic 
abnormalities observed in the study population during duplicate 
dobutamine-atropine echocardiography tests. 
Test I Test II Agreement 
(23 Patients) (23 Patients) (%) 
Side effects 3 3 100 
Angina 8 8 100 
ST depression 5 5 100 
ST elevation 1 1 100 
Transient dyssynergy 6 6 100 
Atropine 10 12 83 
Metoprolol 12 13 92 
HeJlrt Rate 
dobut.omll1OO (m~II/XaImln) 
B Iood Pressure 
_ T=I E:2a T~t II 
Figure 1. Comparison of mean values of heart rate and systolic blood 
pressure between dobutamine-atropine echocardiography tests. 
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Discussion 
Two-dimensional stress echocardiography is increasingly used in the 
evaluation of patients with coronary artery disease. Among the different 
types of stress proposed, pharmacological stimulation with dipyridamole 
or dobutamine is largely used in the clinical setting for its well-
established safety, and high sensitivity and specificity in detecting single 
and multivessel coronary disease. The mechanism by which these two 
drugs induce ischemia is different: dipyridamole!4 mainly by a blood flow 
maldistribution, with reduction of subendocardial flow in the territory 
related to the stenotic coronary artery; and dobutamine lS by a complex 
stimulation of alpha!, beta! and betaz adrenoreceptors, which induces an 
increase in heart rate, systolic blood pressure and myocardial 
contractility with consequent marked increase in myocardial oxygen 
consumption. Reproducibility is the first feature of a stress test that 
needs to be defined before using the test for assessing efficacy of 
therapeutic interventions. A high reproducibility is well documented for 
conventional treadmill and bicycle exercise stress testing but no studies 
exist regarding dobutamine stress echocardiography. Recently Picano et 
al!3 reported good reproducibility of dipyridamole stress 
echocardiography in patients with effort and rest angina. The 
reproducibility of a stress test depends on some biological and technical 
variables: the time course evolution of the disease that influences the 
threshold of angina; the effects of therapy; and the inter- and 
intraobserver variability in performing the procedure and interpreting 
the results. To avoid these problems, we emoled patients with stable 
effort angina or chest pain, the two tests were performed at a short time 
interval, no therapeutic changes were made during the study, and two 
experienced echocardiographers with good training in stress 
echocardiography reviewed the examinations. In this study, symptoms, 
side effects, heart rate, blood pressure, heart-pressure product, and wall 
motion did not significantly differ for the two tests. However, we must 
take into account that our data are expressed as mean group values, and 
some minimal individual differences have been observed in heart rate 
and systolic blood pressure, particularly because these parameters can 
be easily influenced by vagal tone and some external factors. This could 
explain, for example, the different number of patients that needed the 
addition of atropine for reaching 85% of the predicted maximum heart 
rate during the first and the second tests. 
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In conclusion, pharmacological echocardiography stress testing by 
dobutamine-atropine has good reproducibility and provides a useful tool 
for assessing disease progression and effects of therapeutic interventions 
in patients with coronary artery disease. 
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CHAPTER 8 
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Abstract 
The aim of this study was to investigate the reproducibility of transmitral 
Doppler parameters of left ventricular filling in subjects undergoing 
dobutamine stress and to estimate threshold values which can be used 
as a reference to detect significant changes in Doppler measurements 
from baseline to peak dobutamine in an individual patient. The study 
groups included 11 male volunteers and 26 patients with coronary artery 
disease. Intra and inter-observer tests were performed on 14 randomly 
selected tracings. The random variation of measurements (beat to beat 
variations plus random observer error) was estimated at baseline and 
peak dobutarnine both in normals and patients. The parameters studied 
were: peak early (E) and atrial (A) filling velocities and their ratio 
(E/ A), early filling acceleration (E-AC) and deceleration (E-DC) rates 
and diastolic time velocity integral (TV!). Intra- and interobserver mean 
differences were generally small «5%) with the largest found in the 
interobserver differences in E-AC (12%) and TV! (7%). The random 
variation of measurements at baseline were similar in normals and 
!Echocardiography 1994; in press 
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patients with the smallest «5%) variation in E and the largest in E-AC 
(12%) and E/A (8%). There was a significant (p<O.Ol) increase in the 
coefficient of variation from baseline to peak dobutamine for E (4.5% 
vs 7.6%), E-AC (11% vs 14.8%) and E-DC (6.5% vs 9.3%) in the 
patient group. The threshold values were calculated based on the 
random variation in a single patient and with the assumption that 3, 5 
or 8 beats were analyzed at both instances. Conclusions: When Doppler 
evaluation of left ventricular filling is used during dobutamine stress, the 
following points should be considered: (a) peak E has the smallest 
variability among Doppler indices that assess early filling phase, (b) the 
variability of Doppler measurements of early filling increases with stress 
intervention in patients with CAD, (c) increasing the number of beats 
averaged from 3 to 8 reduces the threshold needed to decide significant 
difference in Doppler measurements between baseline and peak 
. dobutamine by more than the half. 
Introduction 
Doppler echocardiography is a noninvasive technique capable of 
providing beat to beat information about left ventricular (LV) filling! 
and has been well validated against other invasive and noninvasive 
methods2,3. Abnormalities of Doppler indices of LV filling have been 
demonstrated in patients during ischaemia induced by dynamic exercise', 
pacini and dipyridamole stress test6 and have been proposed as more 
sensitive indicators of myocardial ischaemia than systolic abnormalities7,8. 
Pharmacological stress testing utilizing dobutamine is increasingly used 
for the evaluation of the functional significance of coronary artery 
disease (CAD)9,!O. We have previously shown that dobutamine 
echocardiography has good reproducibility and provides a useful tool for 
assessing disease progression and the effects of therapeutic interventions 
in patients with CADll. The use of the Doppler technique with 
dobutamine stress, as well as other interventions, is limited by the 
uncertainty as to whether a change induced by dobutamine is indeed 
significant or caused by measurement variability. 
The reproducibility of the Doppler method is determined by the 
consistent error (bias) and the random variation of measurements. 
Differences in bias can be measured with interobserver tests. The overall 
random variation (beat-to-beat variation plus random observer error) 
can be estimated by performing serial measurements of consecutive 
cardiac cycles. Previous studies on the reproducibility of Doppler 
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measurements of LV filling have been performed in subjects in the 
resting state
'
2,13 and have not defined the reproducibility of Doppler 
measurements of LV filling during dobutamine stress, or any other stress 
modalities, or determined the threshold values which constitute a 
significant difference in Doppler measurements in an individual patient 
during stress intervention. 
The purpose of this study, therefore, is to assess the reproducibility of 
Doppler indices of LV filling both at baseline and peak dobutamine in 
normal subjects and CAD patients and to estimate threshold values 
which can be used as a reference to detect significant changes in 
Doppler measurements from baseline to peak dobutantine in an 
individual patient. 
Methods 
Study population: The study population comprised two groups. Group 
I consisted of 11 clinically healthy volunteers, all men with a mean age 
of 41 ± 12 years. All subjects had normal exantination, resting 
electrocardiogram (ECG) and two-dinlensional echocardiogram and 
Doppler and none had history of cardiovascular or any other disease or 
was on any medication. Group II consisted of 26 patients (22 men and 
4 women, with a mean age of 56 ± 10 years) with documented CAD. 
Twenty two patients had single-vessel disease and 4 had multivessel 
disease. Sixteen patients were treated with beta blockers, 14 with nitrates 
and 11 with calcium antagonists. All subjects included were in sinus 
rhythm. 
Study protocol: After giving informed consent dobutamine stress test 
was performed according to the previously described protocol9• 
Dobutamine was infused starting at a dose of 10 !-'g/kg/min, increasing 
by 10 !-'g/kg/min every 3 minutes to a maximum of 40 !-'g/kg/min which 
was continued for 6 minutes. 
Doppler technique: Doppler signals of the transmitral flow were 
obtained at baseline and peak dobutamine by an experienced 
cardiologist using a Hewlett-Packard Sonos 1000 echo apparatus with 2.5 
MHz transducer. The velocity profile was recorded from the apical 4-
chamber view with the sample volume located between the mitral leaflet 
tips. Doppler signals with simultaneous ECG were recorded, at least 20-
25 beats, on paper at a speed of 50 mm/s. 
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Figure 1: Schematic representation of transmitral flow velocity profile 
with simultaneous electrocardiogram (BCG), demonstrating Doppler 
measurements of: A = peak atrial filling velocity, AT = acceleration 
time, E = peak early filling velocity, E-AC = E wave acceleration rate, 
E-DEC = E wave deceleration rate, DT = deceleration time, TVI = 
total diastolic time velocity integral. 
Analysis of Doppler data: All Doppler recordings were analyzed by an 
experienced cardiologist by tracing the maximum velocity envelope. All 
measurements were performed utilizing an off-line computer, a digitizing 
tablet (Summagraphics MM961) and a dedicated software14• The 
following measurements were obtained from simultaneous Doppler 
siguals of mitral flow andECG (Figure 1): (1) Indices of early filling: a-
peak early filling velocity (E); b. average early filling acceleration rate 
(B-AC), calculated by dividing peak E over the time interval from 
beginning of the flow to peak E; c. average early filling deceleration rate 
(E-DC), calculated by dividing peak E over the time interval from peak 
E to the time when flow velocity returns to baseline; (2) indices of atrial 
contribution to LV filling: a- peak atrial filling velocity (A); b. the ratio 
between peak early and atrial filling velocities (BI A); (3) diastolic time-
velocity integral (TVI) as an index of global LV filling and (4) 
corresponding heart rate (HR). For each of the Doppler measurements 
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7 to 8 consecutive cardiac cycles were analyzed to avoid respiratory 
effect. 
Variability oj measurements and statistical methods: Intra- and 
interobserver variability were assessed by analysis of 14 randomly 
selected Doppler recordings twice by one observer and once by anotber 
experienced echocardiographer independently. Differences in observer 
bias were estimated for every parameter by calculating tbe mean values 
of tbe differences of tbe paired measurements. The significance of tbe 
difference of observer bias was tested using a paired t-test. 
Overall random variation (beat-to-beat variation plus random observer 
error) was estimated by applying one way analysis of variance IS. Random 
variation was expressed as standard deviation and as a % relative to tbe 
mean (coefficient of variation). Coefficients of variation at baseline and 
peak dobutamine were compared using an F-ratio test. 
Based on tbe number of measurements taken at botb instances and 
witb tbe knowledge of the mean values of respective measurements and 
tbe standard deviation of the total random variation, threshold values for 
statistically significant changes between 2 consecutive Doppler 
examinations were calculated with an unpaired t-test'6. In this way one 
can assess whetber a change induced by dobutamine is indeed significant 
(fall outside tbe range of random measurement variability), for an 
individual patient. A level of p < 0.05 was considered statistically 
significant. 
Results 
Intra- and inter observer variability: The means and standard deviations 
of tbe intra-and interobserver differences with tbe mean values, standard 
deviations and ranges of tbe measurements obtained from 108 
measurements in 14 randomly selected recordings are shown in Table 1. 
Small (~5%) but significant differences in observer bias were found in 
some Doppler indices. The largest differences, relative to tbe mean of 
tbe measurements, were observed in tbe interobserver test of E-AC 
(12%) and TV! (7%). 
Random measurement variability: The random measurement variation 
(beat-to-beat variation plus random observer error) of the respective 
Doppler parameters estimated at baseline and peak dobutamine in the 
healtby volunteers and expressed as standard deviation and coefficient 
of variation are shown in table II. The smallest variations were found in 
tbe HR and peak E eitber at baseline or peak dobutamine. There were 
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no significant differences in the coefficients of variation of the 
measurements between baseline and peak dobutamine for all parameters 
except E-DC. The latter showed significantly larger variations at peak 
dobutamine compared to that at baseline. 
Table 1. The results of the intra- and interobserver tests. 
Intra-observer Interwobserver 
Univariate statistics# differences differences 
parameter mean SO range mean SO mean SO 
Em/s 0.653 0.186 0.200·1.D4 .0.002 0.029 0.024' 0.043 
Am/s 0.652 0.163 0.289-1.01 -0.001 0.029 0.016' 0.042 
E/A 1.12 0542 0.239·1.12 0.003 0.081 0.01 0.143 
E-ACm/s2 8.91 2.44 4.68·16.4 0.478' 1.43 1.08' 2.4 
E.OC m/s2 356 1.08 154-756 0.145 0544 -0.027 1.04 
TVIem 16.6 4.04 8.01-27.6 ·0.6' 1.44 1.15' 1.98 
HR b/min 80 26 48-137 0.118 131 -0.156 3.78 
. P < 0.01; #" mean values, standard deviation and ranges of 108 measurements; A = 
peak atrial filling velocity; E = peak early filling Velocity; E/A peak early to atrial 
filling velocity ratio; E-AC average early filling acceleration rate; E-DC average early 
filling deceleration rate; HR = heart rate; SO = standard deviation; TVI = time 
velocity integral. 
Table ll. The random variation of the measurements in the normal 
subjects at baseline and peak dobutamine. 
Normals (n,. = 11) Baseline (nb = 81) Peak dobutarnine (nb = 81) 
mean SO ev (%) mean SO ev (%) i 
Em/s 0.675 0.Q3 4.494 0.902 0.047 5.07 
Am/s 05 0.035 7.66 0.675 0.053 7.83 
E/A 1.43 0.141 8.41 1.4 0.149 10 
E.AC m/s2 10.1 133 12.2 135 1.9 14.4 
E.OC m/s2 433 0313 7.06 5.15 0.526 959 
TVI em 13 0.739 5.65 17.2 0.976 554 
HR b/min 71 234 3.46 995 355 352 
. 
P < 0.01 F-ratio test versus baseline. cv = coefficient of variation; Db = number of 
beats; ~ = number of patients; SD =. standard deviation. Abbreviations of 
parameters; sec Table I. 
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Table ill presents the random measurement variation of the respective 
Doppler parameters estimated at baseline and peak dobutamine in 
patients with CAD. At baseline the coefficients of variation of the 
measurements in patients were similar to those found in normals with 
the smallest variations found in the HR and peak E. At peak 
dobutamine, statistically significant increases in the coefficient of 
variation were observed for E, E-AC and E-DC. 
Table ill. The random variation of the measurements in patients at 
baseline and peak dobutamine. 
Patients (n" = 26) Baseline (nb = 200) Peak dobutamine (nb = 198) I 
Parameter mean SD cv (%) mean SD cv (%) : 
Em/s 0.671 0.031 451 0516 0.035 756" I 
Am/s 0.672 0.045 6.91 0.861 0.049 5.88 
E/A 1.03 0.086 7.71 0.607 0.05 8.86 
E.ACm/s2 105 1.29 11 756 1.18 14.8" 
E·DC m/s2 3.18 0.214 65 3.12 0.291 9.27" 
TVIcm 17.9 1.01 5.48 133 0.832 6.25 
HR b/min 63.2 131 2.06 110 234 2.23 
" P < 0.01 F~ratio test versus baseline. cv = coefficient of variation; D.t, = number of 
beats; ~ = number of patients; SD = standard deviation. Abbreviations of 
parameters; see Table L 
Table IV. The percent threshold values for a significant difference in 
Doppler measurements at a levels of significance p < 0.01 and p < 0.05 
and based on various numbers of averaged beats (3, 5 and 8). 
Patients (n" = 26) % threshold at p<O.Ol % threshold at p < 0.05 
Parameter mean Db = 3 nb = 5 nb = 8 Db = 3 nb = 5 Db = 8 
Em/s 0.671 233% 13.2% 93% 14.1% 9.1% 6.7% 
Am/s 0.672 24.1% 13.6% 9.6% 145% 9.4% 6.9% 
E/A 1.037 31.1% 17.6% 12.4% 18.8% 12.1% 8.9% 
E.AC m/s2 105 48.9% 27.7% 19.4% 295% 19% 14% 
E-DC m/s2 3.78 30% 17% 11.9% 18.1% 11.7% 8.6% 
TVIcm 17.86 22% 125% 8.8% 133% 8.6% 63% 
HR b/min 63.2 8.1% 4.6% 3.2% 4.7% 3.1% 23% 
on = number of beats; ~ = number of patients. Abbreviations of parameters; see 
Table I. 
.-
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Threshold values: The threshold values, expressed as percentages, for 
a significant difference in 2 consecutive Doppler examinations, i.e. 
baseline and peak dobutamine, are shown in Table VI. These values are 
calculated at two different levels of significance (p < 0.01 and p < 0.05) 
and for various numbers of averaged beats (3, 5 and 8). The largest 
threshold values, calculated on the consideration of 8 beats either at 
baseline or peak dobutamine, were found in E-AC , E-DC and Ej A 
Table VI also shows that threshold values increase progressively with the 
decrease in the numbers of beats considered, as expected. 
Discussion 
Dobutamine is a potent inotropic agent that causes a dose-dependent 
increases in HR, cardiac contractility, arterial pressure and oxygen 
consumption with a slight change in cardiac filling pressures'7,18. In a 
normal heart these changes are associated with an increase in the speed 
of LV relaxation which augments filling'9. The expected Doppler findings 
would be an increase in transmitral flow velocities and an increase in 
early filling acceleration2o• On the other hand, demand ischaemia 
associated with inotropic stimulation would result in no change or a 
decrease in the speed of LV relaxation. In this instance peak mitral early 
filling velocity would decrease in proportion to the slowing in relaxation 
while late filling velocity will increase partly due to the increase in HR 
and partly as a compensation to maintain LV filling2'.22. Therefore, the 
addition of Doppler evaluation of LV filling to electrocardiographic and 
wall motion analysis would be of significant clinical importance. 
Can Doppler echocardiography effectively monitor the effect of 
dobutamine on parameters of LV filling in individual patients? To 
answer this question, two factors should be considered: (a) the 
reproducibility of Doppler parameters of LV filling including 
measurement variability, and (b) the magnitude of the change of 
Doppler parameters after dobutamine. Only if the serial changes are 
large enough and fall outside the range of measurement variability 
should the changes be considered significant. We have recently reported 
the effect of high dose dobutamine stress on Doppler indices of LV 
filling in healthy subjects and patients with CAD before and after 
coronary angioplas~. Our findings demonstrated a significant reduction 
in early filling indices in response to dobutamine in patients with CAD 
before angioplasty compared with a significant increase in the same 
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indices in normal subjects. Furthermore, the response of early filling 
indices changed toward the normal response after angioplasty. 
The reproducibility of the Doppler method depends on 2 determinants: 
(a) the consistent error (bias); which itself cannot be measured because 
the true value of the measurement is unknown, but differences in 
observer bias can be estimated with intra- and interobserver tests, and 
(b) the random variation of measurements; which can be estimated by 
taking consecutive measurements in a number of patients. 
The overall random variation of the measurements is usually the result 
of the interplay of several factors. These include: (a) beat-to-beat 
variability of the measurements which can be due to variations in HR, 
respiration or variation in the position of the sample volume with 
changing in the motion of the heart or the patient position, and (b) 
observer error which introduced by the observer measuring the Doppler 
recordings and can be due to factors related to adjustment of the 
Doppler instrument or the method of obtaining or analyzing the 
recordings. In fact we did not try to investigate the different sources of 
variability independently, rather we chose to imitate a routine clinical 
stress testing, in which one observer obtains and analyzes the recordings 
according to the standard method in our laboratory. 
Consistent e"or (bias): The results of the intraobserver test showed that 
intraobserver differences were small (:55%) for the Doppler parameters 
studied. Interobserver differences in bias were :55% in the measurements 
of E, A, E/ A and E-DC, while the largest differences were found in the 
measurements ofE-AC (12%) and TV! (7%). Since E-AC and TV! are 
dependent on the definition of the beginning and ending of velocity 
curve, it seems possible that poor-definition of these points due to the 
wall filter of the Doppler machine, specially at high HR, was the reason 
for the relatively large differences in the measurements of these indices. 
Random measurement variability: The random variation of the Doppler 
parameters at baseline were similar in normals and CAD patients. The 
smallest «5%) variations were found in the measurements of peak E. 
Whereas the largest variations were observed in the measurements of E-
AC both in normals (11%) and CAD patients (12%). Of interest, was 
the relatively large variability (8%) of the E/ A, which is commonly used 
in the Doppler assessment of LV filling. This may be explained by the 
fact that E/ A is calculated from 2 velocities with their own inherent variability. 
Since previous studies on the reproducibility of Doppler transmitral 
flow indices were performed in the resting condition'2.'3.'6, we decided 
to test if the variability of the measurements changes with stress. When 
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the coefficients of variation of the Doppler measurements in the healthy 
volunteers were compared between baseline and peak dobutamine, only 
E-DC showed statistically significant greater variability at peak 
dobutamine (9.59%) than baseline (7.06%). Increased HR results in a 
shortened diastasis and loss of separation between E and A, and 
consequently the point at the end of the descent of the early diastolic 
velocity will not be on the baseline. This may result in greater variations 
in the measurement of deceleration time and consequently in E-DC. 
Patients with CAD had statistically significant larger variations in E, 
E-AC and E-DC, indices of early filling, at peak dobutamine compared 
to variations at baseline. The larger variations in E, E-AC and E-DC at 
peak dobutamine in CAD patients compared to normals can be 
explained by the fact that the magnitude of changes in mean values, 
from baseline to peak dobutamine, were smaller in CAD group. 
Therefore, percent wise, the difference in coefficient of variation will be 
magnified. In addition, calculations of E-AC and E-DC are dependent 
on measurements of their corresponding time intervals (acceleration 
time and deceleration time, respectively). Therefore, technical difficulties 
in the definition of the beginning and ending of E wave velocity curve 
at high HR may have contributed, at least in part, to the large variations 
in these parameters. Several factors are known to independently 
influence early filling velociry23. Among these is changes in HR. It is 
noteworthy that the coefficient of variation in HR in CAD patients was 
not different between baseline (3.46%) and peak dobutamine (3.52%). 
Therefore the observed increase in the coefficient of variation during 
dobutamine can not be explained by increase in HR variation. Finally, 
our patients were older than the normals, on a variety of antianginal 
medications, and 65% of the patients developed new wall motion 
abnormalities with dobutamine. Factors which may have contributed to 
the variability of the measurements. However, we are not aware of 
studies addressing the independent influence of such factors on the 
variability of Doppler measurements. 
Threshold values: In order to relate our data to clinical practice, we 
calculated the statistically significant thresholds needed to decide 
whether a change in Doppler measurements induced during dobutamine 
stress test is indeed significant. The threshold differences are dependent 
on the number of measurements taken at baseline and peak dobutamine 
and the significance level. Several studies examining the value of 
Doppler parameters of LV filling with stress interventions in the 
diagnosis of CAD were performed on the basis of analysis of 324.25, 526 
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or 4 to 827,28 cardiac cycles. It is clear from table VI, that if one uses the 
average of 3 beats in Doppler measurements during stress intervention, 
only changes in E; for example, greater or lesser than 23% can be 
considered as being significant (at a level of significance p < 0.01) change 
due to the intervention. Thus we run the risk of overlooking a significant 
change that does not exceed this rather high threshold. Increasing the 
number of beats analyzed to 8 reduces the threshold on all cases by 
more than a factor of 2. Finally, it should be realized that the coefficient 
of variation and the threshold values might be valid only around the 
mean values of the parameters estimated in this study. 
Conclusions: When Doppler evaluation of LV filling is used during 
dobutamine stress, the following points should be considered: (a) peak 
E has the smallest variability among Doppler indices that assess early 
flliing phase of diastole, (c) the variability of Doppler measurements of 
early filling increases with stress intervention in patients with CAD, (d) 
increasing the number of beats averaged from 3 to 8 reduces the 
threshold needed to decide significant difference in Doppler 
measurements between baseline and peak dobutamine by more than the 
half. 
Acknowledgment: We gratefully acknowledge Eric Boersma MS, for the 
valuable statistical advice. 
References 
1. Appleton CP, Hatle LK, Popp RL: Relation of transmitral flow velocity patterns to 
left ventricular diastolic function: New insights from a combined hemodynamic and 
Doppler echocardiographic study. J Am Coll Cardiol 1988;12:426-440. 
2. Rokey R, Kuo LC, Zoghbi W A, Limacher MC, Quinoes MA. Determination of 
parameters of left ventricular diastolic filling with pulsed Doppler ecbocardiography. 
Comparison with cineangiography. Circulation 1985,71:543-550. 
3. Friedman BJ, Drinkovic N, Miles H, Shih W, Mazzoleni A, DeMaria AN. 
Assessment of left ventricular diastolic function: comparison of Doppler 
echocardiography and gated blood pool scintigraphy. J Am Coll CardioI1986;8:l348-
1354. 
4. Kuecherer HF, Ruffmann K, Schaefer E, Kuebler W. Doppler ecbocardiographie 
asSessment of left ventricular filling dynamics in patients with coronary heart disease 
and normal systolic function. Eur Heart J 1988, 9:649-656. 
5, Ilieeto S, Amico A, Marangelli V, D'Ambrosio G, Rizzon P: Doppler ecbocardiogr-
aphic evaluation of the effect of atrial pacing-induced ischemia on left ventricular 
filling in patients with coronary artery disease, J Am Coll Cardiol 1988;11:953-%1. 
106 
6. Tomimoto S, Takeuchi M, Fukuzaki H: Noninvasive assessment of left ventricular 
diastolic filling in coronary artery disease by Doppler dipyridamole-stress testing. J pn 
Heart J 1989;30:765-778. 
7. Labovitz AJ, Lewen MK, Kern M, Vandormael M, Deligonal U, Kennedy HL. 
Evaluation of left ventricular systolic and diastolic dysfunction during transient 
myocardial ischemia produced by angioplasty. J Am Coli CardioI1987,10:748-755. 
8. Aroesty JM, Mckay RG, Heller GV, Royal HD, AIs AC, Grossman W. Simultaneous 
assessment of LV systolic and diastolic dysfunction during pacing-induced ischemia. 
Circulation 1985,71:889-900. 
9. McNeill AJ, Fioretti PM, El-Said EM, Salustri A, De Feyter PJ, Roelandt JRTC: 
Dobutamine echocardiography before and after angioplasty; early reduction in stress 
induced myocardial ischemia. Am J Cardiol 1992;69:740-745. 
10. Mazeika PK, Nadazdin A, Oakley CM. Stress Doppler echocardiography using 
dobutamine in coronary patients with and without ischemia induction. Eur Heart J 
1992,l3:1020-1027. 
11. Bellotti B, FIoretti PM, Forster T, McNeill AJ, El-Said EM, Salustri A, Roelandt 
JRTC. Reproducibility of dobutamine-atropine echocardiography stress test. 
Echocardiography 1993;10:93-97. 
12. Spirito P, Maron BJ, Verter I, Merrill JS. Reproducibility of Doppler 
echocardiographic measurements of left ventricular diastolic function. Eur Heart J 
1988,9:879-886. 
13. Myreng Y, Ihlen H. Reproducibility of transmitral flow velocity parameters 
measured by pulsed Doppler echocardiography. J Cardiovascular Ultrasound 
1988;7:257-261. 
14. Van der Borden SG, Roelandt J, Rijsterborgh H. Computer-aided analysis of 
Doppler echocardiograms. In Roelandt J, ed. Colour flow imaging and other 
advances in Doppler echocardiography. Martinus Nijhoff Publishers, Dordrecht, 
Boston, Lancaster, 1986:39-49. 
15. Armitage P. Statistical methods in medical research. Oxford: Blackwell Scientific 
Publications 1973;189-202. 
16. Rijsterborgh H, Mayala A, Forster T, Vletter W, van der Borden B, Sutherland GR, 
Roelandt J. The reproducibility of continuous wave Doppler measurements in the 
assessment of mitral stenosis or mitral prosthetic function: the relative contributions 
of heart rate, respiration, observer variability and their clinical relevance. Eur Heart 
J 1990;11:592-600. 
17. Meyer SL, Curry GC, Domsky MS, Twieg DB, Parkey RW, Wilierson IT. Influence 
of dobutamine on hemodynamics and coronary blood flow in patients with and 
without coronary artery disease. Am J Cardiol 1976,38:103-108. 
18. Pierard LA, Berthe C, Albert A, Carlier J, Kulbertus E. Hemodynamic alterations 
during ischemia induced by dobutamine stress testing. Eur Heart J 1989, 10:783-790. 
19. Morad M. Rolett EL. Relaxing effects of catecholamines on mammalian heart. J 
Physiol (lond) 1972, 224: 537-558. 
20. Vandenberg BF, Stark CA, Rumberger JA, Kerber RE. Dose-dependent use of 
dobutarnine to alter early diastolic filling in normal subjects. Am J Cardiol 1988, 62 
: 333-334. 
21. El-Said EM, Fioretti PM, McNeill AJ, VIetter WB, Forster T, Roelandt JRTC, 
Linker DT. The response of Doppler indices of left ventricular fliling during 
107 
dobutamine stress test is a more sensitive indicator of coronary artery disease than 
wall motion abnormalities. Circulation 1992;86(4):1-378. 
22. EI-Said EM, Fioretti PM, Roelandt JRTC, McNeill AJ, Rijsterborgh H, Forster T, 
DiMario C, Linker DT. Dobutamine stress Doppler ecbocardiography before and 
after coronary angioplasty. Eur Heart J 1993;14:1011-1021. 
23. Voutilainen S, Kupari M, Hippelainen M, Karppinen K, Ventila M, Heikkila J: 
Factors influencing Doppler indexes of left ventricular filling in healthy persons. Am 
J Cardiol 1991;68:653-659. 
24. Graybum PA, Popma JJ, Pryor SL, Wafker BS, Simon TR, Smitherman TC. 
Comparison of dipyridamole Doppler ecbocardiography to thaIliurn-201 imaging in 
the assessment of coronary artery disease. Am J Cardiol 1989;63:1315-1320. 
25. Mazeika P, Nihoyannopoulos P, Joshi J, Oakley CM. Evaluation of dipyridamole 
Doppler ccbocardiography for detection of myocardial iscbaemia and coronary artery 
disease. Am J Cardiol 1991;68:478-484. 
26. Kuecherer HF, Ruffmann K, Schaefer E, Kuebler W. Doppler ecbocardiographic 
assessment of left ventricular filling dynamics in patients with coronary heart disease 
and normal systolic fnnction. Eur Heart J 1988,9:649-656. 
27. Furukawa K, Tsuji H, Inoue N, Azuma A, Tatsukawa H, Kawata K, Nakamura T, 
Katsume H, Nakagawa M. Effects of transient myocardial ischaemia on the 
transmitral blood flow profile. Am J Noninvas Cardiol 1990;4:29-39. 
28. Presti CF, Walling AD, Montemayor I, Campbell JM, Crawford MH. Influence of 
exercised-induced myocardial ischaemia on the pattern of left ventricular diastolic 
filling: a Doppler ecbocardiographic study. J Am Coil Cardiol 1991;18:75-82. 
108 
CHAPTER 9 
DISCUSSION AND CONCLUSIONS 
Dobutamine-atropine stress testing closely mimics exercise physiology 
because it can be performed in an incremental stepwise manner 
equivalent to the stages of exercise protocol, thereby having the potential 
to detect an ischaemic threshold. Dobutamine stress testing with or 
without the addition of atropine has been combined with 
electrocardiography (ECG),I myocardial perfusion scintigraphy,2 
magnetic resonance imaging,' and echocardiography,4,s,6 for the 
evaluation of patients with coronary artery disease (CAD). Its 
combination with Doppler7.9 has also attracted recent interest. The 
dobutamine stress testing is increasingly applied for the diagnosis of 
CAD,IO,l1 assessment of revascularization procedures,12,13 identification 
of myocardial viability,!' and risk stratification in patients after 
myocardial infarction, !,IS and in those undergoing major vascular 
surgery.16 The application of dobutamine stress echocardiography and 
Doppler for the detection of CAD and assessment of coronary 
angioplasty (PTCA) will be discussed in details. 
Diagnosis of myocardial ischaemia 
Table I summarizes results of studies from our laboratolf,11.18,25 and 
those from others,4-6,17.19.24 that have utilized the assessment of regional 
wall motion during dobutamine stress echocardiography for the diagnosis 
of CAD. These studies confirm the ability of dobutamine echo to detect 
the presence of significant CAD (> 50% diameter stenosis) with an 
overall sensitivity ranging from 54 to 96% and specificity ranging from 
60 to 95%. Close analysis of the data derived from these studies 
identifies several observations of important clinical implications. 
(1) Comparison of dobutamine and other stress modalities: Direct 
comparison of dobutamine and dipyridamole stress echo testing in the 
same patients have been conducted in few studiesp,ls,21 In one study 
from our group, the sensitivities and specificities of dobutamine and 
dipyridamole stress echo for the detection of myocardial ischaemia were 
similar.ls On the other hand, the results of the other studies were in 
favour of dobutamine echocardiographyY·21 Dobutamine echo has also 
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been shown to be superior to adenosine echop·19 In our experience26 as 
well as others,20 dobutamine echo was comparable in efficacy of 
detecting CAD with exercise stress echo. 
(2) Dobutamine stress Echo vs myocardial perfusion scintigraphy: We and 
others have shown equivalent levels of sensitivities and specificities, and 
a reasonable agreement between the two techniques for detection of 
myocardial ischaemia, specially in absence of resting wall motion 
abnormalities (WMA).11.19 
(3) ECG changes and chest pain as markers of ischaemia during 
dobutamine stress testing: The diagnosis of myocardial ischaemia based 
on ECG changes or the development of chest pain during dobutamine 
stress testing was generally associated with a considerably low sensitivity, 
although the specificity was consistently high.s.6.17.19 The reduced 
sensitivities of dobutamine stress ECG compared to those usually 
reported with exercise stress testing probably reflect a lower cardiac 
work load during dobutamine stress than may be achieved with 
exercise.19 The use of WMA as an end point and the continuation of 
antianginal medications are also factors that have been suggested to 
reduce the sensitivity of EeG changes or angina during pharmacologic 
stress testing.6 
(3) Factors influencing the interpretation of stress echocardiography: 
- DobutanJine stress echo is more sensitive in detecting myocardial 
ischaemia in patients with multivessel coronary disease than in those 
with single vessel disease.3.6·19.22,24.2S 
- The relation between the severity of coronary stenosis measured by 
quantitative angiography and stress-induced WMA detected by 
dobutamine echo has also been investigated. Segar et al4 demonstrated 
that dobutamine stress echo is equally sensitive for the detection of 
CAD in the three major coronary arteries. They also showed that the 
correct assignment of WMA to coronary lesions is improved when 
evaluation was confined to lesions with a minimal luminal diameter 
< 1 mm. Similarly, Salustri et al,2S reported that the sensitivity of 
dobutamine echo for the detection of CAD was higher in patients with 
diameter stenosis > 70% than in those with diameter stenoses in the 
range of 50 to 70% or <50%. 
- The addition of resting WMA, as a criterion for the presence of CAD, 
to the development of dobutamine-induced WMA have been reported 
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to increase the sensitivity of dobutamine stress echo.18 However, the 
presence of resting WMA adversely affect the specificity of the test.23,4 
Table I: Studies using dobutamine stress echocardiography for the 
diagnosis of CAD. 
Author Stress Subjects Sensitivity (%) Spec. 
Tot. CAD SVD MVD ~WM Overall (%) 
Martin!? (1992) DOB 40 25 76 60 
DIP 56 67 
ADN 40 93 
Salustril8 (1992) DOB 46 28 57 78 
DIP 64 89 
Marwickl9 (1993) DOB 97 59 84 86 85 82 
ADN 52 64 58 87 
Cohen20 (1993) DOB 52 37 75 95 86 87 
SBE 63 90 78 87 
Previtali21 (1993) DOB 80 57 62 88 79 83 
DIP 33 88 60 96 
Cohen22 (1991) DOB 70 51 69 100 86 95 
Sawada6 (1991) DOB 103 81 81 100 89 8S¥ 
Marcovit? (1992) DOB 141 109 95 97 87 96 66 
91# 
Mazeika24 (1992) DOB 50 36 50 75 78 93 
Segar4 (1992) DOB 85 63 90 95 82 
86# 
McNeill5 (1992) DOB 80 47 70 88 
Salustri25 (1992) DOB 52 37 40 70 54 80 
MarwicklO (1993) DOB 217 142 66 77 72 83 
ForsterU (1993) DOB 21 75 89 
# = specificity in patients with normal resting wall motion. 
ADN = adenosine, CAD = number of patients with significant coronary disease 
(>50% diameter stenosis), DIP = dipyridamole, DOB= dobutarnine, MVD = 
multivessel coronary disease, NRW11 = patients with normal resting wall motion, 
Spec. = specificity, SVD = single vessel coronary disease, SupBE = supine bicycle 
~!~se, T?~. =~~numbc_~ of s~_~_~ts. 
- - - -
- Difficulties in the interpretation of stress echocardiography for the 
presence of myocardial ischaemia occur in patients with previous 
myocardial infarction and severe hypokinesia or akinesia at restY,25 
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Controversy exist, whether the worsening of akinesia, becoming 
dyskinesia during stress, represents myocardial ischaemia or mainly a 
nonischaemic mechanical event.27 Recently, we studied 20 patients, 
with previous myocardial infarction and resting regional akinesia, using 
simultaneous two-stage (low- and high-dose) dobutamine stress 
echocardiography and myocardial perfusion scintigraphy.28 We 
demonstrated that, in the absence of improvement in wall thickening 
with low-dose dobutamine, the echocardiographic pattern of an 
akinetic segment at rest, becoming dyskinetic during peak stress, does 
not represent myocardial ischaemia 
- Antianginal medications, in particular B-blockers, may adversely 
influence the diagnostic accuracy of dobutamine stress testing. 
Recently, we demonstrated that B-blockers blunt the chronotropic 
effect of dobutamine and decrease the incidence of myocardial 
ischemia as indicated by the reduced incidence of new WMA or ST 
changes in patients on B-blockers than after washout of the drug.29 
However, with the use of our "standard" dobutamine-atropine protocol 
(reported in Chapter 3), it was possible to overcome the lack of 
chronotropic effect in such patients and to equalize the detection of 
myocardial ischaemia in patients on and off B-blockers.29 
- Potential limitations for the widespread use of stress echocardiography 
remain the high degree of operator dependency, which necessitates the 
availability of a skilled and experienced operator-interpreter, to obtain 
an accurate test and the subjective analysis of WMA Until now there 
is no standard objective criteria for the interpretation of the stress 
echo results. Quantitative approaches for analysis of regional wall 
motion have been attempted.30,31,32 These approaches require a user-
interactive system in which the operator identifies the endocardial 
border in diastole and systole and then measurements are made by 
computer. Therefore, the operator dependence is still retained in this 
form of analysis. In addition, there are great difficulties in establishing 
a normal range for systolic wall thickening because of the high 
variability between subjects and between segments and levels within 
the LV and limited image quality by endocardial dropout in some 
patients using the transthoracic approach.32 
Assessment of patients undergoing PTCA 
The main goal of revascularization therapy is to relief ischaemia and 
improve prognosis in CAD patients, therefore, functional testing is often 
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needed to identify objective clinical improvement. Wall motion analysis 
during dipyridamole33 or exercise34.35 stress echo allowed the 
identification of a successful PTCA by detecting resolution of stress-
induced WMA that was present before the intervention (Table ll). We 
introduced the use of dobutamine-atropine stress testing in this clinical 
situation and proved the usefulness of the test in detecting the reduction 
in myocardial ischaemia early after PTCA (Chapter 4).12 Recent reports 
confirmed our findingsP 
Table II Stress echo for the evaluation of patients undergoing PTCA 
. 
Author Stress Patients TIme* Stress-induced WMA 
pre·PTCA post·PTCA 
Pican033 (1989) DIP 63 110 3 days 58 16 
Brodericl?' (1990) TME/UpBE 36 28 ± 26 days 25 12 
Fioretti3S (1992) UpBE 23 4 weeks 13 2 
McNeill12 (1992) DOBjA 28 within 3 days 20 4 
Akosah13 (1993) DOB 35 1 to 2 days 31 3 
. 
= angiographically successful PTCA, # = timing of the post-PTCA test. 
DIP = dipyridamole, DOB = dobutamine, DOBjA = dobutamine plus atropine, 
TME = treadmill exercise, UpBE = upright bicycle ergometer, WMA = wall 
motion abnormalities. 
The timing for the assessment of the functional improvement after 
PTCA is an important consideration. Some investigators suggested that 
the detection of early restenosis may be missed if stress testing is 
performed soon after PTCA, and therefor some delay may permit better 
prediction of long-term success.34 Others, supported performing stress 
echo testing early after PTCA so that important baseline information 
can be available for later comparison and thus allow full assessment of 
the effects of the procedure.12,13,33 Pharmacological stress testing with 
dipyridamole or dobutamine, unlike exercise, can be performed early 
after PTCA even while the patient is still at bed rest (Table ll). Another 
point in favour of applying the pharmacologic type of stress early after 
PTCA is its ability to stratify the response not only on the basis of 
associated ECG changes (indicating transmural involvement), and spatial 
circumferential extent but also by providing the timing of occurrence of 
WMA during the test.13,33 
The persistence of a positive stress echo test after PTCA is another 
important consideration. Several explanations have been suggested for 
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such an observation. One explanation was based on the poor correlation 
between percent luminal reduction and regional flow reserve, leading to 
a disparity between a residual stenosis which ap~ears angiographically 
insignificant but remains functionally important.3 Another explanation 
is the possibility of early post-PTCA restenosis which could be 
insignificant at the time of post-PTCA angiography. This explanation is 
supported by the findings of Picano et al,33 who demonstrated that all 
patients with recurrent angina and WMA during the early post-PTCA 
dipyridamole stress test had angiographic evidence of restenosis of the 
dilated vessel in the long-term follow up. The phenomena of myocardial 
hibernation or stunning have also been suggested as an alternative 
explanation.36 Finally, persistent positivity in a remote region from the 
territory of the dl1ated artery may indicate that dilatation of such a 
"functionally dominant" artery resulted in unmasking of another lesion 
which was originally less severe.33 Further studies are needed to evaluate 
the clinical importance of a persistently positive stress echo testing after 
angiographically successful PTCA. 
Reproducibility of stress echo testing 
Reproducibility is a major feature of a stress test that needs to be 
defined when using the test for assessing efficacy of therapeutic 
interventions. Sources of error in repeat echo studies include the 
instability of the testing routine and equipment, patient variability and 
observer variability both in perfornting the procedure and interpreting 
the results. At the Thoraxcentre, the inter- and intraobserver agreement 
for the interpretation of exercise echo is 91% and 92%, respectively.37 
In Chapter 7, we reported an excellent short-term reprodUCIbility of 
dobutamine-atropine stress testing with regard to, time of onset of 
symptoms, haemodynamic response, and the frequency of the induction 
of ischaemia (WMA, ECG changes and angina).38 
Assessment of global LV systolic function using Stress Doppler-
echocardiography for the diagnosis of myocardial ischaemia 
There have been few studies exarrumng the utility of Doppler 
assessment of aortic flow indices during stress for the detection of CAD. 
Table ill summarizes findings from previous studies using exercise 
Doppler-echo for the detection of CAD.3942 In aggregate, these studies 
demonstrated that changes in aortic flow indices during exercise tended 
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to distinguish, as a group, between healthy subjects and patients with 
CAD. They all confirmed that the Doppler technique appeared to be 
most helpful in identifying patients with multivessel CAD. 
Table IV summarizes findings from previous studies using 
dipyridamole4346 or dobutarnine7•9 as stress agents in conjunction with 
Doppler assessment of transaortic flow for the detection of CAD. Unlike 
the exercise Doppler studies, findings from dipyridamole Doppler studies 
were conflicting. Two studies43•45 demonstrated that changes in Doppler 
systolic indices during dipyridamole infusion could distinguish between 
healthy subjects and patients with CAD. Whereas, the other studies44•46 
indicated that Doppler-determined changes in systolic indices during 
dipyridamole were insensitive in detecting patients with significant CAD. 
The use of Doppler assessment of global LV systolic function during 
dobutarnine stress testing has recently been attempted?-9 Mazeika et al7 
studied the effect of dobutamine (up to 20 I'g/kg/min) on pulsed-
Doppler LV ejection indices and observed similar response in normal 
subjects and patients with CAD and a blunted response only in 6 
patients with WMA in 2:3 segments all of whom had multivessel disease. 
Using continuous wave Doppler during high-dose dobutamine stress (up 
to 40 I'g/kg/min), we reported similar responses of Doppler-derived LV 
ejection indices in healthy subjects and patients with significant single 
vessel CAD, and a blunted response in patients with multivessel disease 
(Chapters 5 and 6).8.9 Furthermore, we demonstrated that the response 
of Doppler ejection indices to high-dose dobutamine stress was the same 
before and early after PTCA (Chapter 5).8 
Feasibility and limitations oj the technique: Using the suprasternal or the 
apical approaches, a high success rate for Doppler recording of the 
aortic velocity curve has been reported.43-46 In our studies (Chapters 5 
and 6), using the nonimaging continuous wave transducer from the 
suprasternal notch window, we were able to obtain adequate Doppler 
recordings of the aortic velocity curves in 53/57 patients (93%) in both 
studies. Several technical considerations concerning Doppler 
measurements of the ascending aortic flow variables during stress are 
worthy of emphasis, among which: 
(1) The potential problem of not maintaining the angle between the 
ultrasound beam and the long-axis of the blood flow during peak stress 
due to movement of the aortic root during hyperdynamic contractions 
and hyperventilation.40•47 This problem would affect the absolute 
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velocities but would not affect the percent change from baseline to peak 
stress, and therefore does not affect any of our conclusions. 
(2) The effect of respiration on both the quality of Doppler recordings 
and the actual measurements of aortic velocity and time intervals.48 To 
avoid this problem, we obtained measurements from 7 to 8 consecutive 
beats with the clearest velocity envelop and averaged the results. 
(4) A considerable number of our patients were receiving anti anginal 
therapy including B blockers, which have been shown to blunt the 
response of aortic velocity and acceleration.49 In the study in Chapter 5, 
medications were not changed during studies (before and after PTCA), 
thus, this should not affect our results. 
(5) Finally, it has to be noted that Doppler derived systolic parameters 
assess the global LV function, therefore, WMA limited to a small 
number of LV segments may not influence the global LV performance. 
Despite these limitations, the use of Doppler approach to quantitate 
the global LV performance remains attractive. First, unlike conventional 
use of echo imaging of cardiac structures, with the possible deterioration 
of image quality due to emphysema, for example, Doppler examination 
avoids this limitation. This is particularly true when using the small non-
imaging continuous wave transducer from the suprasternal position. 
Second, the use of Doppler derived flow velocity and acceleration as 
indicators of global systolic performance is not based on geometric 
assumptions regarding the shape of the left ventricle but rather based on 
haemodynamic considerations. 50 
Reproducibility of Doppler-derived aortic flow velocity measurements 
Data on reproducibility of Doppler aortic flow velocity measurements 
obtained by nonirnaging transducer in normal subjects have been 
reported. Hatle and Angelsen51 reported reproducibility data in 16 
subjects for Doppler ejection measurements performed within minutes 
of each other in each subject. The mean coefficient of variation was 
5.9% for peak velocity, 6.7% for TV! and 15.1 % for acceleration. These 
investigators concluded that changes in flow velocity of 20 to 25% 
represent true haemodynamic changes. Gardin et al52 studied 10 normal 
subjects in order to establish the intraobserver, interobserver and day-to-
day variability in Doppler aortic flow measurements. They found that if 
one were to set the mean ± 2 standard deviations as a range beyond 
which a measurement difference would be significant, a difference of 
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10% in TVI, 11% in ejection time, 13% in peak velocity and 17% in 
acceleration time would suggest a significant haemodynamic change. 
Assessment of global LV diastolic function using stress Doppler-
echocardiography for the diagnosis of myocardial ischaemia 
(1) Abnonnal Doppler LV filling pattern at rest, in patients with CAD: 
Three different patterns of transmitral velocity profile have been 
described in patients with CAD:53-S8 
- Reduced LV early filling: This pattern is described in patients with 
impaired relaxation, as evidenced by increasing time constant of 
relaxation, and normal or slightly elevated pulmonary artery wedge 
pressurep.54 The transmitral velocity profile may show, prolonged IRP 
and E-wave DT; decreased peak E velocity, mean E-wave acceleration 
rate and Ej A ratio; and increased peak A velocity.53-56 This pattern has 
also been described during balloon occlusion of the coronary arteries 
during PTCA57,58 
- Restricted LV filling: This pattern is described in patients with 
increased chamber stiffness, as evidenced by increasing chamber stiffness 
constant, 54 and those with elevated pulmonary capillary wedge pressure, 
marked symptoms, left atrial enlargement, and impaired LV relaxation. 53 
The transmitral velocity profile may show; increased E velocity and Ej A 
ratio; shortened E-wave DT and IRP; and reduced A velocity.53.54 
- "Pseudonormal" LV filling: This pattern is noted in patients with 
impaired relaxation and increased left atrial pressure.53 
(2) Abnonnal Doppler LV filling pattern during stress-induced ischaemia: 
There have been few clinical studies that described abnormalities of LV 
diastolic filling in patients during transient ischaemia provoked by 
exercise,s9-61 pacing,.2-64 or dipyridamole stress testing44•46,64,65 (Tables V, 
VI and VII, respectively). 
Studies in table V demonstrated abnormal LV diastolic filling in 
response to exercise, however, the types of filling patterns have varied. 
Unlike the studies performed with exercise, pacing-induced ischemia was 
associated with changes in the Doppler pattern of transmitral flow 
consistent with the pattern of impaired relaxation. 
Most studies46•64,65 on dipyridamole-stress Doppler for the assessment 
of LV filling dynamics have reached the conclusion that the response of 
Doppler diastolic indices is similar in healthy subjects and patients with 
significant CAD (Table VII). Little information is available regarding 
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the changes in LV filling dynamics in response to dobutamine stress 
testing. In Chapter 6, we described the effects of high-dose dobutamine 
(up to 40 I'g/kg/rnin) on Doppler parameters of LV diastolic function 
in a control group of patients with chest pain but a low likelihood of 
CAD and patients with significant single vessel CAD and assessed the 
utility of this approach in detection of CAD compared to wall motion 
analysis. Our findings demonstrated a significant increase in Doppler 
parameters of LV filling in response to high-dose dobutamine in patients 
with low likelihood of CAD; and a significant decrease in early filling 
indices in all patients with significant single vessel CAD. 
(3) Doppler LV filling pattern in patients uruiergoing PTCA: The use of 
Doppler transmitral flow velocity recordings to detect improvements in 
LV diastolic filling following PTCA has been attempted at rest (Table 
VIII).8,66-69 Three of the five studies in Table VIII demonstrated early 
improvement in LV filling after PTCA 67-69 Our fmdings, as well as 
others, demonstrated unchanged resting diastolic parameters early after 
PTCA, compared to before PTCA 8,66 Differences in patient populations 
and methodology (Table VIII) may explain these discrepancies. 
Studies of LV filling during cardiac stress testing after PTCA have 
been limited to radionuclide angiography?O In Chapter 5, we presented 
the initial experience in the use of Doppler assessment of LV filling in 
conjunction with high-dose dobutamine stress testing in patients 
undergoing PTCA Our findings demonstrated improvements after 
PTCA, in the response of early filling indices to dobutamine, as 
evidenced by changing the direction of the response of these parameters 
from decreasing before PTCA to increasing after PTCA8 
Reproducibility of Doppler transmitral flow velocity measurements 
Previous studies on the reproducibility of pulsed-Doppler transmitral 
flow velocity measurements have been performed in subjects at rest.71•73 
Data from these studies suggested that: (a) the technical and biological 
sources of variability are generally small for early filling indices, whereas, 
day-to-day variability is relatively large for parameters of atrial filling; 71 
(b) the commonly used E/ A ratio appears to be able to detect only 
changes greater than 44% with a confidence probability of 0.95 in an 
individual patient;72 (c) that abnormal transmitral flow patterns in 
patients with CAD, persist unchanged in the absence of therapeutic 
intervention. 73 
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The dramatic differences in the response of Doppler transmitral filling 
indices to dobutamine stress; between healthy subjects and patients with 
CAD and between patients before and after PTCA (Chapters 5 and 6); 
encouraged as to test the reproducibility of the Doppler measurements 
both at rest and peak dobutamine and to estimate threshold values 
which can be used as a reference to detect significant changes in these 
measurements form baseline to peak dobutamine in an individual 
patient (Chapter 8). Our findings demonstrated that: (a) intra- and 
interobserver mean differences were generally small; (b) the random 
variations of Doppler measurements at rest (beat-to-beat variations plus 
random observer error) were similar in healthy subjects and patients 
with CAD; ( c) the variability of Doppler measurements may increase 
with stress intervention in patients with CAD; (d) increasing the number 
of beats averaged from 3 to 8 reduces the threshold needed to decide a 
significant difference in Doppler measurements between baseline and 
peak dobutamine by more than the halC3 
In addition to the reproducibility of the technique, a wide variety of 
physiologic and pathologic variables may be considered as confounding 
factors in the interpretation of Doppler transmitral filling velocities 
(Chapter 2). The influence of such factors on our findings has been 
discussed in Chapters 5 and 6. 
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SUMMARY AND CONCLUSIONS 
Since the introduction of dobutamine to the field of stress 
echocardiography testing, efforts have been directed to assess the 
feasibility, safety and diagnostic accuracy of the test; to improve the 
sensitivity; and to evaluate the applicability of the test in different 
clinical situations for the evaluation of patients with CAD. This thesis 
aimed mainly at testing different methods that may improve the 
sensitivity of the dobutamine stress testing; and assessing the utility of 
the test in the assessment of patients undergoing PTCA This was 
achieved by: (a) modifying the dobutamine stress protocol by addition 
of atropine (Chapter 3); (b) adding Doppler examination of the global 
LV systolic and diastolic function to the conventional analysis of regional 
wall motion during the dobutamine stress test (Chapters 5 and 6); (c) 
testing the reproducibility of echocardiographically detected WMA and 
Doppler measurements of LV diastolic filling during dobutamine stress 
testing (Chapters 7 and 8); and (d) evaluating changes in ECG, regional 
wall motion, and Doppler measurements of global LV systolic and 
diastolic function during high-dose dobutamine stress testing before and 
early after PTCA (Chapters 4 and 5). 
The results reported in this thesis confirm the superiority of 
dobutamine-induced WMA, as a marker of myocardial ischaemia, over 
ECG changes or the development of chest pain. The addition of 
atropine to dobutamine stress echocardiography increases the sensitivity 
of the test for detection of CAD without loss of specificity or increase 
the incidence of side effects. This is particularly useful in patients 
undergoing dobutamine stress test without discontinuation of antianginal 
medications, specifically B blockers. 
Dobutamine-atropine stress echocardiography is also useful in 
identifying objective manifestations of reduction in myocardial ischaemia, 
early after PTCA. In our institution, the reproducibility of 
dobutamine-atropine stress testing is excellent. A factor which makes the 
test to be a useful tool for assessing disease progression and effects of 
therapeutic interventions in patients with CAD. 
The addition of Doppler examination of aortic flow velocity during 
dobutamine stress testing is not useful in identifying individual patients 
with CAD. On the other hand, the addition of Doppler examination of 
transmitral flow velocity during dobutamine stress testing, appears to add 
useful indictors of myocardial ischaemia which may be more sensitive 
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than WMA Furthermore, Doppler evaluation of LV diastolic filling 
during dobutamine stress testing, before and after therapeutic 
interventions, appears to be useful in predicting beneficial effect of the 
intervention. However, when Doppler examination of LV filling is to be 
used during dobutamine stress, a reproducibility study is necessary to 
estimate threshold values (based on the number of beats to be averaged) 
which can be used as a reference to detect significant changes in 
Doppler measurements from baseline to peak dobutamine in an 
individual patient. 
Despite the fact, that dobutamine stress testing is being increasingly 
applied in a wide variety of clinical applications, further research is 
needed to clarify some related problems. First, we are not aware of 
studies testing the inter-observer variability in the interpretation of stress 
echo results between different echocardiography laboratories. Such 
studies may contribute in establishing the reliability of the technique as 
a practical tool in the noninvasive evaluation of patients with CAD. 
Second, controversy stilI exist in the interpretation of dobutamine-
induced worsening of WMA that existed at rest. Should we consider 
severe hypokinesia or akinesia which become dyskinesia during stress as 
an indication of myocardial ischaemia or as a nonischaemic mechanical 
event? This is an important clinical topic which requires further 
evaluation. 
Third, simple and reproducible methods for quantification of LV 
volumes or segmental wall thickening are lacking. With newer 
automated contour-detection equipment, trans-esophageal approach, and 
the technology of three dimensional reconstruction of echocardiographic 
images, quantitative analysis may become easier and more widely 
applicable. 
In spite of the limitations in Doppler methodology, dobutamine stress 
testing should not be limited to the echocardiographic evaluation of wall 
motion, but rather expanded to include assessment of haemodynamics 
by means of Doppler examination of LV systolic and diastolic function. 
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Table m. Studies evaluating the value of Doppler ejection 
parameters during exercise stress testing for the detection of CAD 
and risk stratification after myocardial infarction. 
Author Technique Subjects Fmdings 
N pis. 
Bry? (1986) TME, 20 17 . 1 Ao V > 80% in N and pts. with single 
PWD vessel disease and normal LV function 
• 1 AoV < 80% or I AoV in pis. with 
more severe CAD and resting LV 
dysfunction 
Mehdirad40 (1987) TME, 14 14 - greater 1 in Ao V in N than in pis. 
PWD - good correlation between % change in 
EF and % change in Ao V 
! 
Maeda4l (1989) TME, 21 34 - no differences between the Doppler 
CWD response in N and pts. with single vessel 
disease with and without ischaemic ECG 
- lower 1 in AoV in pts. with multivessel 
disease or pts. with exercise-induced T in 
PAWP 
Harrison42 (1987) TME, 28 74 - greater t in Ao V and AoAce in N than 
CWD, pis. with normal (25 pts.) or abnormal (49 
thallium pts.) thallium scans 
perfusion ·pts. with abnormal scans had lower 
scanning AoAcc than pis. with normal scans with 
the most pronounced difference seen in 
pts. with multivessel disease 
T = increase, 1 = decrease. AoAce = aortic acceleration, Ao V = peak aortic 
velocity, CWO = continuous wave Doppler, EF = ejection fraction, N = normal 
subjects, PA WP = pulmonary artery wedge pressure, pts. = patients with CAD, 
PWD = pulsed wave Doppler, TME = treadmill exercise, TV! = systolic time 
velocity integral. 
---~ .. -----~ .... - ---~ 
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Table IV. Studies evaluating the value of Doppler ejection 
parameters during pharmacologic stress testing for the evaluation 
patients with CAD 
-
Author Technique Subjects Fmdings 
N pts. 
Labovitz43 (1988) DIP, 94 - greater t in EF, Ao V and AoAce in 
CWD, response to DIP in.. pts. with normal scans 
Echo, (41 pts.) than abnormal scans (53 pts.) 
thallium - these differences .were more pronounced 
in pts. with multivessel disease 
Grayburn44 (1989) DIP, 10 23 -Doppler systolic indices arc .. insensitive in 
CWD, detecting reversible perfusion defects or 
thallium significant CAD 
, ,,' 
, 
Agati4S (1990) DIP, 13 29 . 1 Ao V and TV1 in N but not in pts. 
CWD, - changes in Doppler indices are closely 
Echo, related to peak positive dp/dt, LV end-
haemo- diastolic pressure, appearance of WMA, 
dynamics and coronary angiographic jeopardy score 
Mazeika46 (1991) DIP, 12 22 - no difference in the effect of DIP on 
PWD, Ao V and AoAcc between N and pts. 
Echo, - 1 Ao V and AoAce in pts. with severe 
ischaemia 
Mazeika7 (1992) DOB, 10 24 - 1 Ao V, AoAcc and TV1 in N and pts. 
PWD, - Doppler indices responded, bluntly to 
Echo DOB in pts. with WMA in,,3 segments 
El-Said8 (1993) DOB, 11 16 - DOB induced similar 1,iD,AoV and' 
CWD, AoAcc in N and pts. with I-vessel disease 
Echo both before and after PTCA. 
- Ao V and AoAcc respondedbhmtly to 
DOB in 3 pts, with multivessel diSease, 
EI-Said9 (1994) DOB, 10 17 - DOB "induced similar t in AoV, AoAcc 
CWD, and TV1 in N and pts. with I-vessel 
Echo disease 
T = increase, 1 = decrease. AoAce = aortic acceleration, Ao V = peak aor:tic 
velocity, CWO = continuous wave Doppler, DIP = dipyridamole stress test, DOB = 
dobutamine stress test, EF = ejection fraction, N = normal subjects, pts. ,= patients 
with CAD, PTCA = coronary angioplasty, PWD = pulsed wave Doppler, TV! = 
CEtolic time velocity integral, WMA = ,wall motion aiJnormalities. 
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Table V. Influence of exercise-induced ischaemia on transmitral 
parameters of LV filling. 
Author Stress Subjects Fmdings 
N pts. 
Kuechere,.59 (1988) UpBE 8 18 - during exercise, E/A 1 in N but I in pts. 
Iwase60 (1989) SupBE Zl - during exercise I E/A in pis. with PAWP 
.20 mm Hg at peak exercise but I in pts. 
with PAWP.lO mm Hg 
Presti61 (1991) TME 20 20 • I E and A from rest to postexercise in N 
and pts. 
I = increase, I = decrease, * = unchanged. A = atrial filling velocity, E = early 
filling velocity, E/A = early to atrial filling velocity ratio, N = normal subjects, 
PAWP = pulmonary artery wedge pressure, pts. = patients with CAD, SupBE = 
supine bicycle ergometer, TME = treadmill exercise, UpBE = upright bicycle 
ergometer. 
Table VI. Influence of pacing-induced ischaemia on transmitral 
parameters of LV filling 
Author Subjects Findings 
N pts. 
llicet062 (1988) 17 . I E, I A and I E/ A from rest to post pacing in pts. 
with pacing-induced ischaemia (ST depression) 
- no changes occurred in pts. without ischaemia 
Gonzalei3 (1990) 17 - during pacing 7 pts. developed new or increasing 
mitral regurgitation with I E, 1 A and I E/ A, 
. 10 pts. did not develop mitral regurgitation and 
showed no changes in Doppler indices during pacing 
Fnrukawa64 (1990) 19 46 - no Doppler changes occurred in N, but there were 1 
E, I A and I E/ A 30·60 seconds postpacing in pts. 
Abbreviations, see Table V. 
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Table VII. Influence of dipyridamole-induced ischaemia on 
transmitral parameters of LV filling. 
Author Subjects Findings 
N pis. 
Furukawa64 (1990) 19 33 . dipyridamole induced 1 in E and A in N and pis. 
Grayburn44 (1989) 10 23 - Doppler diastolic indices are insensitive in detecting 
reversible perfusion defects or CAD 
Tomimoto6S (1989) 8 73 - ! E/ A in pts. with dipyridamole·induced angina 
- no changes in N and pts. with negative test 
Mazeika46 (1991) 12 20 ·1 EandAand! E/A in Nand pis. 
Abbreviations, see Table V. 
Table VIII. Influence of PTCA on transmitral parameters of LV 
filling. 
Author Time . Number of pts. Findings 
Wmd66 (1987) within 34 - no differences in Doppler 
1 day (17 underwent parameters before and after 
PTCA) PTCA 
Masuyami7 (1988) 2&9 50 with stable · gradual 1 in E and E/ A 
days angina after PTCA 
Castello68 (1990) within 31 - 1 E/ A and 1/3 fIlling 
1 day (15 stable and fraction and ! IRP and % 
16 unstable atrial contribution to filling 
angina) after PTCA 
Snow69 (1990) 2±1 42 - after PTCA LV filling was 
days improved (! IRP and DT) 
El-Said8 (1993) within 17 with stable · Doppler filling indices were 
3 days angina comparable at rest, before and 
after PTCA 
· successful PTCA resulted in 
improvement in diastolic filling 
response to dobutamine stress 
. 
= timing of the Doppler examination after PTCA, t = increase. 1 = decrease. 
A = atrial filling velocity, DT = deceleration time, E = early fIlling velocity, E/A 
= early to atrial filling velocity ratio, IRP = isovolumic relaxation period, PTCA 
= coronary angioplasty 
- - -
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SAMENV A1TING EN CONCLUSIES 
Sedert het gebruik van dobutamine bij stress echocardiografisch 
onderzoek zijn de volgende aspecten belicht: de uitvoerbaarheid, de 
veiligheid en de diagnostische nauwkeurigheid van de test. Tevens is 
getracht de gevoeligheid te verbeteren en de toepasbaarheid in 
verschillende klinische situaties te evalueren bij patienten met 
coronarialijden. Dit proefschrift richt zich vooral op het uittesten van 
verschillende aanvullende methoden om de gevoeligheid van de 
dobutamine stress test te verhogen. Tevens is de bruikbaarheid van deze 
test onderzocht bij de beoordeling van patienten die een PTCA 
ondergaan. Hiertoe werd(en): (a) het dobutamine stress protocol 
uitgebreid door toevoeging van atropine (hoofdstuk 3); (b) Doppler 
onderzoek toegevoegd aan de bestaande analyse van regionale 
wandbeweging ter evaluatie van de globale systolische en diastolische 
linker ventrikelfunctie (hoofdstuk 5 en 6); (c) de reproduceerbaarheid 
onderzocht van de beoordeling van wandbewegingsstoornissen en van de 
Doppler metingen betreffende de vullingsfase van de linker ventrikel 
(hoofdstuk 7 en 8); en (d) de veranderingen beoordeeld, v~~r en na 
PTCA, van het electrocardiogram, de regionale wandbewegingen en de 
Doppler metingen van de mitralis- en aortaflow gedurende de 
dobutamine stress test (hoofdstuk 4 en 5). 
De in dit proefschrift beschreven resultaten bevestigen de 
superioriteit van de door dobutamine geinduceerde wandbewegings-
stoornissen als teken van myocard ischemie boven ECG veranderingen 
of angina pectoris. Toevoeging van atropine aan stress echocar-
diografisch onderzoek verhoogt de gevoeligheid van de test voor het 
opsporen van coronarialijden zonder verlies van specificiteit en zonder 
toename van bijwerkingen. Deze bevinding is met name van belang bij 
patienten, die nog anti-angineuze medicatie gebruiken, in het bijzonder 
B-blockers, tijdens een dobutamine stress test. 
Dobutamine-atropine stress echocardiografie blijkt eveneens van 
waarde voor het aantonen van de afname van induceerbare myocardi-
schemie kort na PTCA In het Thoraxcentrum wordt uitstekende 
reproduceerbaarheid verkregen van de dobutamine-atropine stress test. 
Hierdoor is de test een potentieel bruikbaar instrument voor het 
aantonen van progressie van coronarialijden. Bovendien kunnen de 
effecten van therapeutisch handelen bij deze patienten hiermee worden 
geevalueerd. 
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Het gebruik van Doppler metingen van de aorta flow snelbeid 
gedurende de dobutamine stress test, is niet waardevol gebleken voor 
het herkennen van individuele patienten met coronarialijden. Echter, de 
toevoeging van Doppler metingen van de linker ventrikelvulling ter 
plaatse van de mitraalklep, lijkt weI bruikbare informatie over het 
optreden van myocard ischemie te verschaffen. Dit is mogelijk een 
gevoeliger methode dan het vaststellen van regionale wandbewe-
gingsstoornissen. Bovendien lijkt Doppler onderzoek van de linker 
ventrikelvulling voor en na therapeutische procedures bruikbaar in het 
voorspellen van het succes van die procedure. Echter, indien een 
dergelijk Doppler onderzoek van de linker ventrikelvulling in de praktijk 
wordt toegepast, dienen drempelwaarden (gebaseerd op een aantal 
slagen) te worden bepaald, ten einde een referentie te hebben om in het 
individuele geval significante veranderingen tussen uitgangswaarde en 
maximale belasting op te kunnen sporen. 
Alhoewel de dobutamine stress test zich op een grote populariteit in 
de kliniek kan verheugen, is verder onderzoek nodig. Ten eerste is de 
interobserver variabiliteit, betreffende de interpretatie van de test tussen 
verschillende centra niet onderzocht. Dergelijke studies zouden de 
betrouwbaarheid van de test kunnen verhogen. 
Ten tweede is er nog steeds een debat gaande omtrent de 
interpretatie van door dobutamine geinduceerde verslechtering van 
reeds in rust bestaande wandbewegingsstoomissen. Het is de vraag of 
akinesie / emstige hypokinesie, welke gedurende stress dyskinetisch wordt, 
beschouwd moe ten worden als myocardischemie of als een mechanisch 
fenomeen. Dit is een belangrijk klinisch probleem, welke nader 
onderzoek verlangt. 
Ten derde, eenvoudige en reproduceerbare methoden om linker 
ventrikel volumina of regionale wandverdikking te kwantificeren 
ontbreken. Kwantitatieve analyse zal in de toekomst eenvoudiger kunnen 
zijn en breder toepasbaar indien gebruik gemaakt wordt van recent 
ontwikkelde automatische contourdetectie, de beeldkwaliteit zoals 
verkregen met slokdarmechocardiografie en de technische 
ontwikkelingen op het gebied van driedimensionale reconstructie. 
Ondanks de beperkingen van de Doppler methode dient dobutarnine 
stress onderzoek zich niet te beperken tot het echocardiografisch 
beoordelen van wandbeweging, maar uitgebreid te worden met 
.hemodynarnische metingen van de systolische en diastolische linker 
ventrikel functie. 
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